[
  {
    "id": "qa_1",
    "question": "Under what conditions can either party assign their rights and obligations under this agreement?",
    "options": {
      "A": "Without consent if assigning to a successor of substantially all business assets.",
      "B": "Without consent if the agreement is executed in counterparts.",
      "C": "With consent only if the assignment is for less than half of the obligations.",
      "D": "With prior written consent from the other party."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Without consent if assigning to a successor of substantially all business assets.\n\nReasoning:\n\nThe documents provide specific conditions under which either party can assign their rights and obligations without the prior written consent of the other party. In the context provided, several documents mention that assignment is permissible without consent if it involves a successor in ownership of substantially all the assets of the business. For instance:\n\n1. Document [1] states: \"either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor in ownership of substantially all the assets of the business.\"\n\n2. Document [3] similarly allows assignment without prior written approval to a successor in ownership of substantially all the assets of the business.\n\n3. Document [5] also permits assignment without written consent to a corporation or other business entity succeeding to all or substantially all the assets and business of the assigning Party by merger or purchase, provided certain conditions are met.\n\nThese clauses collectively indicate that the assignment can occur without consent if it involves a successor of substantially all business assets, aligning with option A. Other options do not accurately reflect the conditions stated in the documents.",
    "latency_ms": 3487.36,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_2",
    "question": "What is the primary restriction on the use and disclosure of Confidential Information under the NDA between ATRIO Health Plans and the Receiving Party?",
    "options": {
      "A": "Confidential Information must be shared with all employees.",
      "B": "Confidential Information can only be used in relation to the Potential Transaction.",
      "C": "Confidential Information can be used for any business purpose.",
      "D": "Confidential Information can be disclosed to third parties without permission."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Confidential Information can only be used in relation to the Potential Transaction.\n\nReasoning:\n\nThe documents provided outline various restrictions and permissions regarding the use and disclosure of Confidential Information. While the specific NDA between ATRIO Health Plans and the Receiving Party is not directly quoted, the general principles from the documents can be applied to infer the likely restrictions.\n\n1. **Use of Confidential Information**: Across the documents, there is a consistent theme that Confidential Information should only be used for the purposes of the agreement or services being performed. For example, document [2] states, \"The Parties promise and hereby agree to hold the Confidential Information in strict confidence; to use Confidential Information only for the purposes of carrying out this Agreement.\"\n\n2. **Disclosure Restrictions**: Confidential Information is generally restricted from being disclosed to third parties without permission. Document [2] specifies, \"not to disclose Confidential Information to third parties without the other party\u2019s prior written approval.\"\n\n3. **Purpose Limitation**: Document [1] mentions that Confidential Information may be disclosed only to those within the organization who need access for the sole purpose of performing the Services, indicating a restriction to the specific context of the agreement.\n\nGiven these points, the primary restriction is that Confidential Information can only be used in relation to the specific purpose outlined in the agreement, which is likely the Potential Transaction between ATRIO Health Plans and the Receiving Party. This aligns with option B, as the use is limited to the context of the transaction or agreement, rather than any broader business purpose or unrestricted disclosure.",
    "latency_ms": 3064.62,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_5",
    "question": "What rights does the Business Associate Agreement (BAA) provide regarding individuals' protected health information?",
    "options": {
      "A": "The right to obtain a copy of information in an electronic format.",
      "B": "The right to terminate the agreement with immediate effect.",
      "C": "The right to receive compensation for disclosed information.",
      "D": "The right to audit and monitor financial transactions."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: The right to obtain a copy of information in an electronic format.\n\nReasoning:\n\nThe Business Associate Agreement (BAA) explicitly provides individuals with the right to obtain a copy of their information in an electronic format. This is clearly stated in the documents provided, where it mentions: \n\n\"a. Individuals' rights to obtain a copy of the individual's information in an electronic format.\"\n\nThis provision is part of the BAA's terms regarding the handling of protected health information, as outlined in the context. The other options (B, C, and D) are not supported by the text:\n\n- B: The right to terminate the agreement with immediate effect is not mentioned as a right provided by the BAA. Instead, the agreement may be terminated with thirty (30) days' prior written notice.\n- C: The right to receive compensation for disclosed information is not a provision of the BAA. In fact, the documents state that the Receiving Party shall not be obligated to compensate the Disclosing Party for Confidential Information.\n- D: The right to audit and monitor financial transactions is not mentioned. The BAA provides the right to audit and monitor activities involving protected health information, not financial transactions.",
    "latency_ms": 3877.72,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_6",
    "question": "What is the non-competition clause in the agreement?",
    "options": {
      "A": "Licensee cannot develop similar products during the term and one year after termination.",
      "B": "Licensee cannot publicly disclose the commercial relationship with Licensor.",
      "C": "Licensee can hire third parties to develop similar products during the agreement.",
      "D": "Licensee can develop similar products immediately after termination."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Licensee cannot develop similar products during the term and one year after termination.\n\nReasoning:\n\nThe non-competition clause in the agreement explicitly states that \"Licensee agrees that during the term of this Agreement and for a term of one year subsequent to the termination of this Agreement, Licensee shall not develop or sell a product, or hire any third party to develop a product, with the same or substantially similar functionality to the Licensed Program\" (Context [1]). This clause clearly restricts the Licensee from engaging in activities that would compete with the Licensed Program both during the agreement and for one year after its termination. \n\nThe other options do not accurately reflect the non-competition clause as described in the documents:\n- Option B is incorrect because it refers to the confidentiality and marketing permissions, not non-competition.\n- Option C is incorrect because the clause specifically prohibits hiring third parties to develop similar products.\n- Option D is incorrect because the restriction extends for one year after termination, not allowing immediate development of similar products post-termination.",
    "latency_ms": 2579.26,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_7",
    "question": "What is required before Cotiviti can use offshore subcontractors or employees to access PHI?",
    "options": {
      "A": "Cotiviti must receive client approval",
      "B": "Cotiviti must notify the client 30 days in advance",
      "C": "No approval is necessary",
      "D": "Cotiviti must provide detailed records of access"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Cotiviti must receive client approval\n\nReasoning:\n\nThe context explicitly states that Cotiviti must receive client approval before offshore vendors, subcontractors, or employees can access protected health information (PHI). This is outlined in the following clause from the document:\n\n\"Client must approve all offshore vendors, subcontractors or employee access to PHI.\"\n\nThis requirement is clear and indicates that client approval is necessary for any offshore access to PHI, making option A the correct answer. The document does not mention that Cotiviti must notify the client 30 days in advance specifically for PHI access, nor does it require detailed records of access or state that no approval is necessary.",
    "latency_ms": 1512.89,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_8",
    "question": "Which type of incident does NOT require Response and Reporting measures according to section 1.1.9?",
    "options": {
      "A": "Service attacks that do not result in a server being taken offline",
      "B": "Introduction of malware that does not result in unauthorized access",
      "C": "Unauthorized acquisition of BSC Data",
      "D": "Invalid password attempts"
    },
    "correct_answer": "A",
    "predicted_answer": "C",
    "is_correct": false,
    "response": "The correct answer is C: Unauthorized acquisition of BSC Data.\n\nExplanation:\n\nAccording to section 1.1.9, the Response and Reporting measures do not apply to incidents that do not result in the actual, unauthorized acquisition, access, use, or disclosure of BSC Data. The section specifically lists examples of incidents that do not require these measures, including:\n\n- \"pings\" on an information system firewall\n- port scans\n- attempts to log on to an information system or enter a database with an invalid password or user name\n- service attacks that do not result in a server being taken offline\n- introduction of malware (e.g., a worm or virus) that does not or is not likely to result in unauthorized access, use, disclosure, modification, or destruction of BSC Data\n\nTherefore, incidents like service attacks that do not result in a server being taken offline (Option A), introduction of malware that does not result in unauthorized access (Option B), and invalid password attempts (Option D) are explicitly mentioned as not requiring Response and Reporting measures. However, unauthorized acquisition of BSC Data (Option C) is precisely the type of incident that would trigger the need for such measures, as it involves the actual unauthorized acquisition of data, which is contrary to the exclusions listed in section 1.1.9.",
    "latency_ms": 2341.76,
    "client": "Blue Shield of California",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_9",
    "question": "Under what circumstances is the Business Associate allowed to receive remuneration in exchange for PHI?",
    "options": {
      "A": "Without any restrictions.",
      "B": "Only for marketing purposes.",
      "C": "Only with prior written consent of MPHC and as permitted by the HITECH Act.",
      "D": "For payment related to health care operations regardless of consent."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Only with prior written consent of MPHC and as permitted by the HITECH Act.\n\nThe documents explicitly state that the Business Associate \"shall not receive remuneration directly or indirectly in exchange for PHI, except with the prior written consent of MPHC and as permitted by the HITECH Act.\" This indicates that any exchange of PHI for remuneration is strictly controlled and requires both the consent of MPHC and compliance with the HITECH Act. Therefore, option C is the correct answer.",
    "latency_ms": 1566.38,
    "client": "Martin's Point Health Care",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_10",
    "question": "Under the MSA, which circumstance requires Cotiviti to indemnify ACA Health Benefits Fund?",
    "options": {
      "A": "Non-payment of Fees by Client",
      "B": "Failure to maintain Required Insurance",
      "C": "Consequential Loss caused by Cotiviti",
      "D": "Wilful Misconduct or Gross Negligence by Cotiviti"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The context provided does not explicitly mention ACA Health Benefits Fund or the specific circumstances under which Cotiviti is required to indemnify ACA Health Benefits Fund. However, we can analyze the indemnification clauses related to Cotiviti's obligations to clients in general.\n\nFrom the documents:\n\n1. Document [2] outlines Cotiviti's indemnification obligations, stating that Cotiviti shall defend the client against third-party claims and indemnify the client for losses arising from claims alleging infringement or violation of U.S. patents or copyrights by Cotiviti's software, applications, or services. This does not directly address ACA Health Benefits Fund or the specific circumstances listed in the options.\n\n2. Document [5] mentions Cotiviti's liability for fines or penalties imposed against Humana due to Cotiviti's breach of the Business Associate Agreement, but again, this does not directly relate to ACA Health Benefits Fund or the options provided.\n\nGiven the options:\n\nA: Non-payment of Fees by Client - There is no mention of indemnification related to non-payment of fees by the client.\n\nB: Failure to maintain Required Insurance - Document [5] discusses insurance requirements but does not link failure to maintain insurance with indemnification obligations.\n\nC: Consequential Loss caused by Cotiviti - There is no explicit mention of indemnification for consequential loss caused by Cotiviti.\n\nD: Wilful Misconduct or Gross Negligence by Cotiviti - The documents do not explicitly state indemnification for wilful misconduct or gross negligence, but this is a common basis for indemnification in many agreements.\n\nBased on typical indemnification clauses and the absence of specific information in the provided context, the most likely circumstance requiring Cotiviti to indemnify a client, such as ACA Health Benefits Fund, would be related to D: Wilful Misconduct or Gross Negligence by Cotiviti. This is a standard provision in many agreements, although it is not explicitly stated in the provided documents.\n\nTherefore, the correct answer is D: Wilful Misconduct or Gross Negligence by Cotiviti, based on common indemnification practices, despite the lack of explicit mention in the provided context.",
    "latency_ms": 4168.47,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_11",
    "question": "What is required of the Receiving Party upon termination of the agreement concerning Confidential Information?",
    "options": {
      "A": "Transfer all Confidential Information to a third-party for safekeeping.",
      "B": "Destroy or deliver all Confidential Information to the Disclosing Party, except for a single archival copy.",
      "C": "Return all Confidential Information without retaining any copies.",
      "D": "Retain all electronic and digital copies of Confidential Information indefinitely."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Destroy or deliver all Confidential Information to the Disclosing Party, except for a single archival copy.\n\nReasoning:\n\nThe documents provide clear guidance on the actions required of the Receiving Party upon termination of the agreement concerning Confidential Information. Specifically, document [1] states:\n\n- \"The Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\nThis clause explicitly allows the Receiving Party to retain a single archival copy for dispute resolution purposes, while requiring the destruction or delivery of all other copies of Confidential Information to the Disclosing Party. \n\nAdditionally, document [2] mentions:\n\n- \"At the request and option of the disclosing Party, the receiving Party(ies) agrees to promptly: (i) return the Confidential Information of the disclosing Party to the disclosing Party; or (ii) destroy or erase...and provide certification within 14 days that all such Confidential Information has been destroyed or erased.\"\n\nThis further supports the requirement to either return or destroy the Confidential Information, with certification of destruction.\n\nTherefore, option B accurately reflects the requirements stated in the documents. Options A, C, and D are incorrect as they do not align with the explicit instructions provided in the documents.",
    "latency_ms": 3174.89,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_12",
    "question": "Which clause describes the effect of a force majeure event on the Licensor\u2019s performance?",
    "options": {
      "A": "Licensor\u2019s performance is terminated and considered a default",
      "B": "Licensor must renegotiate terms with Licensee",
      "C": "Licensor\u2019s performance is excused and the time for performance is extended",
      "D": "Licensor must continue performance without delay"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Licensor\u2019s performance is excused and the time for performance is extended.\n\nReasoning:\n\nThe clause describing the effect of a force majeure event on the Licensor\u2019s performance is found in the context provided in [1]. It states: \"In the event that Licensor\u2019s performance is delayed, prevented, obstructed or inhibited because of any Act of God, fire, casualty, delay or disruption in transportation, flood, war, strike, lockout, epidemic, destruction or shut-down of production facilities, shortage or curtailment, riot, insurrection, governmental acts or directives, or any other cause beyond the reasonable control of Licensor, including financial requirements or manufacturing limitations imposed by third-party manufacturers, suppliers, or vendors, Licensor may give notice to Licensee, via Email or in writing, and thereupon Licensor\u2019s performance shall be excused and the time for the performance shall be extended for the period of delay or inability to perform resulting from such occurrence.\"\n\nThis clause clearly indicates that in the event of a force majeure, the Licensor's performance is excused, and the time for performance is extended, which aligns with option C. The clause also specifies that such an event does not constitute grounds for default under the Agreement, further supporting that option A is incorrect. There is no mention of renegotiating terms (option B) or continuing performance without delay (option D).",
    "latency_ms": 3223.86,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_14",
    "question": "What does the agreement state regarding the creation of formal business relationships between the parties?",
    "options": {
      "A": "There is no obligation to enter into a formal business organization.",
      "B": "The parties must share profits and liabilities.",
      "C": "The parties are bound to enter into a partnership.",
      "D": "The agreement establishes a joint venture."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: There is no obligation to enter into a formal business organization.\n\nExplanation:\n\nThe agreements explicitly state that there is no obligation to enter into a formal business organization between the parties. Specifically, in document [1], it is mentioned: \"This Agreement is not intended to be a joint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into any further agreement with the other Party.\" This clause clearly indicates that the agreement does not create any formal business relationship such as a joint venture or partnership, nor does it obligate the parties to enter into such relationships.\n\nAdditionally, document [2] reinforces this by stating: \"This Agreement (a) does not create any agency, partnership or joint venture,\" further confirming that the agreement does not establish any formal business relationship between the parties.\n\nTherefore, option A is the correct answer as the agreements explicitly state that there is no obligation to enter into a formal business organization.",
    "latency_ms": 3044.69,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_15",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon written request from the Disclosing Party?",
    "options": {
      "A": "Retain all copies for future reference",
      "B": "Deliver all copies to the Disclosing Party",
      "C": "Distribute copies to relevant departments for processing",
      "D": "Destroy all documents and materials except a single archival copy for legal purposes"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Destroy all documents and materials except a single archival copy for legal purposes\n\nReasoning:\n\nThe documents provide specific guidance on the actions the Receiving Party must take regarding Confidential Information upon termination of the Agreement or upon a written request from the Disclosing Party. \n\n1. Document [1] states that the Receiving Party must \"destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\" This indicates that the Receiving Party is required to destroy all copies except for one archival copy.\n\n2. Document [2] allows the Receiving Party to retain one copy of Confidential Information for regulatory compliance or verification purposes, provided it is held in secure storage and kept confidential.\n\n3. Document [3] similarly requires the destruction of all Confidential Information, with exceptions for automatically generated computer backups, which must be kept confidential.\n\n4. Document [5] requires the Receiving Party to return or destroy all Confidential Information within thirty days of a written request, with exceptions for information that falls into the public domain or is rightfully received from a third party.\n\nOverall, the consistent requirement across these documents is the destruction of Confidential Information, with the allowance for retaining a single archival copy for specific legal or compliance purposes. Therefore, option D is the correct answer.",
    "latency_ms": 2932.99,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_16",
    "question": "What remedy is available to the Disclosing Party for a breach of the agreement?",
    "options": {
      "A": "Termination of the agreement",
      "B": "Money damages only",
      "C": "Arbitration",
      "D": "Specific performance and/or injunctive relief"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Specific performance and/or injunctive relief\n\nReasoning:\n\nThe documents consistently state that the Disclosing Party is entitled to specific performance and/or injunctive relief as a remedy for a breach of the agreement. This is explicitly mentioned in multiple sections across the provided context:\n\n1. In document [1], it states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\"\n\n2. Document [2] similarly states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\"\n\n3. Document [3] mentions: \"The disclosing Party shall be entitled, in that case, to temporary, preliminary and/or injunctive relief, or any other equitable remedy deemed appropriate by the reviewing court, to protect its interests in its Confidential Information.\"\n\n4. Document [4] and [5] both affirm: \"Disclosing Party may seek injunctive relief or other equitable relief to restrain a breach or threatened breach of this Agreement or to specifically enforce this Agreement, without proving that any monetary damages have been sustained.\"\n\nThese consistent references across the documents indicate that specific performance and/or injunctive relief is a recognized remedy for breaches, emphasizing the inadequacy of money damages alone and the necessity of equitable relief to protect the Disclosing Party's interests. Therefore, option D is the correct answer.",
    "latency_ms": 2944.13,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_17",
    "question": "What actions must be taken if a party becomes aware of a data breach according to the MSA?",
    "options": {
      "A": "Notify the regulatory authorities immediately and cease communication with the other party.",
      "B": "Delay notifying the other party until a full investigation is complete.",
      "C": "Promptly notify the other party and meet to discuss the next steps regarding investigation and handling of the breach.",
      "D": "Promptly notify the other party and then handle the breach independently."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Promptly notify the other party and meet to discuss the next steps regarding investigation and handling of the breach.\n\nReasoning:\n\nAccording to the MSA document [1], Section 7.8 outlines the actions required when either party becomes aware of an actual or suspected data breach. The specific steps are as follows:\n\n- **Prompt Notification**: The party that becomes aware of the data breach must promptly notify the other party of the breach, referred to as a \"Data Breach Notice\" (Clause 7.8(a)).\n  \n- **Meeting to Discuss Next Steps**: The parties are required to meet as soon as practicable to discuss in good faith the appropriate next steps regarding the investigation and handling of the data breach. This includes discussing the parties' respective responsibilities and mandatory requirements for data breach notification in accordance with the Privacy Act (Clause 7.8(b)).\n\n- **Reasonable Assistance**: Each party must provide all reasonable assistance to the other to ensure compliance with obligations under the Privacy Act (Clause 7.8(c)).\n\nThese clauses clearly indicate that the correct course of action is to promptly notify the other party and collaboratively discuss and handle the breach, making option C the correct answer.",
    "latency_ms": 2511.99,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_18",
    "question": "Under the NDA, when do the obligations regarding Confidential Information cease to apply?",
    "options": {
      "A": "When the receiving party independently develops the information without reference to the Confidential Information",
      "B": "When the receiving party sells the information to a competitor",
      "C": "When the information is disclosed to a third party",
      "D": "When the receiving party uses the information for its own purposes"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: When the receiving party independently develops the information without reference to the Confidential Information.\n\nReasoning:\n\nThe documents provide specific clauses that outline when information is not considered confidential and when the obligations regarding Confidential Information cease to apply. Across multiple documents, it is consistently stated that Confidential Information does not include information that was independently developed by the receiving party without any use of the disclosing party's Confidential Information. \n\nFor instance, in document [2], it states: \"Confidential Information shall exclude information that: (a) was independently developed by the Receiving Party without any use of the Disclosing Party\u2019s Confidential Information or by the Receiving Party\u2019s employees or other agents (or independent contractors hired by the Receiving Party) who have not been exposed to the Disclosing Party\u2019s Confidential Information.\"\n\nSimilarly, document [3] mentions: \"the term 'Confidential Information' shall not include, and the Receiving Party\u2019s obligations herein, shall not extend to, information that the Receiving Party can demonstrate (ii) was or is independently developed by the Receiving Party without use of Confidential Information.\"\n\nThese clauses clearly indicate that the obligations regarding Confidential Information cease to apply when the receiving party independently develops the information without reference to the Confidential Information. \n\nOptions B, C, and D do not align with the clauses provided in the documents. Selling the information to a competitor (B), disclosing it to a third party (C), or using it for its own purposes (D) are not mentioned as conditions under which the obligations cease. In fact, these actions could potentially violate the confidentiality obligations unless specific exceptions apply, such as legal disclosures or prior written consent from the disclosing party.",
    "latency_ms": 3122.16,
    "client": "Advise Insurance",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_19",
    "question": "What is the permitted use of Confidential Information under the NDA?",
    "options": {
      "A": "To reverse engineer prototypes to improve own products.",
      "B": "To disclose to third parties for marketing purposes.",
      "C": "To evaluate a business relationship with the disclosing party.",
      "D": "To develop new products independently."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: To evaluate a business relationship with the disclosing party.\n\nExplanation:\n\nThe permitted use of Confidential Information under the NDA is primarily to further the purpose of the agreement and the performance thereof. This is evident from the context provided in document [2], which states that the Parties agree to use Confidential Information only for the purposes of carrying out the Agreement. Specifically, document [2] mentions: \"to use Confidential Information only for the purposes of carrying out this Agreement.\"\n\nAdditionally, document [5] outlines that Confidential Information includes information related to potential transactions, business and marketing plans, strategies, and programs, which are typically evaluated in the context of a business relationship. The NDA does not permit reverse engineering, disclosure to third parties for marketing purposes, or independent development of new products using the Confidential Information, as these actions would violate the confidentiality obligations outlined in the documents.\n\nTherefore, the correct answer is C, as the NDA allows the use of Confidential Information to evaluate a business relationship with the disclosing party, aligning with the purpose of the agreement.",
    "latency_ms": 2076.62,
    "client": "Advise Insurance",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_20",
    "question": "What is included in the Technical Specification Document according to the Work Order / Change Request?",
    "options": {
      "A": "Only Roles and Responsibilities",
      "B": "System Access Requirements and Data Mapping Requirements",
      "C": "Functional and Technical Design Requirements such as Scope and Business Parameters",
      "D": "B and C are both included"
    },
    "correct_answer": "D",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The context provided does not explicitly mention a \"Technical Specification Document\" or a \"Work Order / Change Request\" that outlines specific contents such as Roles and Responsibilities, System Access Requirements, Data Mapping Requirements, or Functional and Technical Design Requirements. Therefore, it is not possible to determine what is included in the Technical Specification Document according to the Work Order / Change Request based on the given information.\n\nThe documents provided discuss various contractual obligations, audit requirements, data retention policies, and service provisions, but they do not detail the contents of a Technical Specification Document or a Work Order / Change Request. As such, none of the options (A, B, C, or D) can be selected based on the information available.\n\nTo answer the question accurately, additional context or specific sections of the contract that address the Technical Specification Document or Work Order / Change Request would be necessary.",
    "latency_ms": 2107.23,
    "client": "1199 SEIU National Benefit Funds",
    "document_type": "Work Order / Change Request",
    "method": "RAG"
  },
  {
    "id": "qa_21",
    "question": "What is the duration of the confidentiality obligations after the expiration or termination of the agreement?",
    "options": {
      "A": "1 year after the Effective Date",
      "B": "3 years after the Effective Date",
      "C": "Until the agreement is terminated",
      "D": "2 years after the Effective Date"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: 3 years after the Effective Date.\n\nReasoning:\n\nThe context provided includes multiple documents with varying terms regarding confidentiality obligations. Specifically, document [3] states: \"Notwithstanding the termination of this Agreement, any negotiations, discussions or possible transaction between the parties, the parties mutually agree that the obligations contained herein will survive for a period of three (3) years after the Termination Date.\" This clause explicitly mentions that the confidentiality obligations will continue for three years after the termination of the agreement.\n\nWhile other documents mention different durations for confidentiality obligations, such as five years in document [1] and [4], the question specifically asks for the duration after the expiration or termination of the agreement, which is clearly stated as three years in document [3]. Therefore, the correct answer is B.",
    "latency_ms": 2216.77,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_22",
    "question": "What is permitted regarding the use of Confidential Information according to the agreement?",
    "options": {
      "A": "Using it in competitive products without restrictions",
      "B": "Using it for product development without restrictions",
      "C": "Sharing it freely with all employees",
      "D": "Using it for any third party\u2019s benefit with prior written approval"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Using it for any third party\u2019s benefit with prior written approval\n\nExplanation:\n\nThe documents provide specific guidance on the use of Confidential Information, emphasizing restrictions and permissions. According to the agreements analyzed:\n\n1. Confidential Information must be held in strict confidence and used only for the purposes of carrying out the agreement (Document [1], Clause C).\n2. The use of Confidential Information is restricted to the purpose set forth in the agreement, and it cannot be used for competitive products or services (Document [4], Clause (c)).\n3. Confidential Information cannot be used for a party's own or any third party's benefit without the prior written approval of an authorized representative of the other party (Document [4], Clause (d)).\n\nThese clauses collectively indicate that while there are strict limitations on the use of Confidential Information, there is a provision for using it for a third party's benefit, but only with prior written approval. This aligns with option D, which specifies that such use requires prior written approval, making it the correct answer.",
    "latency_ms": 1919.14,
    "client": "Arthur J Gallagher & Co.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_23",
    "question": "What does the Miscellaneous section of the MSA state regarding reliance on representations?",
    "options": {
      "A": "Parties can rely on written representations made after the Agreement.",
      "B": "Parties can rely on inducements from third parties.",
      "C": "Parties cannot rely on any representations outside of those expressly contained within the Agreement.",
      "D": "Parties can rely on oral representations made before the Agreement."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Parties cannot rely on any representations outside of those expressly contained within the Agreement.\n\nReasoning: The Miscellaneous section of the MSA explicitly states that each party acknowledges entering into the Agreement solely based on the agreements and representations contained within the document itself. It further clarifies that parties have not relied upon any representations, warranties, promises, or inducements of any kind, whether oral or written, from any source other than those expressly contained within the Agreement. This indicates that reliance is limited to the contents of the Agreement, excluding any external representations.",
    "latency_ms": 1339.62,
    "client": "Accenture",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_24",
    "question": "What restrictions are placed on the use of Confidential Information according to the NDA with 7-Eleven?",
    "options": {
      "A": "It must only be used for evaluating the Potential Transaction and cannot be disclosed without prior written consent.",
      "B": "It can only be used for marketing purposes related to the Potential Transaction.",
      "C": "It can be used for any commercial purpose as long as it remains confidential.",
      "D": "It can be shared with any third party if they agree to confidentiality."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: It must only be used for evaluating the Potential Transaction and cannot be disclosed without prior written consent.\n\nReasoning:\n\nThe NDA between 7-Eleven and the Vendor explicitly outlines the restrictions on the use of Confidential Information. According to the document, the Confidential Information is shared in connection with the evaluation of one or more potential transactions between 7-Eleven or one of its affiliates and the Vendor. The document states that each Party, as a Disclosing Party, is furnishing the other Party, as a Nondisclosing Party, with certain Confidential Information that is either not public or is confidential or proprietary in nature (see [2]).\n\nFurthermore, the NDA requires that each Party will return all Confidential Information to the Disclosing Party and destroy all related materials upon termination of the agreement, except for one archival copy retained by legal counsel (see [3]). This indicates that the use of the information is restricted to the purposes outlined in the agreement, specifically the evaluation of the Potential Transaction, and cannot be disclosed without prior written consent.\n\nThe document does not mention any permissions for using the information for marketing purposes, sharing it with third parties without consent, or using it for any commercial purpose beyond the scope of the Potential Transaction. Therefore, option A is the correct choice.",
    "latency_ms": 3306.1,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_26",
    "question": "What does the NDA specify about the ownership of Confidential Information?",
    "options": {
      "A": "Confidential Information becomes joint property of both parties.",
      "B": "Ownership of Confidential Information is transferred to the Receiving Party.",
      "C": "The Receiving Party gains partial ownership of the Confidential Information.",
      "D": "Confidential Information remains the sole property of the Disclosing Party."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Confidential Information remains the sole property of the Disclosing Party.\n\nReasoning: The documents consistently specify that the ownership of Confidential Information remains with the Disclosing Party. For instance, in document [1], it states, \"All ownership rights in the Confidential Information shall remain with the Disclosing Party providing the Confidential Information.\" Similarly, document [3] mentions, \"Confidential Information shall remain the sole and exclusive property of the Disclosing Party.\" Document [4] also reinforces this by stating, \"The Confidential Information is the sole property of the Disclosing Party.\" Lastly, document [5] confirms, \"The Confidential Information is the sole property of the Disclosing Party.\" These clauses clearly indicate that the Receiving Party does not gain any ownership rights, title, or license to the Confidential Information, thus supporting option D.",
    "latency_ms": 2231.23,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_27",
    "question": "What actions must the contractor take when receiving a request for access or amendment of PHI?",
    "options": {
      "A": "Amend the PHI directly without involving HHS.",
      "B": "Promptly forward the request to HHS or notify HHS if forwarding violates HIPAA.",
      "C": "Immediately respond to the request without notifying HHS.",
      "D": "Forward the request to the individual who made it."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Promptly forward the request to HHS or notify HHS if forwarding violates HIPAA.\n\nReasoning:\n\nThe documents explicitly state the contractor's obligations regarding requests for access or amendment of PHI. According to both documents [1] and [2], the contractor must:\n\n- \"If Contractor receives a request for access, amendment or accounting of PHI by any individual, promptly forward the request to HHS or, if forwarding the request would violate HIPAA, promptly notify HHS of the request and of Contractor\u2019s response.\"\n\nThis clause clearly outlines that the contractor is required to either forward the request to HHS or notify HHS if forwarding the request would violate HIPAA. The contractor is not authorized to amend the PHI directly without involving HHS, nor is it permitted to respond to the request without notifying HHS. Additionally, forwarding the request to the individual who made it is not mentioned as an option in the documents. Therefore, option B is the correct action the contractor must take.",
    "latency_ms": 2390.92,
    "client": "Accenture",
    "document_type": "DUA",
    "method": "RAG"
  },
  {
    "id": "qa_28",
    "question": "Under what circumstances can Community First request Business Associate to use or disclose PHI?",
    "options": {
      "A": "In any manner deemed necessary by Community First",
      "B": "In any manner that enhances business operations",
      "C": "Only in ways permissible under the Privacy Rule",
      "D": "Only for marketing purposes"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Only in ways permissible under the Privacy Rule.\n\nReasoning:\n\nThe document explicitly states that \"Community First shall not request Business Associate to use or disclose PHI in any manner that would not be permissible under the Privacy Rule, the Security Rule, HITECH or any other applicable law or regulation if done by Community First.\" This clause clearly restricts Community First to only request uses or disclosures of PHI that are compliant with the Privacy Rule and other relevant regulations. Therefore, the request must align with legal and regulatory standards, not just any manner deemed necessary or beneficial for business operations or marketing purposes.",
    "latency_ms": 1860.08,
    "client": "Community First Health Plans",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_29",
    "question": "What rights does the Business Associate have regarding the ownership of PHI?",
    "options": {
      "A": "The Business Associate shares ownership rights of PHI with MPHC",
      "B": "The Business Associate can acquire ownership rights to PHI after fulfilling obligations",
      "C": "The Business Associate has full ownership rights to PHI",
      "D": "The Business Associate has no ownership rights to PHI"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: The Business Associate has no ownership rights to PHI.\n\nReasoning:\nThe documents explicitly state that the PHI and any related information created for or received from MPHC is, and will remain, the property of MPHC. The Business Associate agrees that it acquired no ownership rights to or title in PHI or any related information. This is clearly outlined in the clause from document [1]: \"The PHI and any related information created for or received from MPHC is, and will remain, the property of MPHC, including any and all forms thereof developed by Business Associate in the course of fulfilling its obligations pursuant to this Agreement. Business Associate agrees that it acquired no ownership rights to or title in PHI or any related information.\" Therefore, the correct answer is D, as the Business Associate does not have any ownership rights to PHI.",
    "latency_ms": 1841.93,
    "client": "Martin's Point Health Care",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_30",
    "question": "What is the requirement for data destruction of ACS PHI or PI according to Accenture's BAA?",
    "options": {
      "A": "Data must be wiped using the US Department of Defense (DoD) 5220.22-M standard only.",
      "B": "Data must be wiped using the Gutmann standard or US Department of Defense (DoD) 5220.22-M (7 Pass) standard, or by degaussing.",
      "C": "Data must be stored indefinitely without destruction.",
      "D": "Data can be destroyed using any method without prior approval."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Data must be wiped using the Gutmann standard or US Department of Defense (DoD) 5220.22-M (7 Pass) standard, or by degaussing.\n\nReasoning:\n\nThe documents provide specific guidance on the standards for \"proper sanitization\" and destruction of data. According to the context provided in documents [1] and [2], \"proper sanitization\" involves using a digital sanitization tool that conforms with standards such as DoD 5220.22-M, The Gutmann Wipe, or Pseudo Number Random Generator (PRNG) Stream with eight passes. Additionally, \"destroyed\" is defined as degaussing using a device properly rated for such type of media or complete physical destruction of the media such as crushing, shredding, or grinding.\n\nWhile the specific mention of ACS PHI or PI destruction methods is not directly quoted in the context, the standards mentioned align with the requirements for secure data destruction, which typically include the Gutmann and DoD standards. Therefore, option B is the most accurate choice based on the provided information. \n\nOptions A, C, and D are incorrect because:\n- Option A limits the method to only the DoD 5220.22-M standard, which is not the only method mentioned.\n- Option C suggests indefinite storage without destruction, which contradicts the requirement for data destruction.\n- Option D implies any method can be used without approval, which is not supported by the specific standards and procedures outlined in the documents.",
    "latency_ms": 3085.35,
    "client": "Accenture",
    "document_type": "BAA",
    "method": "RAG"
  },
  {
    "id": "qa_31",
    "question": "According to the document, how often can audits be conducted to ensure compliance with Data Protection Laws?",
    "options": {
      "A": "Annually",
      "B": "Monthly",
      "C": "Biannually",
      "D": "Quarterly"
    },
    "correct_answer": "A",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The documents provided do not explicitly state the frequency at which audits can be conducted to ensure compliance with Data Protection Laws. However, there is actionable information regarding audits in document [4], which outlines the conditions under which BSC Audits can be conducted. Specifically, it mentions:\n\n- BSC Audits will be conducted during Consultant's customary business hours and upon at least fifteen (15) business days\u2019 written notice to Consultant, except in certain cases like audits by regulators, security incidents, or investigations of illegal behavior, where reasonable prior written notice will be given as legally permitted.\n\nThis implies that audits can be conducted as needed, based on the conditions outlined, rather than at a fixed frequency such as annually, monthly, biannually, or quarterly. Therefore, none of the options (A, B, C, or D) directly apply based on the information provided.\n\nAnswer: None of the options directly apply based on the information provided. The document does not specify a fixed frequency for audits related to Data Protection Laws.",
    "latency_ms": 3643.08,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_32",
    "question": "What is the duration of the Nondisclosing Party\u2019s obligations for Confidential Information that constitutes a trade secret under applicable law according to the NDA?",
    "options": {
      "A": "Three years after disclosure",
      "B": "Indefinitely regardless of trade secret status",
      "C": "For as long as the information remains a trade secret under applicable law",
      "D": "Until all agreements between the Parties are terminated"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: For as long as the information remains a trade secret under applicable law.\n\nReasoning:\n\nThe NDA explicitly states in [5] that \"for Confidential Information that constitutes a trade secret under applicable law, the Nondisclosing Party\u2019s obligations under this Agreement shall continue for so long as such information constitutes a trade secret under applicable law.\" This clause clearly indicates that the duration of the obligations is tied to the status of the information as a trade secret. As long as the information qualifies as a trade secret, the obligations remain in effect, which aligns with option C. \n\nOther options are incorrect based on the document:\n- Option A is incorrect because the three-year duration applies to general Confidential Information, not trade secrets.\n- Option B is incorrect because the obligations are not indefinite; they are contingent on the information's status as a trade secret.\n- Option D is incorrect because the termination of all agreements does not affect the duration of obligations related to trade secrets.",
    "latency_ms": 1957.54,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_33",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the agreement or upon request from the Disclosing Party?",
    "options": {
      "A": "Retain all documents and materials for future reference.",
      "B": "Destroy or deliver all documents and materials, except for a single archival copy retained by the legal department.",
      "C": "Store all documents and materials indefinitely on backup media.",
      "D": "Convert all documents and materials into non-confidential information."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Destroy or deliver all documents and materials, except for a single archival copy retained by the legal department.\n\nReasoning:\n\nThe documents provide clear guidance on the actions the Receiving Party must take regarding Confidential Information upon termination of the agreement or upon request from the Disclosing Party:\n\n1. Document [1] states: \"promptly following the earlier of (i) the termination of this Agreement, or (ii) the written request of Disclosing Party, the Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\n2. Document [3] similarly requires the Receiving Party to \"return to the other Party, or to destroy and to delete from any of its electronic storage devices, all Confidential Information received from the other, in whatever form.\"\n\n3. Document [4] specifies that the Receiving Party must \"destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives\" and confirm such destruction in writing, with exceptions for automatically generated computer back-up or archival copies.\n\nThese documents consistently indicate that the Receiving Party must destroy or deliver all Confidential Information, with the exception of retaining a single archival copy for specific purposes, such as dispute resolution or compliance verification. Therefore, option B is the correct choice based on the explicit requirements outlined in the documents.",
    "latency_ms": 2881.59,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_34",
    "question": "Under what conditions can a party assign its rights and obligations under this agreement without prior written consent from the other party?",
    "options": {
      "A": "Assignment is allowed if the successor in ownership expressly assumes the agreement terms in writing.",
      "B": "Assignment can occur freely without any conditions.",
      "C": "Assignment is never allowed without prior written consent.",
      "D": "Assignment is allowed only if both parties agree verbally."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Assignment is allowed if the successor in ownership expressly assumes the agreement terms in writing.\n\nReasoning:\n\nThe documents provide specific conditions under which a party can assign its rights and obligations without prior written consent from the other party. In document [1], it states that either party may assign its rights and obligations under the Agreement to a parent or Affiliate or in the event of a merger, sale of a business unit, or majority stock ownership, provided that the party assuming obligations agrees to do so in writing and has adequate resources to meet its obligations. This is a clear indication that the successor must expressly assume the agreement terms in writing.\n\nSimilarly, document [3] mentions that each party may assign the Agreement to a person or entity into which it has merged or which has otherwise succeeded to all or substantially all of its business and assets, provided that the successor has assumed in writing or by operation of law its obligations under the Agreement.\n\nDocument [5] also supports this by stating that either Party may assign its rights and obligations to a successor in ownership of substantially all the assets of the business without prior written approval, which implies that the successor must assume the obligations.\n\nTherefore, the consistent requirement across these documents is that the successor must expressly assume the agreement terms in writing, making option A the correct choice.",
    "latency_ms": 2469.9,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_35",
    "question": "What is required before a Provider can file a legal proceeding against Blue Cross and Blue Shield of Nebraska?",
    "options": {
      "A": "A peer-to-peer discussion involving the Provider, Client, and Cotiviti",
      "B": "Cotiviti providing testimony at State Fair Hearings",
      "C": "Immediate filing without any discussions",
      "D": "Approval of process documented via email"
    },
    "correct_answer": "A",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The documents provided do not explicitly state the requirements before a Provider can file a legal proceeding against Blue Cross and Blue Shield of Nebraska. Therefore, none of the options (A, B, C, or D) can be directly confirmed from the given context.\n\nHowever, based on the nature of the agreements and amendments discussed, it is common in such legal and business relationships to have some form of dispute resolution process or requirement for discussions before legal proceedings can be initiated. This might involve peer-to-peer discussions or other forms of negotiation or mediation, but this is not explicitly mentioned in the provided documents.\n\nThe documents primarily focus on confidentiality, nondisclosure, amendments to agreements, and terms related to service agreements and clinical chart validation. They do not provide specific guidance or clauses related to the initiation of legal proceedings by Providers against BCBSNE.\n\nTherefore, the correct answer cannot be determined from the provided context, and additional information or documentation would be needed to accurately answer the question.",
    "latency_ms": 1836.85,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_36",
    "question": "Under the agreement, how may the Receiving Party use the Disclosing Party's Confidential Information?",
    "options": {
      "A": "For personal use",
      "B": "Only for exercising rights and performing obligations related to the Potential Transaction",
      "C": "For disclosure to any Third Party without restriction",
      "D": "For any business purpose"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Only for exercising rights and performing obligations related to the Potential Transaction.\n\nReasoning:\n\nThe documents consistently state that the Receiving Party and its Representatives are restricted in their use of the Disclosing Party's Confidential Information. Specifically, the use of such information is limited to activities directly related to a transaction or a Potential Transaction with the Disclosing Party. This is explicitly mentioned in several clauses across the documents:\n\n1. Document [1] states that Confidential Information \"shall not be used by the Receiving Party or its Representatives in any way other than in connection with a transaction or a Potential Transaction with the other Party\" and \"shall be used solely for the purpose of evaluating, considering, or performing a Potential Transaction.\"\n\n2. Document [2] reiterates the same restrictions, emphasizing that the information \"shall be used solely for the purpose of evaluating, considering, or performing a Potential Transaction.\"\n\n3. Document [4] mirrors these restrictions, again stating that the information \"shall be used solely for the purpose of evaluating, considering, or performing a Potential Transaction.\"\n\n4. Document [5] further supports this by stating that Confidential Information should not be used for the Receiving Party's own benefit or for the benefit of any third parties, other than for the performance of the agreement.\n\nThese clauses collectively indicate that the use of Confidential Information is strictly limited to activities related to the Potential Transaction, thereby excluding options A, C, and D.",
    "latency_ms": 2711.93,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_37",
    "question": "What is required from Vendor and/or Consultant when accessing the benefit administration systems?",
    "options": {
      "A": "Use commercially reasonable security measures",
      "B": "Share their access with other entities",
      "C": "Ignore the Company\u2019s security measures",
      "D": "Transfer their access rights to another party"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Use commercially reasonable security measures.\n\nReasoning:\n\nThe document explicitly states that when Vendor and/or Consultant access the benefit administration systems, they are required to \"use commercially reasonable security measures.\" This includes measures to protect the confidentiality of user identification and passwords, as well as data accessed through the Systems from unauthorized access or damage, including damage by computer viruses. Additionally, Vendor and/or Consultant must comply with the Company's security measures as notified to them.\n\nThe document also imposes restrictions on sharing or transferring access rights. It states that the right to access the Systems is nonexclusive and nontransferable, and Vendor and Consultant shall not share, lease, or otherwise transfer their right to access and use the Systems to any other person or entity. Therefore, options B and D are incorrect.\n\nOption C is incorrect because the document requires compliance with the Company's security measures, not ignoring them. \n\nThus, the requirement is clearly stated as using commercially reasonable security measures, making option A the correct choice.",
    "latency_ms": 2309.13,
    "client": "Boston Benefit Partners",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_38",
    "question": "Under the MSA agreement, to whom may the Client disclose Confidential Information, and under what conditions?",
    "options": {
      "A": "To any third party without restrictions",
      "B": "To employees of Advantmed India LLP and Optum Health \u2013 CDO with specific conditions",
      "C": "Only to Optum Health \u2013 CDO with no conditions",
      "D": "To any subcontractors without any prior permissions"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: To employees of Advantmed India LLP and Optum Health \u2013 CDO with specific conditions.\n\nReasoning:\n\nUnder the MSA agreement, the Client is permitted to disclose Confidential Information to specific parties under certain conditions:\n\n1. **Advantmed India LLP Employees**: The Client may disclose Confidential Information to employees of its wholly-owned subsidiary, Advantmed India LLP, but only to the minimum extent necessary for the implementation and provision of services under Statement of Work #1 (SOW #1) for Risk Adjustment. Additionally, these employees must agree to restrictions no less stringent than those imposed on the Client regarding the use and disclosure of such Confidential Information.\n\n2. **Optum Health \u2013 CDO**: The Client may disclose specific information to the Optum Health \u2013 CDO business segment, but this is limited to:\n   - Periodic status reports for the services performed under SOW #1, strictly limited to the number of records retrieved by Cotiviti under SOW #1 at a given point in time.\n   - The minimum volume commitment under SOW #1.\n   - Fees set forth in SOW #1, provided that Optum Health \u2013 CDO agrees to hold such pricing in strict confidence within the business segment and agrees not to further disclose such pricing.\n\nThese conditions are explicitly stated in the document, and no other third-party disclosures are permitted without prior written permission from the Disclosing Party. Therefore, option B accurately reflects the specific conditions under which the Client may disclose Confidential Information.",
    "latency_ms": 3370.16,
    "client": "AdvantMed",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_39",
    "question": "What must occur when either party becomes aware of a data breach according to the MSA?",
    "options": {
      "A": "The party must promptly notify the other party and meet to discuss next steps.",
      "B": "The party must immediately fix the breach without notifying the other party.",
      "C": "The party must ensure all personnel are informed of the breach before notifying the other party.",
      "D": "The party must notify the regulatory authorities before informing the other party."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: The party must promptly notify the other party and meet to discuss next steps.\n\nReasoning:\n\nAccording to the MSA document [1], when either party becomes aware of any actual or suspected Data Breach, the following actions are required:\n\n- **Prompt Notification**: The party that becomes aware of the Data Breach must promptly notify the other party of the breach, as stated in clause 7.8(a): \"that party must promptly notify the other party of the Data Breach (Data Breach Notice).\"\n\n- **Meeting to Discuss Next Steps**: The parties are required to meet as soon as practicable to discuss in good faith appropriate next steps regarding the investigation and handling of the Data Breach, including their respective responsibilities, as outlined in clause 7.8(b): \"the parties will meet as soon as practicable discuss in good faith appropriate next steps regarding investigation and handling of the Data Breach, including the parties\u2019 respective responsibilities including, without limitation, mandatory requirements for data breach notification in accordance with the Privacy Act.\"\n\n- **Assistance for Compliance**: Each party must provide all reasonable assistance to the other to ensure compliance with obligations under the Privacy Act, as mentioned in clause 7.8(c): \"each party must provide all reasonable assistance to the other to ensure each party is in compliance with its obligations under the Privacy Act.\"\n\nThese requirements clearly indicate that the correct course of action is option A, where the party must promptly notify the other party and meet to discuss next steps. Options B, C, and D do not align with the specified requirements in the MSA document.",
    "latency_ms": 3377.65,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_40",
    "question": "What is the requirement for Business Associate when receiving a request, subpoena, or order to disclose PHI?",
    "options": {
      "A": "Business Associate must notify Covered Entity within 30 days.",
      "B": "Business Associate must notify Covered Entity within 5 days.",
      "C": "Business Associate must challenge the validity independently.",
      "D": "Business Associate must comply immediately without notification."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: Business Associate must notify Covered Entity within 5 days.\n\nThe documents explicitly state that the Business Associate is required to notify the Covered Entity within five (5) days of receiving any request, subpoena, or judicial or administrative order to disclose PHI. This requirement is outlined in multiple sections, including [2] and [4], which both mention the five-day notification period. Additionally, the Business Associate is expected to cooperate with the Covered Entity if the Covered Entity decides to challenge the validity of such requests, subpoenas, or orders. This cooperation indicates that the Business Associate should not act independently in challenging the validity but rather work in conjunction with the Covered Entity.",
    "latency_ms": 1900.23,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_42",
    "question": "What is the Receiving Party required to do with the Confidential Information upon request by the Disclosing Party?",
    "options": {
      "A": "Retain all Confidential Information but cease its use.",
      "B": "Destroy all Confidential Information except automatically generated backups.",
      "C": "Destroy all copies, including automatically generated backups.",
      "D": "Continue using Confidential Information but with increased security measures."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Destroy all Confidential Information except automatically generated backups.\n\nReasoning:\n\nThe documents provide clear guidance on the actions required by the Receiving Party upon request by the Disclosing Party regarding the handling of Confidential Information:\n\n1. **Document [2] and [5]** state: \"At any time upon the request of the Disclosing Party, the Receiving Party shall promptly (and in no event later than five business days after such request) (i) destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing Party, provided, however, that the obligation to destroy such Confidential Information does not extend to automatically generated computer back-up or archival copies generated in the ordinary course of Receiving Party\u2019s information systems procedures.\"\n\n2. **Document [1]** also mentions that electronic copies stored in computer system backups that cannot reasonably be isolated for deletion need not be returned or destroyed, provided that access to the system backup is restricted and the Confidential Information is held in confidence.\n\nThese clauses explicitly state that while the Receiving Party is required to destroy all Confidential Information upon request, this obligation does not extend to automatically generated backups. The Receiving Party must ensure that no further use is made of these backups and must continue to protect them under the terms of the agreement. Therefore, option B is the correct choice.",
    "latency_ms": 2911.69,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_43",
    "question": "What rights are included in the Business Associate Agreement regarding individuals' protected health information?",
    "options": {
      "A": "The right to obtain PHI in a paper format only",
      "B": "The right to audit and monitor activities involving PHI",
      "C": "The right to prevent any disclosure of PHI",
      "D": "The right to delete personal information permanently"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: The right to audit and monitor activities involving PHI.\n\nReasoning:\n\nThe Business Associate Agreement (BAA) includes provisions that require the Business Associate to document and make available disclosures of PHI. Specifically, [3] states that the Business Associate must document and provide information necessary to respond to a request for an accounting of disclosures of PHI in accordance with HIPAA, the HITECH Act, and implementing regulations. This includes details such as the date of disclosure, the name and address of the entity or person who received the PHI, a brief description of the PHI disclosed, and a brief statement of the purpose of the disclosure. This requirement effectively allows for auditing and monitoring of activities involving PHI, as it ensures that there is a record of how PHI is disclosed and to whom.\n\nThe other options are not supported by the context provided:\n\n- A: The right to obtain PHI in a paper format only is incorrect because [3] specifies that if Business Associate maintains an electronic health record with PHI, they must make such information available in electronic format as required under the HITECH Act and 45 C.F.R. \u00a7 164.524(c)(2)(ii).\n\n- C: The right to prevent any disclosure of PHI is incorrect because the agreement allows for disclosures under certain conditions and requires documentation of such disclosures.\n\n- D: The right to delete personal information permanently is incorrect because the agreement discusses the return or destruction of PHI upon termination, but also provides for situations where destruction is infeasible, requiring continued protection of PHI.",
    "latency_ms": 3422.15,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_44",
    "question": "How is Confidential Information defined in the agreement between the Parties?",
    "options": {
      "A": "Information shared only through electronic communication.",
      "B": "Only information shared in written form marked as confidential.",
      "C": "Only Proprietary Information and Third Party Information explicitly marked as confidential.",
      "D": "All non-public information concerning the Disclosing Party or its business, including oral, visual, written, electronic, or other forms."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: All non-public information concerning the Disclosing Party or its business, including oral, visual, written, electronic, or other forms.\n\nReasoning: The definition of \"Confidential Information\" across the provided documents consistently includes a broad range of information types and formats. Specifically, the agreements define \"Confidential Information\" as encompassing any non-public information related to the Disclosing Party's business, which can be communicated in various forms such as writing, orally, electronically, photographically, or in recorded or any other form. This includes, but is not limited to, technical, financial, legal, operational, or business information. The documents also specify that Confidential Information is not limited to information explicitly marked as confidential, but rather includes any information that a reasonable person would consider confidential based on its nature and the circumstances of its disclosure. Therefore, option D accurately captures the comprehensive nature of the definition as provided in the agreements.",
    "latency_ms": 2309.82,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_45",
    "question": "What is the duration of the Nondisclosing Party\u2019s obligations concerning Confidential Information that is considered a trade secret under the NDA?",
    "options": {
      "A": "Until the Confidential Information no longer constitutes a trade secret",
      "B": "Three (3) years after disclosure",
      "C": "Until the termination of all agreements between the Parties",
      "D": "Indefinitely"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Until the Confidential Information no longer constitutes a trade secret\n\nReasoning:\n\nThe documents explicitly state that the obligations concerning trade secrets continue for as long as the information qualifies as a trade secret. In [1], it is mentioned, \"Receiving Party\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\" This indicates that the duration of the obligation is tied to the status of the information as a trade secret, not a fixed period like three years or until the termination of agreements. Therefore, the correct answer is A, as the obligation lasts until the information no longer meets the criteria of a trade secret.",
    "latency_ms": 1585.85,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_46",
    "question": "What must Vendor and Consultant do with Proprietary Information at the conclusion of services?",
    "options": {
      "A": "Relinquish or destroy the information",
      "B": "Store the information securely for 5 years",
      "C": "Share the information with authorized third parties",
      "D": "Transfer ownership to Employer"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Relinquish or destroy the information.\n\nReasoning:\n\nThe documents specify several requirements and restrictions regarding the handling of Proprietary Information. Specifically, the context indicates that the Systems and any documentation related to them are to be treated as Proprietary Information and are subject to confidentiality restrictions. Upon termination of Systems access, Vendor and Consultant are required to \"cease all use of the Systems\" (Context [1]). This implies that they must relinquish or destroy any Proprietary Information they have access to, as continued use or retention would violate the confidentiality and access termination clauses.\n\nAdditionally, while the documents do not explicitly state the need to destroy the information, the requirement to cease all use and the emphasis on confidentiality suggest that retaining the information would not be permissible. There is no mention of storing the information securely for a specific period, sharing it with third parties, or transferring ownership, which rules out options B, C, and D. Therefore, the most appropriate action is to relinquish or destroy the information to comply with the confidentiality and termination requirements.",
    "latency_ms": 2947.86,
    "client": "Boston Benefit Partners",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_47",
    "question": "Under what conditions can the Recipient disclose Confidential Information?",
    "options": {
      "A": "If the Recipient has prior knowledge before receiving it from the Owner",
      "B": "If required by law, with prompt notification to the Owner",
      "C": "If the information becomes generally known by third parties",
      "D": "If the information is independently developed by the Recipient"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: If required by law, with prompt notification to the Owner.\n\nExplanation:\n\nThe documents provide several conditions under which the Recipient can disclose Confidential Information. Specifically, document [1] states that if the Recipient is \"requested or required by judicial and other regulatory or investigative orders to disclose any of Discloser\u2019s Confidential Information,\" the Recipient must \"first, to the extent practicable give Discloser prompt written notice prior to such disclosure (unless such notice is prohibited by law) such that Discloser may seek any protective relief.\" This aligns with option B, which allows for disclosure if required by law, with the condition of notifying the Owner.\n\nWhile options A, C, and D are mentioned in the documents as conditions under which information may not be considered confidential, they do not directly address the conditions for disclosure. Specifically:\n\n- Option A: Document [3] mentions that information \"was rightfully known to the Recipient without restriction, at the time of disclosure,\" but this pertains to what is not considered Confidential Information rather than a condition for disclosure.\n- Option C: Document [3] also states that information \"was in the public domain at the time it was disclosed or becomes in the public domain through no wrongful act or omission of Recipient,\" which again pertains to what is not considered Confidential Information.\n- Option D: Document [1] mentions that information \"is independently developed by Recipient without reference to Discloser Confidential Information,\" which is a condition for information not being considered confidential, not a condition for disclosure.\n\nTherefore, the correct condition under which the Recipient can disclose Confidential Information is option B, when required by law, with prompt notification to the Owner.",
    "latency_ms": 4158.59,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_48",
    "question": "What does the term \"Sensitive Personal Information\" include according to the document?",
    "options": {
      "A": "First name or initial and last name with credit card information",
      "B": "Only driver\u2019s license number",
      "C": "Just the social security number",
      "D": "Any combination of first name and last name"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: First name or initial and last name with credit card information.\n\nReasoning:\n\nAccording to the document, \"Sensitive Personal Information\" is defined as an individual\u2019s first name or first initial and last name in combination with any one or more of the following items: a) social security number; driver\u2019s license number or government-issued identification number; or account number or credit or debit card number in combination with any required security code, access code, or password that would permit access to an individual\u2019s financial account. This definition explicitly includes the combination of a name with credit card information, which matches option A. \n\nOptions B, C, and D are incorrect because they do not fully capture the definition provided in the document. Option B mentions only the driver's license number, option C mentions just the social security number, and option D refers to any combination of first name and last name without the additional sensitive data elements required by the definition.",
    "latency_ms": 2446.46,
    "client": "Community First Health Plans",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_49",
    "question": "What security measures must COMPANY implement for network security according to the document?",
    "options": {
      "A": "Utilizing only wireless connections without firewalls",
      "B": "Using a switched-network topology without password protection",
      "C": "Establishing thresholds and alarms to notify personnel of potential problems or outages",
      "D": "Allowing unrestricted access to network scan results"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Establishing thresholds and alarms to notify personnel of potential problems or outages.\n\nReasoning:\n\nThe documents provide specific requirements for network security that COMPANY must implement. These include:\n\n1. **Password Protection for Monitoring Ports**: If COMPANY uses a switched-network topology, monitoring ports on the switches must be password protected (Documents [1], [2], [5]).\n\n2. **Protection of Interconnections**: COMPANY must ensure that interconnections within the COMPANY, with other companies, and with the Internet (\"Access Points\"), whether wired or wireless, are protected by using firewalls, secure tunnels, or access lists on routers (Documents [1], [2], [3], [4], [5]).\n\n3. **Network Management System**: COMPANY must use a network management system to monitor its local network and servers. Thresholds and alarms must be established to notify COMPANY and Humana personnel of potential problems or outages (Documents [1], [2], [3], [4], [5]).\n\n4. **Intrusion Detection/Protection Solutions**: COMPANY must implement either host-based or network-based Intrusion Detection Solution (IDS) or Intrusion Protection Solution (IPS) with response and recovery plans to monitor potential unauthorized access to COMPANY network and systems (Documents [1], [2], [3], [4], [5]).\n\n5. **Network Scan Results**: Upon Humana's request, COMPANY must make available internal and external network scan results to Humana for review (Documents [1], [2], [3], [4], [5]).\n\nOption C is correct because the requirement to establish thresholds and alarms to notify personnel of potential problems or outages is explicitly stated in the documents. Options A, B, and D are incorrect because they contradict the explicit requirements stated in the documents, such as the need for firewalls, password protection, and controlled access to network scan results.",
    "latency_ms": 3203.76,
    "client": "Humana",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_50",
    "question": "What rights are provided to individuals under the BAA regarding their protected health information?",
    "options": {
      "A": "The right to transmit their information to another entity or person",
      "B": "The right to delete their information permanently",
      "C": "The right to receive compensation for data usage",
      "D": "The right to obtain a copy of information in paper format"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: The right to transmit their information to another entity or person.\n\nReasoning:\n\nThe documents explicitly state that the BAA includes provisions regarding individuals' rights related to their protected health information. Specifically, the BAA provides:\n\n- \"Individuals' rights to obtain a copy of the individual's information in an electronic format.\"\n- \"Individuals' rights to have the individual's information transmitted to another entity or person designated by the individual, provided the request is clear, conspicuous, and specific.\"\n\nThese provisions clearly outline the rights individuals have concerning their protected health information. Option A is directly supported by the text, which mentions the right to have information transmitted to another entity or person.\n\nThe other options are not supported by the text:\n\n- Option B (The right to delete their information permanently) is not mentioned in the documents.\n- Option C (The right to receive compensation for data usage) is not mentioned in the documents.\n- Option D (The right to obtain a copy of information in paper format) is incorrect because the documents specify the right to obtain a copy in an electronic format, not paper.",
    "latency_ms": 2205.03,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_51",
    "question": "What requirement must be met before the disclosure of PHI to a Business Associate as per the HIPAA Privacy Rule?",
    "options": {
      "A": "Business Associate must undergo a HIPAA compliance audit.",
      "B": "Business Associate must sign a contract containing specific requirements.",
      "C": "Business Associate must provide proof of data encryption.",
      "D": "Business Associate must be registered with the U.S. Department of Health and Human Services."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: Business Associate must sign a contract containing specific requirements.\n\nReasoning:\n\nThe context provided in the documents indicates that a Business Associate must enter into an agreement that outlines specific requirements related to the handling of Protected Health Information (PHI). For instance, document [2] mentions that \"Business Associate\u2019s obligations under this Agreement shall commence with respect to such PHI upon such receipt,\" indicating that the agreement itself is a prerequisite for handling PHI. Additionally, document [5] specifies the \"Obligation of Business Associate\" and lists permitted uses and disclosures of PHI, which are detailed in the agreement. This aligns with the HIPAA Privacy Rule, which requires covered entities to have a Business Associate Agreement (BAA) in place before disclosing PHI to a Business Associate. The agreement must include terms that ensure the Business Associate will appropriately safeguard the PHI. Therefore, option B is the correct answer, as it reflects the requirement for a contract containing specific requirements before PHI can be disclosed.",
    "latency_ms": 2215.11,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_52",
    "question": "What is the main purpose of the Work Order (WO) #1 executed between Cotiviti, Inc. and the 1199 SEIU National Benefit Funds?",
    "options": {
      "A": "To outline the process for data interface between the Client and Cotiviti.",
      "B": "To provide payment details and deadlines for services rendered.",
      "C": "To confirm legal binding and execution of signatures.",
      "D": "To establish roles and responsibilities for IT deliverables."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: To outline the process for data interface between the Client and Cotiviti.\n\nReasoning: The main purpose of Work Order (WO) #1, as described in the provided context, is to outline the process for the data interface between the Client and Cotiviti. This is explicitly stated in the document where it mentions that Cotiviti will assign employees and/or subcontractors to design, build, test, and operationalize the data interface between the Client and Cotiviti. The scope of this work includes receiving and processing the Client\u2019s prepay, post-adjudication, and paid claim data. This aligns with option A, which focuses on the data interface process. \n\nThe other options do not accurately reflect the primary purpose of WO #1:\n- Option B is incorrect as there is no mention of payment details and deadlines in the context provided.\n- Option C is incorrect because while the document does confirm legal binding and execution of signatures, this is a standard procedural element rather than the main purpose of the Work Order.\n- Option D is incorrect as the document does not primarily focus on establishing roles and responsibilities for IT deliverables, although it does mention high-level IT roles and responsibilities in Exhibit A.",
    "latency_ms": 3073.81,
    "client": "1199 SEIU National Benefit Funds",
    "document_type": "Work Order / Change Request",
    "method": "RAG"
  },
  {
    "id": "qa_53",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the agreement or upon Disclosing Party\u2019s request?",
    "options": {
      "A": "Retain all Confidential Information indefinitely",
      "B": "Backup all Confidential Information and delete all original copies",
      "C": "Transfer all Confidential Information to a third party",
      "D": "Destroy or return all Confidential Information, except for a single archival copy for dispute resolution"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: Destroy or return all Confidential Information, except for a single archival copy for dispute resolution.\n\nReasoning:\n\nThe documents consistently outline the requirement for the Receiving Party to either destroy or return all Confidential Information upon termination of the agreement or upon the Disclosing Party's request. Here are the specific requirements and permissions from the documents:\n\n1. Document [1] states: \"the Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\n2. Document [2] specifies: \"At any time upon the request of the Disclosing Party, the Receiving Party shall promptly (and in no event later than five business days after such request) (i) destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing Party.\"\n\n3. Document [3] mentions: \"Receiving Party may (if Disclosing Party consents in writing) use commercially reasonable efforts to destroy all copies of the Confidential Information in its possession, and certify the destruction in writing to Disclosing Party.\"\n\n4. Document [4] outlines: \"At any time after the disclosure of any Confidential Information by any Party, and at the request and option of the disclosing Party, the receiving Party(ies) agrees to promptly: (i) return the Confidential Information of the disclosing Party to the disclosing Party; or (ii) destroy or erase... and provide certification within 14 days that all such Confidential Information has been destroyed or erased.\"\n\n5. Document [5] reiterates: \"At any time upon the request of the Disclosing Party, the Receiving Party shall promptly (and in no event later than five business days after such request) (i) destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives confirm such destruction in writing to the Disclosing Party.\"\n\nAcross these documents, the consistent actionable guidance is to destroy or return all Confidential Information, with the exception of retaining a single archival copy for specific purposes such as dispute resolution or regulatory compliance, as outlined in document [1]. Therefore, option D is the correct choice.",
    "latency_ms": 4730.48,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_54",
    "question": "Which of the following is considered \"Confidential Information\" according to the NDA?",
    "options": {
      "A": "Publicly available marketing strategies",
      "B": "General industry knowledge",
      "C": "Information disclosed before the Effective Date",
      "D": "Pricing and terms under agreements"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Pricing and terms under agreements\n\nExplanation:\n\nThe documents provide specific definitions and exclusions regarding what constitutes \"Confidential Information.\" According to the context provided:\n\n1. Document [4] explicitly states that \"Confidential Information\" includes \"pricing information\" and \"the existence and terms of this Agreement.\" This indicates that pricing and terms under agreements are considered confidential.\n\n2. Document [5] also includes \"information relating to the businesses, services, suppliers, projections, prospects, financial condition, management, operations, and marketing strategies of the disclosing party\" as confidential, which would encompass pricing and terms under agreements.\n\nThe other options are not considered \"Confidential Information\" based on the provided context:\n\n- A: Publicly available marketing strategies are explicitly excluded from being confidential if they are publicly available, as stated in multiple documents ([2], [3], [4], [5]).\n\n- B: General industry knowledge is not specifically mentioned as confidential in any of the documents, and typically, such knowledge would not be considered confidential unless it is proprietary or unique to the disclosing party.\n\n- C: Information disclosed before the Effective Date is not automatically considered confidential unless it meets the criteria outlined in the agreements. Document [5] mentions that information disclosed \"prior to, on or after the effective date\" can be confidential, but it must be related to the purpose and meet other criteria for confidentiality.",
    "latency_ms": 2526.33,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_55",
    "question": "Under the NDA between Abarca Health LLC and Cotiviti, Inc., what is the status of ownership of the Confidential Information?",
    "options": {
      "A": "Ownership rights are shared equally between both parties.",
      "B": "The Receiving Party gains joint ownership with the Disclosing Party.",
      "C": "The Disclosing Party retains sole and exclusive ownership of the Confidential Information.",
      "D": "The Receiving Party gains full ownership of the Confidential Information."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: The Disclosing Party retains sole and exclusive ownership of the Confidential Information.\n\nReasoning: According to the NDA between Abarca Health LLC and Cotiviti, Inc., the document explicitly states that \"Confidential Information shall remain the sole and exclusive property of the Disclosing Party.\" This clause clearly indicates that the Disclosing Party retains full ownership rights over the Confidential Information shared under the agreement. Furthermore, the agreement specifies that \"Nothing in this Agreement shall be construed as granting to the Receiving Party any right, title or interest in or to any patent, trademark, license, copyright or other right of the Disclosing Party.\" This reinforces the notion that the Receiving Party does not gain any ownership rights over the Confidential Information.",
    "latency_ms": 1623.15,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_56",
    "question": "According to the NDA, what is required for the Nondisclosing Party to share Confidential Information with its Representatives?",
    "options": {
      "A": "Verbal consent from the Disclosing Party",
      "B": "Notification to the Disclosing Party",
      "C": "Written agreement from Representatives to be bound by confidentiality provisions",
      "D": "Prior written consent from the Disclosing Party"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Written agreement from Representatives to be bound by confidentiality provisions.\n\nReasoning:\n\nAccording to the NDA, specifically in the context provided from document [1], the Nondisclosing Party is permitted to share Confidential Information with its Representatives only under certain conditions. The relevant clause states:\n\n\"The Nondisclosing Party will transmit the Confidential Information only to those Representatives who need to know the Confidential Information for the purpose of evaluating the Potential Transaction, who are informed by the Nondisclosing Party of the confidential nature of the Confidential Information, and who have agreed in writing to be bound by provisions no less restrictive than those contained in this Agreement.\"\n\nThis clause clearly indicates that the Representatives must agree in writing to be bound by confidentiality provisions that are at least as restrictive as those in the NDA. Therefore, option C is the correct requirement for sharing Confidential Information with Representatives. \n\nOptions A, B, and D are not correct because the clause does not mention verbal consent, notification, or prior written consent from the Disclosing Party as requirements for sharing information with Representatives.",
    "latency_ms": 2718.95,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_57",
    "question": "What must a party do when they become aware of a Data Breach according to the MSA with ACA Health Benefits Fund?",
    "options": {
      "A": "Ignore the breach and continue business as usual.",
      "B": "Notify the other party and discuss next steps regarding investigation and handling.",
      "C": "Immediately terminate the agreement with the other party.",
      "D": "Disclose all confidential information related to the breach publicly."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Notify the other party and discuss next steps regarding investigation and handling.\n\nReasoning:\n\nAccording to the MSA with ACA Health Benefits Fund, when either party becomes aware of any actual or suspected Data Breach, the following actions are required:\n\n1. **Notification**: The party aware of the breach must promptly notify the other party of the Data Breach, as stated in clause 7.8(a): \"that party must promptly notify the other party of the Data Breach (Data Breach Notice).\"\n\n2. **Discussion and Investigation**: The parties are required to meet as soon as practicable to discuss in good faith appropriate next steps regarding the investigation and handling of the Data Breach. This includes discussing the parties\u2019 respective responsibilities and mandatory requirements for data breach notification in accordance with the Privacy Act, as outlined in clause 7.8(b).\n\n3. **Assistance**: Each party must provide all reasonable assistance to the other to ensure compliance with obligations under the Privacy Act, as specified in clause 7.8(c).\n\nThese steps clearly indicate that the parties must engage in a collaborative process to address the breach, rather than ignoring it, terminating the agreement, or disclosing confidential information publicly.",
    "latency_ms": 2514.94,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_58",
    "question": "Under what circumstances is the Confidential Information not protected by the NDA?",
    "options": {
      "A": "If the information becomes public due to actions of the Disclosing Party.",
      "B": "If the information is known to the Nondisclosing Party before disclosure.",
      "C": "If the information is available from a public source and the Nondisclosing Party is unaware of any confidentiality obligation.",
      "D": "If the Nondisclosing Party discloses the information to the public."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: If the information is known to the Nondisclosing Party before disclosure.\n\nReasoning:\n\nThe documents provide specific exceptions to the protection of Confidential Information under the NDA. According to the context provided, particularly from documents [2], [3], and [4], Confidential Information is not protected by the NDA under the following circumstances:\n\n1. **Pre-existing Knowledge**: The information was already known to the Nondisclosing Party on a non-confidential basis before it was disclosed by the Disclosing Party. This is explicitly mentioned in document [3]: \"were known to the Nondisclosing Party on a non-confidential basis prior to their disclosure to the Nondisclosing Party by the Disclosing Party or its Representatives.\"\n\n2. **Public Availability**: The information becomes generally available to the public, but this is not due to the actions of the Nondisclosing Party. This is mentioned in document [3]: \"are or become generally available to the public, other than as a result of a disclosure by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives.\"\n\n3. **Non-confidential Source**: The information becomes available to the Nondisclosing Party from a source other than the Disclosing Party, provided that the source is not bound by a confidentiality agreement with the Disclosing Party. This is also mentioned in document [3]: \"become available to the Nondisclosing Party on a non-confidential basis from a source other than the Disclosing Party or its Representatives, provided that such source is not, to the knowledge of the Nondisclosing Party, bound by a confidentiality agreement with the Disclosing Party or its Representatives.\"\n\n4. **Independent Development**: The information is independently developed by the Nondisclosing Party without using the Disclosing Party's Confidential Information. This is mentioned in document [3]: \"are developed independently by the personnel of the Nondisclosing Party or any of its Representatives who have not had access to the Disclosing Party\u2019s Confidential Information.\"\n\nOption B is correct because it directly aligns with the exception that if the information was known to the Nondisclosing Party before disclosure, it is not protected by the NDA. Options A, C, and D do not accurately reflect the conditions under which the NDA does not protect the information, based on the provided context.",
    "latency_ms": 5195.41,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_59",
    "question": "What is the time frame within which the Business Associate must report improper use or disclosure of PHI?",
    "options": {
      "A": "Within 30 days of becoming aware",
      "B": "Within 60 days of becoming aware",
      "C": "Within 15 days of discovery",
      "D": "Immediately upon discovery"
    },
    "correct_answer": "A",
    "predicted_answer": "D",
    "is_correct": false,
    "response": "D: Immediately upon discovery\n\nThe documents explicitly state that the Business Associate is required to provide \"immediate written notice to HUMANA of any use or disclosure of PHI other than as specifically provided for by the Arrangement or this Agreement.\" This requirement is mentioned in multiple sections of the context provided, indicating that the reporting must occur immediately upon discovery of any improper use or disclosure of PHI. There is no mention of a specific number of days within which the report must be made, reinforcing the requirement for immediate action.",
    "latency_ms": 1316.51,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_61",
    "question": "What is the definition of \"Medically Necessary\" under the provisions of this SOW?",
    "options": {
      "A": "Services or supplies determined to be appropriate and necessary for the symptoms, diagnosis, or treatment of the medical condition.",
      "B": "Services or supplies provided primarily for the convenience of the Participant's physician.",
      "C": "Services or supplies within good medical practice standards, regardless of necessity.",
      "D": "Services or supplies that are convenient for the Participant."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A\n\nReasoning: The definition of \"Medically Necessary\" under the provisions of the Statement of Work (SOW) is explicitly outlined in the context provided. According to the document, \"Medically Necessary means covered services or supplies which, under the provisions of this SOW, are determined through Client\u2019s Utilization Management to be (i) appropriate and necessary for the symptoms, diagnosis or treatment of the medical condition; (ii) provided for diagnosis or direct care and treatment of the specific medical condition; (iii) within standards of good medical practice within the organized medical community; and (iv) not primarily for the convenience of the Participant, the Participant's physician or another provider.\"\n\nThis definition clearly aligns with option A, which states that services or supplies are determined to be appropriate and necessary for the symptoms, diagnosis, or treatment of the medical condition. The other options (B, C, and D) do not accurately reflect the definition provided, as they either focus on convenience or disregard the necessity and appropriateness criteria outlined in the SOW.",
    "latency_ms": 2111.83,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_62",
    "question": "What is the procedure to withdraw consent for receiving electronic notices and disclosures via DocuSign?",
    "options": {
      "A": "Mail a written request to Self Insured Services Co.",
      "B": "Call customer service for Self Insured Services Co.",
      "C": "Send an email request to Self Insured Services Co.",
      "D": "Use the DocuSign \"Withdraw Consent\" form on the signing page."
    },
    "correct_answer": "D",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The context provided does not explicitly state the procedure for withdrawing consent for receiving electronic notices and disclosures via DocuSign. The documents mention that you can change your mind and decide to receive notices and disclosures in paper format, but they do not specify the exact method or procedure to inform the company of this decision.\n\nThe options given (A, B, C, D) are not directly referenced in the provided text. Therefore, without explicit information on the procedure, it is not possible to accurately select one of the options as the correct answer. The documents do not provide details on whether you should mail a request, call, send an email, or use a specific form within DocuSign to withdraw consent.\n\nThus, the correct answer cannot be determined from the information provided. The documents lack explicit instructions on the withdrawal process, which is necessary to choose among the given options.",
    "latency_ms": 2240.46,
    "client": "Self Insured Services Co",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_64",
    "question": "What is the minimum period for which Vendor is required to perform a criminal conviction check on Vendor Personnel?",
    "options": {
      "A": "5 years",
      "B": "7 years",
      "C": "Indefinite",
      "D": "10 years"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: 7 years\n\nReasoning: The context from document [1] explicitly states that the Vendor will perform a criminal conviction check on Vendor Personnel through an authorized background reporting agency. It specifies that, to the extent permitted by law, this criminal conviction check will cover at a minimum a seven (7) year period. This requirement is clearly outlined in the document, making option B the correct answer.",
    "latency_ms": 1322.23,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_65",
    "question": "What is the permitted use of Confidential Information according to the NDA with Advise Insurance?",
    "options": {
      "A": "To enter into a subcontract or contract automatically",
      "B": "To develop new products independently",
      "C": "To disclose information to third parties without consent",
      "D": "To evaluate a business relationship with the disclosing party"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: To evaluate a business relationship with the disclosing party.\n\nReasoning:\n\nAccording to the NDA with Advise Insurance, the permitted use of Confidential Information is explicitly stated in the document. The agreement provides for the protection from unauthorized disclosure or use of Confidential Information that may be furnished by one of the parties to the other party. It specifies that the Confidential Information may be used by the receiving party \"solely for the purpose of evaluating or engaging in a business relationship between the disclosing party and the receiving party.\" This directly aligns with option D, which is to evaluate a business relationship with the disclosing party.\n\nThe other options are not supported by the document:\n- Option A is incorrect because the document does not mention entering into a subcontract or contract automatically.\n- Option B is incorrect because the document does not mention developing new products independently.\n- Option C is incorrect because the document does not permit disclosing information to third parties without consent.",
    "latency_ms": 2506.97,
    "client": "Advise Insurance",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_66",
    "question": "Under the agreement, what happens if a party fails to exercise its rights due to a Force Majeure event?",
    "options": {
      "A": "The party can have its performance obligations extended by a reasonable period.",
      "B": "The party can exercise its rights after notifying the other party within 30 days.",
      "C": "The party forfeits its rights permanently.",
      "D": "The party must terminate the agreement immediately."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: The party can have its performance obligations extended by a reasonable period.\n\nReasoning:\n\nThe documents explicitly state that in the event of a Force Majeure, neither party will be liable for delays or damages if prevented from fulfilling its obligations due to events beyond its reasonable control. Specifically, the agreement provides that \"In case of Force Majeure, the party\u2019s performance obligations will be extended by a reasonable period of time corresponding to the delay caused by the Force Majeure\" (as seen in documents [2], [4], and [5]). This indicates that the affected party is allowed additional time to fulfill its obligations, rather than forfeiting rights or being required to terminate the agreement. \n\nThere is no mention of a requirement to notify the other party within 30 days to exercise rights, nor is there any indication that rights are forfeited permanently or that immediate termination is required. Therefore, option A is the correct choice based on the provided context.",
    "latency_ms": 2536.53,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_67",
    "question": "What must the company do to protect Personal Data according to the document?",
    "options": {
      "A": "Maintain any security measures regardless of relevance.",
      "B": "Implement and maintain current and reasonable security measures.",
      "C": "Implement outdated security measures.",
      "D": "Ignore Data Protection Laws when processing Personal Data."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: Implement and maintain current and reasonable security measures.\n\nReasoning:\n\nThe document explicitly states in section 5.1 that the company is required to \"implement, prior to executing this DPA, and maintain current and reasonable technical and organizational security measures appropriate to the nature of the Personal Data Processed as required by applicable Data Protection Laws, or otherwise necessary to adequately protect Personal Data against Data Incidents.\" This indicates that the company must ensure that the security measures are both current and reasonable, aligning with the nature of the data and the requirements of applicable laws.\n\nAdditionally, section 8.6 from document [2] reinforces the need for appropriate technical and organizational measures to ensure data security, including protection against breaches. It specifies that the parties should consider encryption or pseudonymization, taking into account the state of the art, costs, and risks involved.\n\nTherefore, option B is the correct choice as it aligns with the explicit requirements stated in the documents for maintaining security measures that are both current and reasonable.",
    "latency_ms": 1883.35,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_68",
    "question": "What remedies are available to the Disclosing Party in case of a breach of the NDA?",
    "options": {
      "A": "Specific performance and termination of the agreement",
      "B": "Specific performance, injunctive relief, and money damages",
      "C": "Money damages and termination of the agreement",
      "D": "Only money damages"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: Specific performance, injunctive relief, and money damages\n\nReasoning:\n\nThe documents consistently state that the Disclosing Party is entitled to specific performance and injunctive relief, either temporary or permanent, as appropriate, to remedy any breach of the NDA. This is explicitly mentioned in multiple sections across the documents:\n\n1. Document [1] states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity, including but not limited to money damages.\"\n\n2. Document [2] similarly states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity, including but not limited to money damages.\"\n\n3. Document [3] mentions: \"The Receiving Party agrees that the Disclosing Party shall be entitled to temporary or permanent injunctive relief to prevent or discontinue such disclosures without the necessity of proving damages or posting bond.\"\n\n4. Document [5] states: \"Therefore, in addition to any other remedies which may be available at law, each receiving party agrees that the disclosing party shall be entitled to injunctive relief, specific performance or other equitable relief or any or all of the foregoing, for any breach or threatened breach of this Agreement without the necessity of proving actual damages and without waiving any other remedies otherwise available at law or in equity.\"\n\nThese clauses collectively confirm that the Disclosing Party has access to specific performance, injunctive relief, and money damages as remedies for a breach of the NDA. Termination of the agreement is not mentioned as a remedy, nor is money damages the sole remedy, thus eliminating options A, C, and D.",
    "latency_ms": 3801.94,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_69",
    "question": "What happens to the obligations regarding Confidential Information when the NDA is terminated?",
    "options": {
      "A": "Obligations are immediately terminated",
      "B": "Obligations remain indefinitely",
      "C": "Obligations remain for 1 year",
      "D": "Obligations remain for 5 years"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Obligations remain for 5 years\n\nThe documents provide clear guidance on the duration for which obligations regarding Confidential Information survive the termination of the NDA. Specifically, both document [2] and document [5] state that \"The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this Agreement for a period of five (5) years.\" This indicates that the obligations related to Confidential Information continue for five years after the termination of the agreement, making option D the correct answer. \n\nAdditionally, document [3] mentions that confidentiality provisions survive termination, but it specifies a minimum period of three years, which does not contradict the five-year period stated in documents [2] and [5]. Therefore, the most consistent and explicit duration across the documents is five years.",
    "latency_ms": 1787.1,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_70",
    "question": "What is the timeframe within which BUSINESS ASSOCIATE must make available information for accounting of disclosures to COVERED ENTITY?",
    "options": {
      "A": "Within 10 days of notice",
      "B": "Within 5 days of notice",
      "C": "Within 15 days of notice",
      "D": "Within 20 days of notice"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Within 10 days of notice.\n\nReasoning:\n\nThe document [1] explicitly states that \"Within ten (10) days of notice by COVERED ENTITY of a request for an accounting of disclosures of Protected Information, BUSINESS ASSOCIATE and its agents or subcontractors shall make available to COVERED ENTITY the information required to provide an accounting of disclosures to enable COVERED ENTITY to fulfill its obligations under the Privacy Rule.\" This clause clearly sets the timeframe for BUSINESS ASSOCIATE to provide the necessary information for accounting of disclosures to COVERED ENTITY as ten days from the notice.",
    "latency_ms": 1494.95,
    "client": "Inogen",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_71",
    "question": "Under what circumstances can a party assign its rights and obligations according to the NDA?",
    "options": {
      "A": "To a successor in ownership of substantially all assets, with written assumption of terms",
      "B": "Without any approval or notification",
      "C": "Only through a court order",
      "D": "With prior written approval from the other party"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: To a successor in ownership of substantially all assets, with written assumption of terms.\n\nReasoning:\n\nThe document from context [1] explicitly states the conditions under which a party can assign its rights and obligations. According to the clause, \"either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor in ownership of substantially all the assets of the business.\" This indicates that assignment is permissible under these specific circumstances without needing prior written approval from the other party.\n\nThe other options are not supported by the document:\n- Option B is incorrect because the document specifies a particular condition (successor in ownership of substantially all assets) under which assignment can occur without approval, implying that other assignments would require consent.\n- Option C is incorrect as there is no mention of court orders being a condition for assignment.\n- Option D is incorrect because the document specifies that prior written approval is not needed when assigning to a successor in ownership of substantially all assets, contrary to what this option suggests.\n\nTherefore, the correct answer is A, as it aligns with the specific clause provided in the document.",
    "latency_ms": 1962.28,
    "client": "Advise Insurance",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_72",
    "question": "What is the legal status of the confidential information according to the NDA between Abarca Health LLC and the Receiving Party?",
    "options": {
      "A": "The confidential information becomes public upon disclosure.",
      "B": "The Receiving Party is required to compensate the Disclosing Party for the confidential information.",
      "C": "The Receiving Party gains ownership rights to the confidential information.",
      "D": "The confidential information remains the sole property of the Disclosing Party."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: The confidential information remains the sole property of the Disclosing Party.\n\nReasoning:\n\nThe context provided from various NDA documents consistently outlines that confidential information disclosed under these agreements remains the property of the Disclosing Party. The NDAs specify that the Receiving Party must protect the confidential information using a reasonable degree of care, restrict its disclosure, and use it only for the specified purpose. For example, document [4] states that the Receiving Party shall protect the Disclosing Party's confidential information using at least the same degree of care as it uses to protect its own confidential information, but no less than a reasonable degree of care. Additionally, the Receiving Party is required to notify the Disclosing Party upon discovery of any unauthorized use or disclosure of the confidential information.\n\nNone of the documents suggest that the Receiving Party gains ownership rights or that the confidential information becomes public upon disclosure. Furthermore, there is no mention of compensation for the confidential information or any transfer of ownership rights to the Receiving Party. Therefore, the confidential information remains the sole property of the Disclosing Party, as indicated by the requirements and restrictions outlined in the NDAs.",
    "latency_ms": 2114.47,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_73",
    "question": "What must happen to latent data according to the NDA between Abarca Health LLC and the Receiving Party?",
    "options": {
      "A": "Latent data must be subject to destruction in due course but remains confidential until destroyed.",
      "B": "Latent data can be freely shared with third parties.",
      "C": "Latent data must be immediately destroyed upon request.",
      "D": "Latent data must be kept permanently as confidential information."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Latent data must be subject to destruction in due course but remains confidential until destroyed.\n\nReasoning:\n\nThe documents explicitly state that \"Latent Data, which is Confidential Information, shall be subject to destruction in due course, but shall remain Confidential Information of the Disclosing Party until it is destroyed.\" This indicates that while the latent data is to be destroyed eventually, it retains its status as confidential information until such destruction occurs. There is no mention of immediate destruction upon request, sharing with third parties, or permanent retention as confidential information. Therefore, option A accurately reflects the requirements regarding latent data as per the NDA.",
    "latency_ms": 1677.92,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_75",
    "question": "What discretion does the Client have regarding the inclusion of Outpatient Claims in the Scope?",
    "options": {
      "A": "Outpatient Claims are automatically included in the Scope.",
      "B": "Client must include Outpatient Claims in the Scope.",
      "C": "Client has no discretion and must follow Cotiviti's decision.",
      "D": "Client has the sole discretion to add Outpatient Claims during the policy selection process."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Client has the sole discretion to add Outpatient Claims during the policy selection process.\n\nReasoning:\nThe document explicitly states that the Client has the sole discretion to decide whether to add Outpatient Claims to the Scope. This decision can be made before or during the policy selection process that takes place during the Implementation. The text states: \"Client will have the sole discretion whether to add Outpatient Claims. So long as Client agrees to add Outpatient Claims before or during the policy selection process that takes place during the Implementation, the parties will implement Outpatient Claims as part of the Scope.\" This indicates that the inclusion of Outpatient Claims is not automatic or mandatory, but rather a decision that the Client can make independently. If the Client decides not to implement Outpatient Claims during this process, a Work Order will be required to add them at a later date, potentially with new implementation fees.",
    "latency_ms": 2416.67,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_76",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon request by the Disclosing Party?",
    "options": {
      "A": "Destroy or deliver all documents containing Confidential Information, except for a single archival copy for dispute resolution.",
      "B": "Only destroy electronic copies and return physical documents.",
      "C": "Return all documents and materials without retaining any copies.",
      "D": "Retain all documents and materials indefinitely."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Destroy or deliver all documents containing Confidential Information, except for a single archival copy for dispute resolution.\n\nReasoning:\n\nThe documents provide specific guidance on what the Receiving Party must do with Confidential Information upon termination of the Agreement or upon request by the Disclosing Party:\n\n1. Document [1] states: \"the Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\n2. Document [2] similarly requires the destruction of all Confidential Information, with exceptions for automatically generated computer back-up or archival copies, provided they are not used further and are protected under the Agreement.\n\n3. Document [3] allows the Receiving Party to retain one copy for regulatory compliance or verification purposes, but emphasizes destruction of other copies.\n\n4. Document [5] mentions the option to return or destroy Confidential Information, with exceptions for backup tapes and regulatory purposes.\n\nAcross these documents, the consistent requirement is to destroy or deliver all documents containing Confidential Information, with specific exceptions for retaining a single archival copy for dispute resolution or regulatory purposes. Therefore, option A accurately reflects the requirements stated in the documents.",
    "latency_ms": 3243.38,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_78",
    "question": "What information must psychologists include in the records for an initial examination according to New Jersey Medicaid/NJ FamilyCare requirements?",
    "options": {
      "A": "Date of service, signature, chief complaints, historical data, evaluation reports, diagnosis, intended treatment course",
      "B": "Diagnosis, intended treatment, and prognosis",
      "C": "Signature and chief complaints only",
      "D": "Only the date of service and diagnosis"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Date of service, signature, chief complaints, historical data, evaluation reports, diagnosis, intended treatment course\n\nReasoning:\n\nThe documents provide explicit requirements for the records that psychologists must maintain for an initial examination under New Jersey Medicaid/NJ FamilyCare. According to the context provided, the records must include:\n\n- Date(s) of service rendered\n- Signature of the psychologist\n- Chief complaint(s)\n- Pertinent historical, social, emotional, and additional data\n- Reports of evaluation procedures undertaken or ordered\n- Diagnosis\n- The intended course of treatment and tentative prognosis\n\nThese requirements are consistently outlined across multiple documents ([1], [2], [3], [4]), indicating that option A is the correct choice. Each of these elements is necessary to fully disclose the kind and extent of services provided, as mandated by the New Jersey Medicaid/NJ FamilyCare program.",
    "latency_ms": 2106.12,
    "client": "Horizon Blue Cross Blue Shield of New Jersey",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_80",
    "question": "What rights does the Receiving Party have concerning the Disclosing Party's Confidential Information according to the agreement?",
    "options": {
      "A": "The Receiving Party is automatically granted a license to all disclosed intellectual property.",
      "B": "The Receiving Party can receive ownership and copy Confidential Information freely.",
      "C": "The Receiving Party must receive a title and ownership of the Confidential Information.",
      "D": "The Receiving Party has no rights to copy or reproduce Confidential Information without written permission."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: The Receiving Party has no rights to copy or reproduce Confidential Information without written permission.\n\nReasoning:\n\nThe documents provide specific guidance on how the Receiving Party must handle the Disclosing Party's Confidential Information. According to the context provided, particularly from document [5], the Receiving Party is restricted in its ability to copy or reproduce the Confidential Information. It states:\n\n\"The Parties agree not to copy, photograph, photocopy, image, reduce to writing, or otherwise reproduce or duplicate the Confidential Information, except (a) to the most limited extent necessary to evaluate a Potential Transaction and for the purpose of preparing Derivative Confidential Information, or (b) with the prior written consent of the Disclosing Party.\"\n\nThis clause clearly indicates that the Receiving Party cannot freely copy or reproduce the Confidential Information without obtaining prior written consent from the Disclosing Party, thus supporting option D. The other options (A, B, and C) are not supported by the text, as there is no mention of automatic licensing, ownership transfer, or free copying rights granted to the Receiving Party.",
    "latency_ms": 2709.55,
    "client": "Horizon Blue Cross Blue Shield of New Jersey",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_81",
    "question": "What is the consequence of withdrawing consent to receive notices and disclosures electronically?",
    "options": {
      "A": "Slower transaction speed",
      "B": "No impact on transaction speed",
      "C": "Additional fees for electronic documents",
      "D": "Increased transaction speed"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Slower transaction speed\n\nThe documents explicitly state that if you elect to receive required notices and disclosures only in paper format, it will slow the speed at which certain steps in transactions can be completed. This is because the process involves sending the required notices or disclosures in paper format and then waiting for acknowledgment of receipt from the recipient. This is mentioned in multiple parts of the context, such as in [1], [4], and [5], where it is noted that withdrawing consent for electronic documents will result in slower transaction processing. Therefore, the correct consequence of withdrawing consent to receive notices and disclosures electronically is a slower transaction speed.",
    "latency_ms": 2059.63,
    "client": "Self Insured Services Co",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_82",
    "question": "What remedy is available for a breach of the NDA according to the document?",
    "options": {
      "A": "Only money damages",
      "B": "Only temporary injunctive relief",
      "C": "Specific performance and/or injunctive relief",
      "D": "No remedy available"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Specific performance and/or injunctive relief\n\nReasoning:\n\nThe documents consistently state that money damages may not be a sufficient remedy for any breach of the Agreement. Instead, the non-breaching party is entitled to seek specific performance and injunctive or other equitable relief as a remedy for any breach. This is explicitly mentioned in multiple sections across the documents:\n\n- Document [1] states, \"the non-breaching party will be entitled to seek specific performance and injunctive or other equitable relief as a remedy for any breach.\"\n- Document [2] mentions, \"the Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\"\n- Document [3] and [4] similarly affirm that \"the Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\"\n\nThese clauses indicate that specific performance and injunctive relief are available remedies, and they are not exclusive, meaning they are in addition to other remedies available at law or equity, including money damages. Therefore, option C is the correct answer.",
    "latency_ms": 2288.0,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_83",
    "question": "What is the duration for which rights and obligations survive after the termination of the NDA agreement?",
    "options": {
      "A": "2 years",
      "B": "Indefinitely",
      "C": "5 years",
      "D": "10 years"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: 5 years\n\nThe documents provide clear guidance on the duration for which rights and obligations survive after the termination of the NDA agreement. Specifically, both document [2] and document [4] state that \"The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this Agreement for a period of five (5) years.\" This indicates that the correct duration for the survival of rights and obligations post-termination is five years, making option C the correct answer. \n\nAdditionally, document [1] mentions that obligations to protect the confidentiality of the Confidential Information shall survive for a period of five years from the date of disclosure, further supporting the five-year survival period. Document [3] mentions a three-year survival period for confidentiality obligations, but this does not pertain to the rights and obligations in general, which are specified as five years in the other documents.",
    "latency_ms": 2943.18,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_84",
    "question": "Which of the following is considered an exception to the definition of \"Confidential Information\" under the agreement?",
    "options": {
      "A": "Information disclosed to the Receiving Party by a third party, regardless of confidentiality obligation",
      "B": "Information developed by the Receiving Party with reference to the Disclosing Party\u2019s Confidential Information",
      "C": "Information publicly known before disclosure by the Disclosing Party",
      "D": "Personal information of customers and employees"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Information publicly known before disclosure by the Disclosing Party.\n\nReasoning:\n\nThe documents provide specific exceptions to what is considered \"Confidential Information.\" Across multiple documents, there is a consistent exception for information that is publicly known prior to disclosure by the Disclosing Party. This is explicitly stated in several sections:\n\n- Document [4] states: \"Confidential Information shall not include any information that the Receiving Party can establish: (i) was publicly known and made generally available in the public domain prior to the time of disclosure by the Disclosing Party.\"\n- Document [5] similarly states: \"The term 'Confidential Information' shall not include information which the Receiving Party can demonstrate by contemporaneous documentation: (i) is already in the Receiving Party\u2019s possession prior to its disclosure by the Disclosing Party to the Receiving Party.\"\n\nThese clauses clearly indicate that information already publicly known before disclosure is not considered confidential under the agreements.\n\nOption A is incorrect because the documents specify that information disclosed by a third party is not confidential only if the third party is free to disclose it without confidentiality obligations. This is not a blanket exception for all third-party disclosures.\n\nOption B is incorrect because information developed by the Receiving Party with reference to the Disclosing Party\u2019s Confidential Information would not be an exception; it would likely be considered confidential.\n\nOption D is incorrect because personal information of customers and employees is explicitly protected as confidential, as stated in document [4]: \"personal information of customers and employees of either party shall be deemed Confidential Information hereunder to the full extent required by applicable law.\"\n\nTherefore, the correct exception is C, as it is consistently recognized across the documents.",
    "latency_ms": 3048.07,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_85",
    "question": "Under the agreement, when is the Business Associate allowed to disclose Protected Health Information (PHI)?",
    "options": {
      "A": "Under no circumstances",
      "B": "Only with explicit permission from the client",
      "C": "Only as permitted by the Agreement or as Required by Law",
      "D": "Any time the Business Associate deems it necessary"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Only as permitted by the Agreement or as Required by Law\n\nReasoning:\n\nThe documents provide clear guidance on when the Business Associate is allowed to disclose Protected Health Information (PHI). Across multiple sections, it is stated that the Business Associate may disclose PHI only in a manner consistent with HIPAA and as permitted or required by the agreement or an underlying agreement. Specifically:\n\n1. Document [2] states, \"Business Associate may request, use, or disclose PHI only in a manner that is consistent with HIPAA, and only as permitted or required by this agreement or an Underlying Agreement.\" It further specifies that PHI may be used or disclosed \"as Required By Law.\"\n\n2. Document [5] reiterates that the Business Associate may disclose PHI \"for the proper management and administration of the Business Associate, provided that disclosures are Required By Law.\"\n\nThese clauses indicate that the Business Associate is restricted to disclosing PHI only under the conditions set forth in the agreement or when legally mandated. There is no provision allowing disclosure at the discretion of the Business Associate without these conditions being met. Therefore, option C is the correct answer.",
    "latency_ms": 2010.14,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_86",
    "question": "Who is considered an Authorised User according to the MSA?",
    "options": {
      "A": "Any member of the public authorized by Client",
      "B": "Any individual with access to the internet",
      "C": "Any employee of Cotiviti",
      "D": "An employee, agent, or independent contractor of Client authorized by Client"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: An employee, agent, or independent contractor of Client authorized by Client.\n\nReasoning:\n\nThe documents provide specific guidance on who can be considered an Authorized User. According to the context provided, an Authorized User account is intended for use by one individual only, and the Client is responsible for the acts and omissions of its Authorized Users. This implies that Authorized Users are individuals who are directly associated with the Client and have been granted access by the Client.\n\nFurthermore, the documents state that the Client may permit its Authorized Users to access and use an Application Service only for the Client\u2019s own internal use, not for the benefit of any third party. This reinforces the idea that Authorized Users are those who are part of the Client's organization or operations.\n\nAdditionally, the Client is required to notify Cotiviti of any unauthorized use of any password or Authorized User account, indicating that the Client has control over who is designated as an Authorized User.\n\nTherefore, the definition aligns with option D, which specifies that an Authorized User is an employee, agent, or independent contractor of the Client authorized by the Client. This is consistent with the requirement that the Client manages access and is responsible for the actions of its Authorized Users.",
    "latency_ms": 2751.56,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_87",
    "question": "What must a Receiving Party do if legally required to disclose Confidential Information?",
    "options": {
      "A": "Notify the Disclosing Party promptly and seek a protective order.",
      "B": "Disclose the information immediately without notifying the Disclosing Party.",
      "C": "Request additional information from the legal entity requiring disclosure.",
      "D": "Destroy the Confidential Information before disclosure."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Notify the Disclosing Party promptly and seek a protective order.\n\nReasoning:\n\nThe documents consistently outline the procedure a Receiving Party must follow if legally required to disclose Confidential Information. The key steps include:\n\n1. **Notification**: The Receiving Party must promptly notify the Disclosing Party of the legal requirement to disclose the Confidential Information. This is explicitly stated in multiple documents:\n   - Document [1] specifies that the Receiving Party should provide \"prompt written notice\" to the Disclosing Party.\n   - Document [2] requires the Nondisclosing Party to \"promptly notify the Disclosing Party.\"\n   - Document [3] mentions \"prior written notice\" to the Disclosing Party.\n   - Document [4] also requires \"prompt notice\" to the Disclosing Party.\n   - Document [5] states the Receiving Party must \"immediately notify the Disclosing Party in writing.\"\n\n2. **Seeking Protective Order**: The Receiving Party should assist the Disclosing Party in seeking a protective order or other remedy to ensure the Confidential Information receives confidential treatment:\n   - Document [1] mentions providing \"reasonable assistance\" to the Disclosing Party in opposing disclosure or seeking a protective order.\n   - Document [2] includes cooperation with the Disclosing Party to obtain a protective order.\n   - Document [3] indicates the Receiving Party will \"reasonably cooperate\" in efforts to seek a protective order.\n   - Document [4] states the Disclosing Party may seek an \"appropriate protective order or other appropriate remedy.\"\n   - Document [5] requires the Receiving Party to provide \"all reasonable assistance\" to the Disclosing Party in attempts to limit or prevent disclosure.\n\nThese consistent requirements across the documents make option A the correct choice, as it aligns with the outlined procedures for handling compelled disclosure of Confidential Information.",
    "latency_ms": 4025.09,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_89",
    "question": "How can you withdraw your consent to receive electronic notices and disclosures from Cotiviti?",
    "options": {
      "A": "Send a letter via US Postal Service",
      "B": "Call Cotiviti customer service",
      "C": "Send an email to legal@verscend.com",
      "D": "Decline to sign a document within your DocuSign account and select a checkbox"
    },
    "correct_answer": "D",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The correct answers are C and D.\n\nThe documents provide two specific methods for withdrawing consent to receive electronic notices and disclosures from Cotiviti:\n\n1. **Send an email to legal@verscend.com**: The documents state that you can send an email to this address, and in the body of the request, you must include your email, full name, IS Postal Address, telephone number, and account number. This is explicitly mentioned in the documents: \"send us an e-mail to legal@verscend.com and in the body of such request you must state your e-mail, full name, IS Postal Address, telephone number, and account number.\"\n\n2. **Decline to sign a document within your DocuSign account and select a checkbox**: The documents also state that you can decline to sign a document from within your DocuSign account, and on the subsequent page, select the checkbox indicating you wish to withdraw your consent. This is explicitly mentioned: \"decline to sign a document from within your DocuSign account, and on the subsequent page, select the check-box indicating you wish to withdraw your consent.\"\n\nOptions A and B are not mentioned in the documents as methods for withdrawing consent. Therefore, the correct options are C and D.",
    "latency_ms": 2410.58,
    "client": "Self Insured Services Co",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_90",
    "question": "What actions may the non-breaching party take upon knowledge of a material breach according to the legal document?",
    "options": {
      "A": "Report the violation to the Secretary immediately without attempting to cure the breach.",
      "B": "Terminate the agreement immediately regardless of the possibility of curing the breach.",
      "C": "Ignore the breach if it cannot be cured.",
      "D": "Provide a reasonable opportunity for the breaching party to cure the breach or end the violation, and terminate the agreement if cure is not possible."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: Provide a reasonable opportunity for the breaching party to cure the breach or end the violation, and terminate the agreement if cure is not possible.\n\nReasoning:\n\nThe documents consistently outline that upon knowledge of a material breach, the non-breaching party is required to provide the breaching party with an opportunity to cure the breach or end the violation. If the breaching party fails to cure the breach within the specified time, or if the non-breaching party reasonably judges that cure is not possible, the non-breaching party may terminate the agreement.\n\nSpecific clauses supporting this include:\n\n- Document [2] states: \"the nonbreaching party shall provide an opportunity for the breaching party, to cure the breach or end the violation, or terminate the Agreement, if the breaching party does not cure the breach or end the violation within the time specified by the non-breaching party, or immediately terminate this Agreement, if, in the non-breaching party\u2019s reasonable judgment cure is not possible.\"\n\n- Document [3] similarly states: \"the nonbreaching party shall provide an opportunity for the breaching party, to cure the breach or end the violation, or terminate the Agreement, if the breaching party does not cure the breach or end the violation within the time specified by the non-breaching party, or immediately terminate this Agreement, if, in the non-breaching party\u2019s reasonable judgment cure is not possible.\"\n\nThese clauses clearly indicate that the non-breaching party must first provide an opportunity to cure the breach, and termination is an option if curing is not feasible. Therefore, option D is the correct choice.",
    "latency_ms": 2774.43,
    "client": "Community First Health Plans",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_91",
    "question": "What must the Recipient do with Discloser\u2019s Confidential Information upon expiration or termination of the Agreement?",
    "options": {
      "A": "Publish a press release about the termination",
      "B": "Keep the information for five years",
      "C": "Return all tangible information and delete electronic information",
      "D": "Destroy all electronic and tangible copies"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Return all tangible information and delete electronic information\n\nReasoning:\n\nThe documents provide clear guidance on the actions required by the Recipient upon expiration or termination of the Agreement regarding the handling of Discloser's Confidential Information. Specifically:\n\n1. Document [5] states: \"Upon expiration or termination of this Agreement or upon written request from Discloser, Recipient will securely and immediately return to Discloser all tangible Confidential Information of Discloser, including but not limited to all reports, media, documentation, notes, plans, drawings, materials, and all copies of the same. With respect to Discloser\u2019s Confidential Information stored in electronic form, Recipient will securely, at Discloser\u2019s sole discretion, either (i) promptly return or (ii) delete all such Confidential Information from its and its Recipient Personnel\u2019s systems pursuant to its electronic records archival policy and certify in writing to Discloser that such information has been so returned or deleted.\"\n\nThis clause explicitly requires the Recipient to return all tangible information and either return or delete electronic information, depending on the Discloser's discretion. Therefore, option C is the correct answer. \n\nOptions A, B, and D are incorrect because:\n- A: Publishing a press release is not mentioned as a requirement upon termination.\n- B: Keeping the information for five years contradicts the requirement to return or delete the information.\n- D: Destroying all copies is not the only option; returning tangible information is also required.",
    "latency_ms": 2776.49,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_92",
    "question": "What is the minimum retrieval rate for medical records in a risk adjustment campaign as specified in the SOW?",
    "options": {
      "A": "95%",
      "B": "90%",
      "C": "87%",
      "D": "75%"
    },
    "correct_answer": "C",
    "predicted_answer": "B",
    "is_correct": false,
    "response": "The correct answer is B: 90%.\n\nReasoning: The document specifies in section 6.1.1 that for Medicare Risk Adjustment (MRA), Commercial Risk Adjustment (CRA), and HEDIS Requests, \"Ninety percent (90%) of Retrievable records shall be provided to Humana by the project due date.\" This indicates that the minimum retrieval rate for medical records in a risk adjustment campaign is 90%.",
    "latency_ms": 1424.68,
    "client": "AdvantMed",
    "document_type": "SOW",
    "method": "RAG"
  },
  {
    "id": "qa_93",
    "question": "What is the duration for which Eliza must maintain records to verify performance and compliance according to the agreement?",
    "options": {
      "A": "For ninety days after the Term",
      "B": "For two years after the Term",
      "C": "During the Term only",
      "D": "For five years after the Term"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: For two years after the Term\n\nExplanation:\n\nAccording to the information provided in document [2], Eliza is required to maintain records necessary to verify its performance and compliance with the Agreement \"During the Term and for two (2) years thereafter or as required by law, whichever is greater.\" This clause explicitly states the duration for which Eliza must keep records, making option B the correct answer. The document does not mention any other duration such as ninety days, five years, or only during the Term, which eliminates options A, C, and D.",
    "latency_ms": 1170.83,
    "client": "Inogen",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_94",
    "question": "What are the requirements for retaining Aetna\u2019s Business Records according to the amendment?",
    "options": {
      "A": "Records must be retained permanently.",
      "B": "Supplier must retain records as per the retention period in the specific Schedule.",
      "C": "Records must be retained until the termination of the Agreement.",
      "D": "Supplier must retain records for 5 years."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: Supplier must retain records as per the retention period in the specific Schedule.\n\nReasoning:\n\nThe amendment explicitly states that the Supplier is required to retain Aetna\u2019s Business Records in accordance with the retention period set forth in the specific Schedule. This is outlined in the clause from document [1]: \"Supplier shall retain Aetna\u2019s Business Records in accordance with the retention period set forth in said Schedule.\" This indicates that the retention period is not fixed universally but is determined by the specific Schedule associated with the records. Document [2] further specifies that for Medicaid and Medicare Advantage requirements, records must be retained for a period of 10 years from the date of the contract period to which the records relate or the date of completion of any government audit, whichever is later. This reinforces the idea that the retention period is defined by the Schedule, not permanently or for a fixed number of years like 5 years.",
    "latency_ms": 1778.47,
    "client": "Aetna Life Insurance Company",
    "document_type": "Amendment",
    "method": "RAG"
  },
  {
    "id": "qa_95",
    "question": "What does the NDA between ATRIO Health Plans and Cotiviti Inc. specify about the nature of the relationship between the parties?",
    "options": {
      "A": "The NDA establishes a joint venture between the parties.",
      "B": "The NDA does not establish a joint venture, partnership, or formal business organization between the parties.",
      "C": "The NDA creates a formal business organization between the parties.",
      "D": "The NDA implies a partnership between the parties."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: The NDA does not establish a joint venture, partnership, or formal business organization between the parties.\n\nReasoning: The NDA explicitly states that \"Neither Party shall be bound by the actions of the other, shall be liable for the debts of the other, or shall have a right to share in the profits of the other.\" Furthermore, it clarifies that \"This Agreement is not intended to be a joint venture, partnership or other formal business organization, and neither Party is under any obligation to enter into any further agreement with the other Party.\" This language clearly indicates that the NDA does not create any formal business relationship such as a joint venture or partnership between ATRIO Health Plans and Cotiviti Inc.",
    "latency_ms": 1877.94,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_96",
    "question": "What is the required timeframe for installing critical security patches on systems processing Company PHI?",
    "options": {
      "A": "Within 30 days of vendor release",
      "B": "Within 7 days of vendor release",
      "C": "Within 14 days of vendor release",
      "D": "Within 60 days of vendor release"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is **A: Within 30 days of vendor release**.\n\nReasoning:\n\nThe documents explicitly state the requirement for installing critical security patches on systems processing Company PHI. According to the context provided in both documents [2] and [3], it is mentioned that:\n\n\"All workstations, laptops and other systems that process and/or store Company PHI must have critical security patches applied, with system reboot if necessary. There must be a documented patch management process which determines installation timeframe based on risk assessment and vendor recommendations. At a maximum, all applicable patches must be installed within thirty (30) days of vendor release.\"\n\nThis clause clearly specifies that the maximum timeframe for installing these patches is within 30 days of their release by the vendor. Therefore, option A is the correct choice based on the explicit information provided in the documents.",
    "latency_ms": 2220.13,
    "client": "Aetna Life Insurance Company",
    "document_type": "Addendum",
    "method": "RAG"
  },
  {
    "id": "qa_97",
    "question": "What actions are prohibited regarding prototypes, software, or other tangible objects that embody a party\u2019s Confidential Information?",
    "options": {
      "A": "Exporting, selling, and marketing",
      "B": "Exporting, disassembling, and distributing",
      "C": "Exporting, reverse engineering, and disassembling",
      "D": "Exporting, reverse engineering, and selling"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Exporting, reverse engineering, and disassembling.\n\nReasoning:\n\nThe documents provide specific restrictions on actions related to Confidential Information, particularly concerning tangible objects such as prototypes and software. Document [4] explicitly states:\n\n\"(c) The Receiving Party shall not tamper with, modify, adapt, translate, reverse engineer, decompile, disassemble or create derivative works based upon the Confidential Information.\"\n\nThis clause clearly prohibits reverse engineering and disassembling of Confidential Information, which includes tangible objects like prototypes and software. While exporting is not explicitly mentioned in the provided excerpts, the prohibition of reverse engineering and disassembling aligns with option C. The other options include actions like selling and marketing, which are not specifically addressed in the context of prohibited actions regarding tangible objects embodying Confidential Information.",
    "latency_ms": 2055.76,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_98",
    "question": "What must the Business Associate do with PHI upon termination of the agreement?",
    "options": {
      "A": "Return or destroy all PHI in its possession.",
      "B": "Encrypt the PHI and keep it for future use.",
      "C": "Transfer the PHI to a third party for safekeeping.",
      "D": "Retain all copies of PHI indefinitely."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Return or destroy all PHI in its possession.\n\nReasoning:\n\nThe documents provide clear guidance on the actions required of the Business Associate regarding PHI upon termination of the agreement. Specifically, the Business Associate is obligated to either return to the Covered Entity or destroy all PHI in its possession or in the possession of its agents or subcontractors. This is explicitly stated in multiple sections of the context:\n\n1. Document [1] states: \"Upon termination of this Agreement and the Master Agreement, Business Associate shall either return to Covered Entity or destroy all PHI in Business Associate\u2019s possession or in the possession of its agents or subcontractors. Business Associate shall not retain any copies of PHI.\"\n\n2. Document [4] reiterates: \"Upon termination of this Agreement, Business Associate will, if feasible, return to MPHC or destroy all PHI, in whatever form or medium... Business Associate will complete such return or destruction promptly, but no later than thirty (30) days after the effective date of the termination or expiration of this Agreement.\"\n\n3. Document [5] further supports this requirement: \"In the event that return or destruction of the PHI is not feasible, Business Associate may retain the PHI subject to this Section 4.2.\"\n\nThese sections collectively emphasize that the Business Associate must either return or destroy all PHI upon termination, and if infeasible, must provide notification and extend protections to the PHI. There is no mention of encrypting for future use, transferring to a third party, or retaining indefinitely, making options B, C, and D incorrect.",
    "latency_ms": 3420.21,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_99",
    "question": "Which federal act must the party receiving Confidential Information comply with according to the document?",
    "options": {
      "A": "The Fair Credit Reporting Act of 1970",
      "B": "The Gramm-Leach-Bliley Act of 1999",
      "C": "The Privacy Act of 1974",
      "D": "The Data Protection Act of 1998"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: The Gramm-Leach-Bliley Act of 1999\n\nReasoning: The document explicitly states that the party receiving Confidential Information must comply with \"all federal, state, provincial and local laws, regulations, or other requirements including the Gramm-Leach-Bliley Act of 1999, 15 U.S.C., Section 6801, as amended from time to time governing the privacy, confidentiality and non-disclosure of such information.\" This indicates that compliance with the Gramm-Leach-Bliley Act of 1999 is a specific requirement for the party receiving Confidential Information.",
    "latency_ms": 1352.63,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_100",
    "question": "What is required for a waiver of a provision or right under the MSA to be binding?",
    "options": {
      "A": "It must be notarized by a third party.",
      "B": "It must be given in writing and signed by the party granting the waiver.",
      "C": "It must be approved by the court.",
      "D": "It must be verbally agreed upon by both parties."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: It must be given in writing and signed by the party granting the waiver.\n\nReasoning:\n\nThe documents consistently state that for a waiver to be binding, it must be in writing and signed by the party granting the waiver. This requirement is explicitly mentioned in multiple documents:\n\n1. Document [1] states: \"Waiver of a breach or of any right of election arising from a breach of this document must be in writing and signed by the party granting the waiver.\"\n\n2. Document [2] mentions: \"Any waiver, which must be in writing from a duly authorized representative of each party...\"\n\n3. Document [4] specifies: \"No waiver shall be binding unless executed in writing by the Party making the waiver.\"\n\n4. Document [5] reiterates: \"No waiver shall be binding unless executed in writing by the Party making the waiver.\"\n\nThese clauses clearly establish that the waiver must be documented in writing and signed by the party granting it, making option B the correct choice. There is no mention of notarization by a third party, court approval, or verbal agreement as valid methods for a waiver to be binding in any of the documents provided.",
    "latency_ms": 2418.1,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_101",
    "question": "What restrictions are imposed on the Client regarding the Verisk IP?",
    "options": {
      "A": "Client can copy Verisk IP for internal use.",
      "B": "Client can reverse engineer Verisk IP.",
      "C": "Client can create derivative works from Verisk IP.",
      "D": "Client cannot distribute or sublicense Verisk IP."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Client cannot distribute or sublicense Verisk IP.\n\nReasoning:\n\nThe documents explicitly state several restrictions imposed on the Client regarding the Verisk IP. According to the text, the Client is prohibited from engaging in activities such as reverse engineering, decompiling, reverse compiling, or disassembling the Verisk IP. Additionally, the Client is not allowed to create derivative works or compilations of the Verisk IP, which includes any product or service derived or compiled from Verisk services or products. Furthermore, the Client is restricted from copying, distributing, marketing, selling, leasing, sublicensing, or otherwise transferring the Licensed Programs or Services to third parties. \n\nThe relevant clause from the document states: \"Client may not copy, distribute, market, sell, lease, sublicense or otherwise transfer the Licensed Programs or Services to third parties.\" This clearly indicates that option D is correct, as the Client is explicitly restricted from distributing or sublicensing the Verisk IP.",
    "latency_ms": 1910.28,
    "client": "Martin's Point Health Care",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_102",
    "question": "What type of information is excluded from being disclosed during discussions of a Potential Transaction according to the agreement?",
    "options": {
      "A": "Proprietary information",
      "B": "Trade secrets",
      "C": "Intellectual property rights",
      "D": "Protected Health Information (PHI)"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Protected Health Information (PHI)\n\nReasoning:\n\nThe agreement explicitly states that information disclosed and received in the course of discussions concerning a Potential Transaction shall not include information defined as Protected Health Information (PHI) under federal regulations at 45 C.F.R. \u00a7 160.103. This exclusion is clearly outlined in the documents, indicating that PHI is not to be included unless it has been de-identified within the meaning of regulations at 45 C.F.R. \u00a7 164.514. This is a specific restriction placed on the type of information that can be shared during discussions of a Potential Transaction, making PHI the correct answer. \n\nThe agreement does not exclude proprietary information, trade secrets, or intellectual property rights from being disclosed; rather, it specifies that the disclosure of information does not grant a license under any of the Disclosing Party\u2019s trade secrets, proprietary, or other intellectual property rights. Therefore, the exclusion specifically pertains to PHI.",
    "latency_ms": 1943.25,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_103",
    "question": "What is the obligation of the Receiving Party regarding the destruction of Confidential Information upon request by the Disclosing Party?",
    "options": {
      "A": "Destroy all Confidential Information within 5 business days and confirm destruction in writing.",
      "B": "Destroy all Confidential Information within 30 days and confirm destruction in writing.",
      "C": "Destroy all Confidential Information within 3 business days and confirm destruction in writing.",
      "D": "Destroy all Confidential Information within 10 business days and confirm destruction in writing."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Destroy all Confidential Information within 5 business days and confirm destruction in writing.\n\nReasoning:\n\nThe documents consistently state that upon the request of the Disclosing Party, the Receiving Party is obligated to destroy all Confidential Information in its possession or control within a specific timeframe. Specifically, the timeframe mentioned is \"promptly (and in no event later than five business days after such request)\" as seen in the excerpts from documents [1], [2], and [3]. Additionally, the Receiving Party must confirm the destruction in writing to the Disclosing Party. This requirement is clearly outlined in the provided context, making option A the correct choice. \n\nThe other options (B, C, and D) do not match the specified timeframe of five business days as stated in the documents.",
    "latency_ms": 1962.82,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_104",
    "question": "Under what conditions does the NDA become inoperative regarding Confidential Information?",
    "options": {
      "A": "When the information is already known to the Nondisclosing Party independently.",
      "B": "When Confidential Information is disclosed by the Nondisclosing Party.",
      "C": "When the information is disclosed in the course of a negotiation.",
      "D": "When the information becomes available from a source bound by confidentiality."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: When the information is already known to the Nondisclosing Party independently.\n\nReasoning:\n\nThe NDA becomes inoperative regarding Confidential Information under specific conditions outlined in the documents. According to document [2], the NDA is inoperative for portions of the Confidential Information that:\n\n- \"(iii) were known to the Nondisclosing Party on a non-confidential basis prior to their disclosure to the Nondisclosing Party by the Disclosing Party or its Representatives.\"\n\nThis clause explicitly states that if the information was already known to the Nondisclosing Party independently and on a non-confidential basis before it was disclosed by the Disclosing Party, the NDA does not apply to that portion of the information. \n\nOther options do not align with the conditions specified in the documents:\n\n- B: The NDA does not become inoperative simply because the Nondisclosing Party discloses Confidential Information; this would likely be a breach of the NDA.\n- C: The NDA does not mention becoming inoperative due to information disclosed during negotiations.\n- D: The NDA specifies that information becomes inoperative if it is received from a source not bound by confidentiality, not from a source that is bound by confidentiality.",
    "latency_ms": 2179.08,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_105",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the Agreement or upon request by the Disclosing Party?",
    "options": {
      "A": "Destroy or return all documents except for a single archival copy for dispute resolution purposes.",
      "B": "Transfer all Confidential Information to a third party.",
      "C": "Delete only electronic copies and retain physical copies indefinitely.",
      "D": "Retain all documents for future reference."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Destroy or return all documents except for a single archival copy for dispute resolution purposes.\n\nReasoning:\n\n1. **Document [1]** specifies that upon termination of the agreement or upon written request by the Disclosing Party, the Receiving Party must \"destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\" This clearly indicates that the Receiving Party must destroy or return all documents except for a single archival copy.\n\n2. **Document [2]** allows the Receiving Party to destroy all copies of the Confidential Information in its possession, with the exception of electronic copies stored in computer system backups that cannot reasonably be isolated for deletion. It also permits retaining one copy for regulatory compliance or verification purposes, provided it is held in secure storage.\n\n3. **Document [3]** states that the Receiving Party must return or destroy the Confidential Information upon request, except for copies existing on backup tapes or other electronic storage devices. It also allows retaining a copy for regulatory and accounting purposes.\n\n4. **Documents [4] and [5]** both require the Receiving Party to destroy all Confidential Information upon request, except for automatically generated computer backup or archival copies, which must be protected under the agreement's terms.\n\nAcross these documents, the consistent requirement is to destroy or return all Confidential Information, with specific exceptions for archival or backup copies under certain conditions. Therefore, option A is the correct choice, as it aligns with the requirements stated in the documents.",
    "latency_ms": 3614.45,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_106",
    "question": "What is the non-competition clause duration mentioned in the agreement between Licensor and Licensee?",
    "options": {
      "A": "No non-competition clause is specified",
      "B": "During the term of the agreement only",
      "C": "For one year after termination of the agreement",
      "D": "For five years after termination of the agreement"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: For one year after termination of the agreement\n\nReasoning: The agreement explicitly states in section H) Non-Competition that \"Licensee agrees that during the term of this Agreement and for a term of one year subsequent to the termination of this Agreement, Licensee shall not develop or sell a product, or hire any third party to develop a product, with the same or substantially similar functionality to the Licensed Program.\" This clearly indicates that the non-competition clause is effective during the term of the agreement and extends for one year after its termination.",
    "latency_ms": 2133.58,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_108",
    "question": "What security measure is required when Humana requests remote access to COMPANY network?",
    "options": {
      "A": "Password protection only",
      "B": "Single-factor authentication",
      "C": "2-factor or dual authentication",
      "D": "Biometric authentication"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: 2-factor or dual authentication\n\nReasoning:\n\nThe documents explicitly state that if Humana remote access into COMPANY network is required, COMPANY shall require 2-factor, or dual authentication prior to allowing access to Humana Confidential Information. This requirement is consistently mentioned across multiple sections of the Master Services Agreement, indicating a clear and actionable security measure that must be implemented for remote access scenarios involving Humana. \n\nFor example, in document [1], it states: \"If Humana remote access into COMPANY network is required, COMPANY shall require 2-factor, or dual authentication prior to allowing access to Humana Confidential Information.\" Similar language is found in documents [2], [3], and [4], reinforcing the requirement for 2-factor or dual authentication as the necessary security measure. \n\nThis requirement ensures that access to sensitive information is protected by an additional layer of security beyond just a password, thereby reducing the risk of unauthorized access.",
    "latency_ms": 1747.97,
    "client": "Humana",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_109",
    "question": "What is the fee for application enhancement and off-hour testing according to the legal document?",
    "options": {
      "A": "$500 per application",
      "B": "$0.10 per record",
      "C": "$250 per hour",
      "D": "$55 per hour"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: $250 per hour\n\nReasoning:\n\nThe fee for application enhancement and off-hour testing is explicitly stated in multiple documents within the context provided. Specifically, document [3] mentions:\n\n\"II.4.a Application Enhancement and Off-Hour Testing Fees: $250 per hour, as needed.\"\n\nSimilarly, document [5] states:\n\n\"2.b Application Enhancement and Off-Hour Testing Fees: $250 per hour.\"\n\nThese clauses clearly indicate that the fee for application enhancement and off-hour testing is $250 per hour, making option C the correct answer. Other options such as A, B, and D do not match the specified fee in the documents.",
    "latency_ms": 1910.27,
    "client": "Inogen",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_110",
    "question": "What is included as part of the License Agreement for the Licensed Program?",
    "options": {
      "A": "Limited technical support during normal business hours",
      "B": "All travel and out-of-pocket expenses covered",
      "C": "Unlimited technical support during business hours",
      "D": "Free on-site training and consulting services"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Limited technical support during normal business hours\n\nExplanation:\n\nThe License Agreement for the Licensed Program includes \"limited technical support with installation and operation of the Licensed Program during normal business hours\" as part of the agreement, at the Licensor\u2019s reasonable discretion. This is explicitly stated in the document under Attachment C, which outlines the contract service rates and the scope of support provided. \n\nThe document does not mention covering all travel and out-of-pocket expenses (Option B); instead, it specifies that these expenses are additional and billed at cost. It also does not offer unlimited technical support (Option C) or free on-site training and consulting services (Option D). On-site training is available but at a cost of $5,000 per day, as indicated in the contract service rates.",
    "latency_ms": 1632.95,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_111",
    "question": "What document contains the sole and exclusive terms and conditions governing the parties' rights with respect to the Services?",
    "options": {
      "A": "Attachments",
      "B": "Business Associate Agreement",
      "C": "Statements of Work",
      "D": "Master Agreement"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Master Agreement\n\nReasoning:\n\nThe document that contains the sole and exclusive terms and conditions governing the parties' rights, responsibilities, and obligations with respect to the Services is the \"Master Agreement.\" This is explicitly stated in the context provided in [1], where it mentions: \"This Agreement contains the sole and exclusive terms and conditions that will govern the rights, responsibilities, and obligations of the parties with respect to the Services.\" The Master Agreement is defined as consisting of the cover page, terms and conditions, any attachments, statements of work, amendments, and any Business Associate Agreement executed between the parties. Therefore, the Master Agreement is the overarching document that governs the services provided between the parties.",
    "latency_ms": 1340.1,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_112",
    "question": "What security measure is required for business-to-business connectivity between COMPANY and Humana?",
    "options": {
      "A": "Firewall only",
      "B": "Firewall, PGP encryption, and access list controls",
      "C": "Access list controls only",
      "D": "PGP encryption only"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Firewall, PGP encryption, and access list controls.\n\nReasoning:\n\nThe documents explicitly state the security measures required for business-to-business connectivity between COMPANY and Humana. According to the context provided in both [1] and [2], the requirement is clearly outlined as follows:\n\n\"COMPANY shall ensure that any business-to-business connectivity between COMPANY and Humana shall be protected by firewall, PGP encryption, and access list controls.\"\n\nThis statement specifies that all three security measures\u2014firewall, PGP encryption, and access list controls\u2014are required to protect the connectivity between COMPANY and Humana. Therefore, option B is the correct choice as it includes all the specified security measures.",
    "latency_ms": 1669.23,
    "client": "Humana",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_113",
    "question": "What actions must a Receiving Party take if compelled to disclose Confidential Information by legal process?",
    "options": {
      "A": "Immediately disclose the information without notifying the Disclosing Party.",
      "B": "Ignore the request and refuse to disclose any information.",
      "C": "Provide prompt written notice to the Disclosing Party and seek a protective order.",
      "D": "Disclose the information and notify the Disclosing Party after disclosure."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Provide prompt written notice to the Disclosing Party and seek a protective order.\n\nReasoning:\n\nThe documents consistently outline the procedure that a Receiving Party must follow if compelled to disclose Confidential Information due to legal processes. Specifically:\n\n1. **Document [1]** states that the Receiving Party must give prior written notice to the Disclosing Party of the requirement to disclose, unless prohibited by law. The Receiving Party should also make reasonable efforts to allow the Disclosing Party to seek a confidentiality agreement, protective order, or modification of the disclosure, and cooperate in such efforts.\n\n2. **Document [2]** and **Document [3]** both specify that the Recipient or its Representatives must provide prompt notice to the Disclosing Party of any request or requirement to disclose Confidential Information. This allows the Disclosing Party to seek a protective order or other remedy. If such a remedy cannot be obtained, the Recipient may disclose only the portion of Confidential Information legally compelled, while making commercially reasonable efforts to ensure confidential treatment.\n\n3. **Document [4]** similarly requires the Receiving Party to provide prompt written notice to the Disclosing Party before making any required disclosure, allowing the Disclosing Party to seek a protective order or other limitations on disclosure.\n\nThese documents collectively emphasize the importance of notifying the Disclosing Party promptly and seeking protective measures before any compelled disclosure occurs. Therefore, option C is the correct choice, as it aligns with the requirements and procedures outlined in the documents.",
    "latency_ms": 3976.02,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_114",
    "question": "What is required of the Vendor before using an external network connection for transmitting Customer Information?",
    "options": {
      "A": "Obtain Customer\u2019s prior written approval",
      "B": "Assess the connection for risk",
      "C": "Review firewall logs regularly",
      "D": "Implement a secure communications protocol"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Obtain Customer\u2019s prior written approval.\n\nReasoning:\n\nThe requirement for the Vendor before using an external network connection for transmitting Customer Information is explicitly stated in the document from context [1]. According to section 8.1(d) of the \"Data Communications Security\" clause, the Vendor must \"obtain Customer\u2019s prior written approval before its use for the transmission of any Customer Information.\" This requirement is clear and specific, indicating that the Vendor cannot use an external network connection for transmitting Customer Information without first securing written approval from the Customer.\n\nWhile assessing the connection for risk (option B) is also mentioned in the same clause, it is part of the process that accompanies obtaining prior written approval, not a standalone requirement before transmission. Therefore, the primary actionable requirement is obtaining the Customer's prior written approval.",
    "latency_ms": 2114.81,
    "client": "AIA Health Insurance Pty Ltd",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_115",
    "question": "What does the NDA between ATRIO Health Plans and the other party specify regarding the nature of their relationship?",
    "options": {
      "A": "It is a formal business organization.",
      "B": "It specifies that neither party is bound by the actions of the other.",
      "C": "It creates a partnership.",
      "D": "It establishes a joint venture."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The NDA between ATRIO Health Plans and the other party specifies the nature of their relationship as follows:\n\nThe document states that \"This Agreement is the entire understanding between the Parties as to the subject matter hereof.\" This indicates that the agreement is comprehensive regarding the subject matter it covers, but it does not explicitly define the nature of the relationship as a business organization, partnership, or joint venture.\n\nFurthermore, the agreement binds \"the Parties and their respective successors, assigns, agents, employers, subsidiaries and affiliates who have access to the Confidential Information.\" This clause suggests that the agreement is primarily concerned with confidentiality and the binding nature of the agreement on various related entities, but it does not specify the creation of a partnership or joint venture.\n\nThe document does not mention any specific organizational structure or relationship such as a partnership or joint venture. It focuses on the binding nature of the agreement and the confidentiality obligations, without establishing a formal business organization or specifying that neither party is bound by the actions of the other.\n\nTherefore, based on the information provided, the correct answer is:\n\nB: It specifies that neither party is bound by the actions of the other.\n\nThis option aligns with the general nature of NDAs, which typically focus on confidentiality and do not establish formal business relationships like partnerships or joint ventures. The document does not explicitly state that neither party is bound by the actions of the other, but it does not establish any formal business relationship either.",
    "latency_ms": 3256.82,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_116",
    "question": "Under what circumstances can a party assign its rights and obligations under the Agreement without prior written consent from the other party?",
    "options": {
      "A": "Only with mutual agreement and consent",
      "B": "To a successor owning substantially all business assets",
      "C": "When assigning to any third party",
      "D": "When assigning a minor part of the Agreement"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: To a successor owning substantially all business assets\n\nReasoning:\n\nThe documents provide specific circumstances under which a party can assign its rights and obligations under the Agreement without prior written consent from the other party. \n\n1. Document [1] states: \"either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor in ownership of substantially all the assets of the business.\"\n\n2. Document [2] similarly allows assignment without consent to a corporation or business entity succeeding to all or substantially all the assets and business of the assigning Party by merger or purchase, provided that such entity is not a direct competitor of Verisk\u2019s.\n\n3. Document [5] also mentions: \"either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor in ownership of substantially all the assets of the business.\"\n\nThese clauses consistently indicate that assignment is permissible without prior written consent when it involves a successor owning substantially all business assets, making option B the correct choice.",
    "latency_ms": 1973.43,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_117",
    "question": "What must the Receiving Party do with Confidential Information upon request from the Disclosing Party?",
    "options": {
      "A": "Transfer all Confidential Information to a secure database",
      "B": "Send all Confidential Information back to the Disclosing Party within 10 business days",
      "C": "Preserve the Confidential Information for future reference",
      "D": "Destroy all Confidential Information within 5 business days and confirm destruction in writing"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Destroy all Confidential Information within 5 business days and confirm destruction in writing\n\nReasoning: The documents consistently state that upon request from the Disclosing Party, the Receiving Party is required to destroy all Confidential Information in their possession or control within a specified timeframe. Specifically, the documents [1], [2], and [3] mention that the Receiving Party must \"promptly (and in no event later than five business days after such request) (i) destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives\" and \"confirm such destruction in writing to the Disclosing Party.\" This requirement is clear and consistent across the documents, making option D the correct choice. \n\nAdditionally, while there are provisions for exceptions regarding automatically generated computer back-up or archival copies, these do not negate the primary obligation to destroy the main copies of the Confidential Information and confirm the destruction in writing.",
    "latency_ms": 2162.63,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_119",
    "question": "What must the Receiving Party do with the Confidential Information after the termination of the Agreement or upon written request by the Disclosing Party?",
    "options": {
      "A": "Retain a single archival copy and destroy all other copies",
      "B": "Deliver all copies to the Disclosing Party and retain no copies",
      "C": "Destroy all copies including electronic and digital copies",
      "D": "Retain all copies for archival purposes"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is **A: Retain a single archival copy and destroy all other copies**.\n\nReasoning:\n\n1. **Document [1]** specifies that upon termination of the agreement or upon written request by the Disclosing Party, the Receiving Party must \"destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\" This clearly indicates that the Receiving Party is allowed to retain a single archival copy for specific purposes while destroying all other copies.\n\n2. **Document [2]** allows the Receiving Party to retain one copy of Confidential Information for regulatory compliance or verification purposes, provided it is held in secure storage and kept confidential. This supports the notion of retaining a single copy for specific purposes.\n\n3. **Documents [3], [4], and [5]** also mention the destruction of Confidential Information upon request, with exceptions for backup copies and archival purposes, indicating that not all copies need to be destroyed if they serve specific purposes such as regulatory compliance or dispute resolution.\n\nTherefore, the consistent theme across these documents is that the Receiving Party must destroy all copies except for a single archival copy retained for specific purposes, aligning with option A.",
    "latency_ms": 2634.5,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_120",
    "question": "What must the Vendor obtain before using an external network connection for transmitting Customer Information?",
    "options": {
      "A": "An internal audit approval",
      "B": "A risk assessment report",
      "C": "A verbal confirmation from the Customer",
      "D": "Customer\u2019s prior written approval"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Customer\u2019s prior written approval\n\nReasoning: According to document [2], specifically section 8.1(d), the Vendor must ensure that each external network connection is assessed for risk, logged, governed by a contract, and obtain Customer\u2019s prior written approval before its use for the transmission of any Customer Information. This clause explicitly states the requirement for written approval from the Customer, making option D the correct answer.",
    "latency_ms": 1368.87,
    "client": "AIA Health Insurance Pty Ltd",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_121",
    "question": "What is excluded from Comparative Data according to the General VH Master Services Agreement?",
    "options": {
      "A": "Membership Information",
      "B": "Application Data",
      "C": "Utilization Management Data",
      "D": "Protected Health Information"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: Protected Health Information.\n\nReasoning: According to the General VH Master Services Agreement, as stated in the context provided, \"Comparative Data\" is defined as aggregated data, including De-identified Data and data provided by other Verisk clients, which allows the Client to compare its calculated values against those of a broader base of similar clients. Importantly, the document explicitly states, \"For purposes of explanation and not exclusion, Protected Health Information will be excluded from Comparative Data.\" This directly indicates that Protected Health Information is not included in Comparative Data, making option D the correct choice.",
    "latency_ms": 1699.98,
    "client": "Martin's Point Health Care",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_122",
    "question": "Under what conditions can the Supplier use or disclose PHI according to the agreement?",
    "options": {
      "A": "For any purpose as long as it is de-identified.",
      "B": "For research purposes without any restrictions.",
      "C": "Only for marketing purposes with individual authorization.",
      "D": "As directed by the Company to carry out obligations or as required by law."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: As directed by the Company to carry out obligations or as required by law.\n\nExplanation:\n\nThe documents explicitly state that the Supplier is restricted in how they can use or disclose PHI. Specifically, the Supplier is permitted to use or disclose PHI only under certain conditions:\n\n1. **Directed by Company**: The Supplier can use or disclose PHI as directed by the Company to carry out the obligations set forth in the Agreement or applicable Supplier Agreements. This is mentioned in multiple sections, such as in [1], [2], and [4], where it states, \"Supplier shall neither use nor disclose PHI for the purpose of creating de-identified information that will be used for any purpose other than as directed by Company to carry out the obligations of Supplier set forth in this Agreement or the applicable Supplier Agreements, or as required by law.\"\n\n2. **As Required by Law**: The Supplier is also allowed to use or disclose PHI as required by law. This is a standard provision in agreements involving PHI to ensure compliance with legal obligations.\n\nThe documents do not provide permissions for using PHI for any purpose as long as it is de-identified (Option A), for research purposes without restrictions (Option B), or for marketing purposes with individual authorization (Option C). In fact, the sale of PHI is explicitly prohibited, and the Supplier is prohibited from seeking an individual's authorization to sell their PHI, as stated in [1], [2], and [5]. Therefore, Option D is the correct answer based on the explicit permissions and restrictions outlined in the documents.",
    "latency_ms": 2614.98,
    "client": "Blue Shield of California",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_123",
    "question": "What restriction does the agreement place on the disclosure of Protected Health Information (PHI)?",
    "options": {
      "A": "PHI cannot be disclosed at all under any circumstances.",
      "B": "PHI can be disclosed if it is part of the Potential Transaction.",
      "C": "PHI can be disclosed if it is de-identified according to federal regulations.",
      "D": "PHI can be disclosed with a written amendment to the agreement."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: PHI can be disclosed if it is de-identified according to federal regulations.\n\nReasoning:\n\nThe agreement explicitly states that information disclosed and received in the course of discussions concerning a Potential Transaction shall not include information defined as Protected Health Information (PHI) under federal regulations at 45 C.F.R. \u00a7 160.103, except insofar as such PHI may have been de-identified within the meaning of regulations at 45 C.F.R. \u00a7 164.514. This indicates that the restriction on the disclosure of PHI is lifted if the PHI is de-identified according to the specified federal regulations. \n\nThe documents do not support options A, B, or D:\n- Option A is incorrect because the agreement allows for the disclosure of de-identified PHI.\n- Option B is incorrect because the agreement specifically excludes PHI from the Potential Transaction unless de-identified.\n- Option D is incorrect because the agreement does not mention that PHI can be disclosed with a written amendment; it only mentions amendments in the context of modifying the agreement itself, not the disclosure of PHI.",
    "latency_ms": 2052.74,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_124",
    "question": "How long do the obligations regarding trade secrets survive after the termination of the agreement?",
    "options": {
      "A": "3 years",
      "B": "For as long as the information qualifies as a trade secret",
      "C": "1 year",
      "D": "5 years"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: For as long as the information qualifies as a trade secret\n\nReasoning:\n\nThe documents consistently state that the obligations regarding trade secrets survive for as long as the information qualifies as a trade secret. This is explicitly mentioned in multiple sections across the provided context:\n\n- In [1], it states, \"Receiving Party\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\"\n- In [2], it similarly states, \"Recipient\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\"\n- In [3], [4], and [5], the same clause is repeated, indicating that the obligations regarding trade secrets are not limited to a specific time frame like 3 years, but rather depend on the information's status as a trade secret.\n\nTherefore, the correct answer is B, as the obligations are tied to the qualification of the information as a trade secret, not a fixed period.",
    "latency_ms": 2307.07,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_126",
    "question": "What is the time frame within which the Business Associate must notify BCBSNE of a discovered or suspected HIPAA Breach?",
    "options": {
      "A": "Within 72 hours after discovery",
      "B": "Within 7 days after discovery",
      "C": "Immediately after discovery",
      "D": "Within 24 hours after discovery"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Within 72 hours after discovery\n\nThe documents explicitly state that if the Business Associate discovers an actual or suspected HIPAA Breach, they are required to notify BCBSNE \"without unreasonable delay and in no event more than 72 hours after the discovery.\" This requirement is clearly outlined in the context provided, ensuring that the Business Associate has a specific time frame to report such incidents. The notification must include identification of each individual whose PHI is believed to have been accessed, acquired, or disclosed during the breach, along with other relevant details.",
    "latency_ms": 1274.19,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_127",
    "question": "Under what circumstances may the Business Associate use PHI without violating the Privacy Rule?",
    "options": {
      "A": "For personal use",
      "B": "For marketing purposes",
      "C": "For the proper management and administration of Business Associate",
      "D": "For selling to third parties"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: For the proper management and administration of Business Associate.\n\nReasoning:\n\nThe documents explicitly state that the Business Associate may use PHI for the proper management and administration of Business Associate without violating the Privacy Rule. This is outlined in several sections:\n\n1. Document [1] states: \"Business Associate may use PHI only as necessary for Business Associate\u2019s proper management and administration or to carry out Business Associate\u2019s legal responsibilities.\"\n\n2. Document [2] further clarifies: \"Business Associate shall not use PHI in any manner that would constitute a violation of the Privacy Rule if so used by Covered Entity, except that Associate may use PHI (i) for the proper management and administration of Business Associate.\"\n\n3. Document [5] reiterates: \"Except as otherwise limited in this Agreement, Business Associate may use PHI for the proper management and administration of Business Associate or to carry out the legal responsibilities of Business Associate.\"\n\nThese clauses collectively confirm that using PHI for the proper management and administration of the Business Associate is permissible and does not violate the Privacy Rule, provided it is done in accordance with the terms of the agreement and applicable laws.\n\nOptions A, B, and D are incorrect because:\n\n- A: Personal use of PHI is not mentioned as permissible in any of the documents.\n- B: Marketing purposes are restricted, as stated in document [5]: \"Business Associate shall not directly or indirectly receive payment for any use or disclosure of PHI for marketing purposes except where permitted by Agreement and consistent with applicable law.\"\n- D: Selling PHI to third parties is explicitly prohibited, as stated in document [5]: \"Business Associate shall not directly or indirectly receive payment in exchange for PHI except where permitted by the Agreement and consistent with applicable law.\"",
    "latency_ms": 3773.0,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_128",
    "question": "Under what circumstances may both parties use or disclose Confidential Information according to the agreement?",
    "options": {
      "A": "Only if it is necessary for marketing purposes",
      "B": "Only if required by the agreement terms",
      "C": "Only if both parties agree in writing",
      "D": "If required by any government authority or law"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: If required by any government authority or law.\n\nReasoning:\n\nThe documents provide specific circumstances under which Confidential Information may be disclosed:\n\n1. Document [2] states: \"Notwithstanding the foregoing, each party may produce the Confidential Information if required by law, or if requested by any judicial, administrative, governmental or regulatory process.\"\n\n2. Document [3] mentions: \"The receiving party may make disclosures required by court order, provided the receiving party uses reasonable efforts to limit disclosure and to obtain confidential treatment or a protective order and has allowed the non-disclosing party a reasonable opportunity to participate in the proceeding.\"\n\n3. Document [4] includes: \"The receiving party retains the right to disclose the Confidential Information pursuant to the requirements of a governmental agency or operation of law.\"\n\nThese clauses collectively indicate that both parties are permitted to disclose Confidential Information if it is required by law or by a governmental authority. This is a common exception in confidentiality agreements to ensure compliance with legal obligations. \n\nThe other options (A, B, and C) are not supported by the documents as permissible circumstances for disclosure. Specifically, marketing purposes (A) are not mentioned, agreement terms (B) are not specified as a condition for disclosure, and mutual written agreement (C) is not highlighted as a necessary condition for disclosure in the context of legal or governmental requirements.",
    "latency_ms": 2765.27,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_129",
    "question": "What is the required procedure for managing user IDs and passwords according to the Aetna Life Insurance Company Addendum?",
    "options": {
      "A": "Passwords must be shared among users for efficiency.",
      "B": "Usernames must be disabled or deleted within 24 hours of employee termination.",
      "C": "Passwords must be changed every 30 days.",
      "D": "Passwords must consist solely of dictionary words."
    },
    "correct_answer": "B",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The context provided does not include specific information from the Aetna Life Insurance Company Addendum regarding the management of user IDs and passwords. Instead, it includes details from other documents related to access control and password policies, such as those from Humana and Lorica Health. \n\nHowever, based on the information from these documents, none of the options provided (A, B, C, or D) align with the described password policies. For example:\n\n- Option A: Passwords must be shared among users for efficiency. This is contrary to the best practices mentioned, which emphasize unique usernames and passwords for each user.\n- Option B: Usernames must be disabled or deleted within 24 hours of employee termination. While immediate termination of access is mentioned, the specific timeframe of 24 hours is not stated.\n- Option C: Passwords must be changed every 30 days. The documents mention a 90-day expiration period for passwords, not 30 days.\n- Option D: Passwords must consist solely of dictionary words. This contradicts the requirement that passwords should not contain words commonly found in a dictionary.\n\nTherefore, none of the options accurately reflect the password management procedures described in the context provided. The correct answer cannot be determined from the given information, as the specific requirements from the Aetna Life Insurance Company Addendum are not included.",
    "latency_ms": 2355.15,
    "client": "Aetna Life Insurance Company",
    "document_type": "Addendum",
    "method": "RAG"
  },
  {
    "id": "qa_130",
    "question": "What is the required timeframe to correct data extract problems according to the State-approved System Deficiency and Notification Process?",
    "options": {
      "A": "Within 10 business days",
      "B": "Within 5 business days",
      "C": "Within 3 business days",
      "D": "Within 1 business day"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Within 5 business days.\n\nReasoning: According to the document [1] (Accenture - Cotiviti SubK Agmt), it states under AHC 16: \"Correct all data extract problems within five (5) business days of problem identification and notify the State of correction.\" This clearly specifies that the required timeframe to correct data extract problems is within five business days, aligning with option B.",
    "latency_ms": 1404.49,
    "client": "Accenture",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_131",
    "question": "Under the agreement, what is the Business Associate allowed to do with de-identified Protected Health Information?",
    "options": {
      "A": "Use it for internal training purposes only",
      "B": "De-identify it and then store it indefinitely without further use",
      "C": "Use it to enrich current services and create new offerings",
      "D": "Use it solely for data aggregation services to the Covered Entity"
    },
    "correct_answer": "C",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The context provided does not explicitly mention what the Business Associate is allowed to do with de-identified Protected Health Information. The documents focus on the handling of Protected Health Information (PHI) in terms of retention, return, destruction, and safeguarding, but they do not specifically address the use of de-identified PHI.\n\nThe documents outline requirements for the Business Associate to:\n\n1. Return or destroy PHI when it is no longer needed for management, administration, or legal responsibilities.\n2. Use appropriate safeguards to prevent unauthorized use or disclosure of PHI.\n3. Not use or disclose PHI except for purposes for which it was retained, under conditions set prior to termination.\n\nHowever, there is no mention of de-identification processes or permissions related to de-identified PHI. Therefore, none of the options (A, B, C, or D) can be selected based on the provided context, as the specific use of de-identified PHI is not addressed.\n\nAnswer: The context does not provide information on the use of de-identified Protected Health Information, so none of the options (A, B, C, or D) can be selected.",
    "latency_ms": 2606.3,
    "client": "Community First Health Plans",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_133",
    "question": "What encryption standard must be used for workstations and laptops processing Company PHI according to the Aetna Life Insurance Company Addendum?",
    "options": {
      "A": "SHA-256",
      "B": "DES 56 bit",
      "C": "RSA 1024 bit",
      "D": "FIPS 140-2 certified algorithm 128 bit or higher"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: FIPS 140-2 certified algorithm 128 bit or higher\n\nThe Aetna Life Insurance Company Addendum explicitly states that all workstations and laptops that process and/or store Company PHI must be encrypted using a FIPS 140-2 certified algorithm which is 128 bit or higher, such as Advanced Encryption Standard (AES). This requirement is clearly outlined in the document, ensuring that the encryption solution must be full disk unless approved by the Company. Therefore, the correct answer is option D.",
    "latency_ms": 1435.04,
    "client": "Aetna Life Insurance Company",
    "document_type": "Addendum",
    "method": "RAG"
  },
  {
    "id": "qa_134",
    "question": "What is the governing law for this Agreement according to the document?",
    "options": {
      "A": "The laws of the State of New York",
      "B": "The laws of the State of Delaware",
      "C": "Federal laws of the United States",
      "D": "The laws of the State of California"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: The laws of the State of Delaware.\n\nReasoning:\n\nThe document explicitly states in multiple instances that the governing law for the agreements is the laws of the State of Delaware. For example:\n\n1. In document [1], it is stated: \"This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware applicable to agreements made and to be performed within the State of Delaware.\"\n\n2. Document [2] also mentions: \"shall be construed according to the laws of the state of Delaware, USA, without giving effect to its conflict of laws provisions.\"\n\n3. Document [5] states: \"This Agreement shall be governed by the laws of the State of Delaware, without regard to its principles of conflicts of laws.\"\n\nThese references clearly indicate that the governing law for the agreements in question is the laws of the State of Delaware. Other options, such as the laws of the State of New York, Federal laws of the United States, or the laws of the State of California, are mentioned in different contexts or documents but do not apply to the governing law of the agreements referenced in the question.",
    "latency_ms": 2439.47,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_136",
    "question": "What restriction is placed on the Licensee regarding product development during and after the term of the Agreement?",
    "options": {
      "A": "Licensee is restricted from developing similar products for two years after the Agreement.",
      "B": "Licensee may develop similar products at any time.",
      "C": "Licensee may hire third parties to develop similar products during the term of the Agreement.",
      "D": "Licensee is restricted from developing similar products for one year after the termination of the Agreement."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Licensee is restricted from developing similar products for one year after the termination of the Agreement.\n\nReasoning:\n\nThe document explicitly states in section H) Non-Competition that \"Licensee agrees that during the term of this Agreement and for a term of one year subsequent to the termination of this Agreement, Licensee shall not develop or sell a product, or hire any third party to develop a product, with the same or substantially similar functionality to the Licensed Program.\" This clause clearly restricts the Licensee from engaging in the development or sale of similar products both during the term of the Agreement and for one year following its termination. Therefore, option D accurately reflects the restriction placed on the Licensee.",
    "latency_ms": 2970.05,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_137",
    "question": "What happens to the obligations related to trade secrets after the termination of the agreement?",
    "options": {
      "A": "They survive for 5 years",
      "B": "They survive for 1 year",
      "C": "They continue indefinitely as long as the information qualifies as a trade secret",
      "D": "They are void immediately after termination"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: They continue indefinitely as long as the information qualifies as a trade secret.\n\nReasoning:\n\nThe documents consistently state that the obligations related to trade secrets will continue for as long as the information qualifies as a trade secret. This is explicitly mentioned in multiple sections across the provided context:\n\n- In [1], it states, \"Receiving Party\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\"\n- In [2], it similarly states, \"Recipient\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\"\n- The same clause is repeated in [3], [4], and [5], indicating a consistent requirement across different agreements.\n\nTherefore, the obligations related to trade secrets do not have a fixed termination period but rather continue indefinitely, contingent upon the information maintaining its status as a trade secret.",
    "latency_ms": 2024.63,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_138",
    "question": "What are Cotiviti's obligations regarding Client Confidential Information upon termination of the agreement?",
    "options": {
      "A": "Cotiviti has no obligations regarding Confidential Information once the agreement is terminated.",
      "B": "Cotiviti must return or destroy the Confidential Information unless it is not reasonably feasible or desirable to Client.",
      "C": "Cotiviti must immediately destroy all Confidential Information.",
      "D": "Cotiviti can continue to use the Confidential Information indefinitely."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: Cotiviti must return or destroy the Confidential Information unless it is not reasonably feasible or desirable to Client.\n\nReasoning:\n\nThe documents provide clear guidance on Cotiviti's obligations regarding Client Confidential Information upon termination of the agreement. Specifically, Section 9.3 of the MSA states: \"Upon any termination of this Agreement, and except as expressly provided in section 4.3 [Exceptions] and 4.4 [Latent Data] of this Agreement, each party will return to the other party any Confidential Information of such other party which is in its possession.\" Furthermore, if return or destruction is not reasonably feasible or desirable to the Client, Cotiviti warrants that it shall ensure the confidentiality of the Confidential Information and shall not use or disclose any Confidential Information after termination of the Agreement, except as required by applicable law.\n\nThis indicates that Cotiviti has an obligation to either return or destroy the Confidential Information, but there is an allowance for situations where return or destruction is not feasible or desirable. In such cases, Cotiviti must maintain the confidentiality of the information and refrain from using or disclosing it. Therefore, option B accurately reflects Cotiviti's obligations as outlined in the documents.",
    "latency_ms": 2377.9,
    "client": "AxialHealthcare",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_139",
    "question": "What restrictions are placed on the use of Confidential Information by the Vendor and Consultant?",
    "options": {
      "A": "They can only use it for purposes related to the Services.",
      "B": "They can duplicate and modify it freely as long as it is kept secure.",
      "C": "They can share it with anyone as long as it is for business purposes.",
      "D": "They can use it freely for any purpose."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: They can only use it for purposes related to the Services.\n\nReasoning:\n\nThe documents explicitly state several restrictions on the use of Confidential Information by the Vendor and Consultant. According to the clauses provided:\n\n1. **Permitted Uses**: The Vendor and Consultant \"shall not use (deemed to include, but not be limited to, using, exploiting, duplicating, recreating, modifying, decompiling, disassembling, reverse engineering, translating, creating derivative works, adding to a Vendor and/or Consultant database, or disclosing Confidential Information to another person or permitting any other person to do so) Confidential Information except for purposes of the Services\" ([1] and [4]). This clearly restricts the use of Confidential Information solely to activities directly related to providing the Services.\n\n2. **Authorized Personnel**: The use of Confidential Information is limited to \"authorized employees... who have a need to know for purposes of providing the Services\" ([1] and [4]). This further emphasizes that the use is strictly for service-related purposes and only by those who need access to perform their duties.\n\n3. **Compliance with Laws**: The Vendor and Consultant must \"comply with all applicable laws and regulations governing the use and disclosure of information\" ([1] and [4]), including HIPAA, which underscores the importance of using the information only within legal and regulatory boundaries.\n\n4. **Security Measures**: The Vendor and Consultant are required to use \"at least the same degree of care to protect the Confidential Information as is used with Vendor\u2019s or Consultant\u2019s own proprietary and confidential information\" ([1] and [4]), indicating that the information must be handled with utmost care and only for its intended purpose.\n\nThese points collectively confirm that the use of Confidential Information is restricted to purposes related to the Services, making option A the correct choice. Options B, C, and D are incorrect as they suggest broader permissions that are not supported by the document's explicit restrictions.",
    "latency_ms": 3505.96,
    "client": "Boston Benefit Partners",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_140",
    "question": "What must Covered Entity do when there is a change or revocation of an Individual's Authorization regarding PHI?",
    "options": {
      "A": "Do not inform Business Associate at all",
      "B": "Inform Business Associate immediately",
      "C": "Inform Business Associate within a reasonable period of time after becoming aware",
      "D": "Wait until the next quarterly report to inform Business Associate"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Inform Business Associate within a reasonable period of time after becoming aware\n\nReasoning:\n\nThe document explicitly states that the Covered Entity agrees to inform the Business Associate of any change to, or revocation of, an Individual's Authorization to use or disclose PHI \"within a reasonable period of time after Covered Entity becomes aware of such change.\" This requirement is outlined in the context provided, ensuring that the Business Associate is kept informed of any changes that may affect their use or disclosure of PHI. Therefore, option C is the correct answer as it aligns with the specific requirement mentioned in the document.",
    "latency_ms": 1445.37,
    "client": "Sierra Health Plan of Nevada",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_141",
    "question": "What is required for remote computing sessions that involve access to Customer Confidential Information according to the document?",
    "options": {
      "A": "Use of a simple password authentication system",
      "B": "Access via a secure Virtual Private Network (VPN)",
      "C": "Use of unencrypted remote desktop access",
      "D": "Prohibited use of any remote computing sessions"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: Access via a secure Virtual Private Network (VPN)\n\nReasoning:\n\nThe documents explicitly state the requirements for remote computing sessions that involve access to Customer Confidential Information. According to the context provided:\n\n- Document [1] specifies in section 2.11.1 that \"All permitted and authorized remote computing sessions that may entail access to Customer Confidential Information shall only be performed via a secure Virtual Private Network (\u201cVPN\u201d) or other security measure that is appropriate given the type of computer access being employed.\"\n\n- Document [2] reiterates this requirement in section 2.9, stating that remote computing sessions must be performed via a secure VPN or other appropriate security measures.\n\nThese sections clearly mandate the use of a secure VPN for remote computing sessions involving Customer Confidential Information, making option B the correct choice. The documents do not mention using a simple password authentication system (A), unencrypted remote desktop access (C), or prohibiting remote computing sessions entirely (D).",
    "latency_ms": 1822.63,
    "client": "Humana",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_142",
    "question": "What does the License Agreement specify regarding changes to professional service rates?",
    "options": {
      "A": "Rates are only adjusted annually.",
      "B": "Rates can be changed by Licensor with prior notice.",
      "C": "Rates may change without prior notice.",
      "D": "Rates are fixed for the duration of the agreement."
    },
    "correct_answer": "C",
    "predicted_answer": "unknown",
    "is_correct": false,
    "response": "The License Agreement does not explicitly specify how or when changes to professional service rates can occur. The context provided mentions that \"Other programming support, file preparation, training, and consulting services may be contracted for by Licensee separately at the rates indicated in Attachment C, entitled 'Contract Service Rates.'\" However, it does not provide details on whether these rates are fixed, subject to change, or require prior notice for adjustments.\n\nGiven the lack of explicit information regarding changes to the rates, none of the options (A, B, C, or D) can be definitively selected based on the provided context. The document does not state that rates are adjusted annually (A), can be changed with prior notice (B), may change without prior notice (C), or are fixed for the duration of the agreement (D). Therefore, the correct answer cannot be determined from the information given.",
    "latency_ms": 2267.59,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_143",
    "question": "What does the legal document specify about the use of a party\u2019s name or trade names in publicity releases?",
    "options": {
      "A": "They can be used freely without any restrictions.",
      "B": "They can be used as long as the other party is informed.",
      "C": "They can be used if the information is not confidential.",
      "D": "They can be used only after securing the party\u2019s written approval."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: They can be used only after securing the party\u2019s written approval.\n\nThe legal document specifies that neither party has the right to use the name, trade name, or any trademark of the other party in any manner, including advertising, publicity, promotion, marketing, or other similar activities, without the documented consent of the other party. This is explicitly stated in the clause: \"Neither party has a right to, and hereby agrees not to use in any manner, the name, trade name or any trademark of the other party provided that, with the documented consent of the other, either party is allowed to use in advertising, publicity, promotion, marketing, or other similar activity, any name, trade name, trademark, or other designation including any abbreviation, contraction or simulation of the other party.\" Therefore, the correct answer is D, as the use of a party\u2019s name or trade names in publicity releases requires prior written approval.",
    "latency_ms": 1854.42,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_144",
    "question": "Under which jurisdiction is the Agreement governed?",
    "options": {
      "A": "State of California",
      "B": "Federal laws of the United States",
      "C": "State of New York",
      "D": "State of Delaware"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: State of Delaware\n\nExplanation:\n\nThe context provided includes multiple documents, each specifying the governing law for the respective agreements. The majority of the documents explicitly state that the agreements are governed by the laws of the State of Delaware:\n\n1. Document [1] states: \"This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware applicable to agreements made and to be performed within the State of Delaware.\"\n\n2. Document [2] mentions: \"shall be construed according to the laws of the state of Delaware, USA, without giving effect to its conflict of laws provisions.\"\n\n3. Document [4] specifies: \"This Agreement shall be governed by the laws of the State of Delaware, without regard to its principles of conflicts of laws.\"\n\nThese documents clearly indicate that the agreements are governed by Delaware law. Although Document [5] mentions compliance with California laws, it does not specify that the agreement itself is governed by California law, but rather that certain compliance requirements are based on California regulations. Therefore, the correct jurisdiction for the governing law of the agreements in the context provided is the State of Delaware.",
    "latency_ms": 2103.89,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_145",
    "question": "What is the procedure for handling a Force Majeure Event according to the agreement?",
    "options": {
      "A": "The unaffected party must suspend all obligations indefinitely.",
      "B": "Both parties must continue performing their obligations without any changes.",
      "C": "The affected party must immediately terminate the agreement.",
      "D": "The affected party must give notice and attempt to resume performance."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: The affected party must give notice and attempt to resume performance.\n\nReasoning:\n\nThe documents outline a clear procedure for handling a Force Majeure Event. Specifically, they state that if a party is unable to perform its obligations due to a Force Majeure Event, the affected party must \"immediately give notice to the other party and shall do everything commercially reasonable possible to resume performance\" ([3]). This indicates that the affected party is required to notify the other party of the Force Majeure Event and make efforts to continue or resume their obligations as soon as possible.\n\nAdditionally, the documents specify that obligations are suspended upon receipt of such notice, and if the period of nonperformance exceeds a certain duration (e.g., thirty days in [3]), the unaffected party may choose to terminate the agreement. However, the initial step is for the affected party to provide notice and attempt to mitigate the impact of the Force Majeure Event, aligning with option D.",
    "latency_ms": 2902.06,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_146",
    "question": "What type of information is considered \"Confidential Information\" under the agreement?",
    "options": {
      "A": "Trade secrets and methodologies",
      "B": "Information available to the public",
      "C": "Expired or terminated agreements",
      "D": "Information shared orally only"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Trade secrets and methodologies\n\nReasoning:\n\nThe documents provide a comprehensive definition of \"Confidential Information\" which includes various types of proprietary and sensitive information. Specifically, the agreements mention:\n\n1. **Trade Secrets**: Document [2] explicitly includes \"trade secrets\" as part of the definition of Confidential Information. Document [5] also lists \"the Disclosing Party\u2019s trade secrets\" as Confidential Information.\n\n2. **Methodologies**: Document [2] includes \"methodologies\" in the list of what constitutes Confidential Information.\n\nAdditionally, the agreements cover a wide range of other types of information that are considered confidential, such as business plans, pricing information, technical documentation, and intellectual property. These are all elements that derive economic value from not being generally known and are protected under the confidentiality clauses.\n\nThe agreements also specify exclusions to what is considered Confidential Information, such as information that is publicly available, known prior to disclosure, or independently developed without violating confidentiality agreements. However, these exclusions do not negate the inclusion of trade secrets and methodologies as confidential.\n\nTherefore, option A is correct because trade secrets and methodologies are explicitly mentioned as types of Confidential Information in the agreements.",
    "latency_ms": 2052.27,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_147",
    "question": "What are the requirements for a Business Associate regarding the use or disclosure of Protected Health Information (PHI) under the Agreement?",
    "options": {
      "A": "Use or disclose PHI only with the consent of the individuals involved",
      "B": "Use or disclose PHI as desired",
      "C": "Use or disclose PHI only as permitted or required by the Agreement or as Required by Law",
      "D": "Use or disclose PHI without any safeguards"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Use or disclose PHI only as permitted or required by the Agreement or as Required by Law\n\nReasoning:\n\nThe documents provide clear guidance on the requirements for a Business Associate regarding the use or disclosure of Protected Health Information (PHI). Specifically, the Business Associate is allowed to use or disclose PHI only in ways that are consistent with HIPAA and as permitted or required by the Agreement or as Required by Law. This is explicitly stated in multiple sections:\n\n1. Document [1] states, \"Business Associate may request, use, or disclose PHI only in a manner that is consistent with HIPAA, and only as permitted or required by this agreement or an Underlying Agreement.\"\n\n2. Document [2] reiterates that PHI may be used or disclosed \"to perform functions, activities, or services for or on behalf of BCBSNE, as specified in the Services Agreement,\" and \"as required by law.\"\n\n3. Document [4] emphasizes that the Business Associate agrees \"not to use or disclose Protected Health Information (PHI) other than as permitted or required by this Agreement or as required by law.\"\n\n4. Document [5] further clarifies that the Business Associate may \"use and disclose PHI as permitted or required by this BAA, the Agreement, as Required by Law, or as directed by Covered Entity or Client.\"\n\nThese documents collectively establish that the use or disclosure of PHI by a Business Associate must adhere to the stipulations of the Agreement and legal requirements, ensuring compliance with privacy regulations. Therefore, option C is the correct answer.",
    "latency_ms": 2906.84,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_148",
    "question": "Which type of visits were added to the advanced illness exclusion according to the legal document?",
    "options": {
      "A": "Telephone visits only",
      "B": "In-person visits only",
      "C": "Telephone visits, e-visits, and virtual check-ins",
      "D": "E-visits and virtual check-ins only"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Telephone visits, e-visits, and virtual check-ins\n\nReasoning: The documents explicitly state that telephone visits, e-visits, and virtual check-ins were added to the advanced illness exclusion across multiple sections. For example, in [1], it mentions, \"Added telephone visits, e-visits and virtual check-ins to the advanced illness exclusion\" for several categories such as Osteoporosis Management in Women Who Had a Fracture, Persistence of Beta-Blocker Treatment After a Heart Attack, and Adherence to Antipsychotic Medications for Individuals with Schizophrenia. Similarly, in [2], the same types of visits are added to the advanced illness exclusion for categories like Breast Cancer Screening and Controlling for High Blood Pressure. This consistent inclusion across various sections confirms that the correct answer is option C.",
    "latency_ms": 1730.72,
    "client": "Martin's Point Health Care",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_149",
    "question": "What measure must the Vendor implement to prevent Customer Information leakage when dealing with email and messaging systems?",
    "options": {
      "A": "Encrypt all email communications",
      "B": "Use only technical security controls",
      "C": "Employ a combination of policy, awareness, procedural, and technical security controls",
      "D": "Block all outbound emails"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Employ a combination of policy, awareness, procedural, and technical security controls.\n\nReasoning:\n\nThe document explicitly states that the Vendor must \"protect email and messaging systems by a combination of policy, awareness, procedural and technical security controls\" to prevent Customer Information leakage. This requirement is clearly outlined in the context provided, indicating that a multifaceted approach involving various types of controls is necessary to secure email and messaging systems effectively. \n\nThis option (C) is the only one that aligns with the specific guidance given in the document. Options A, B, and D do not capture the comprehensive approach required, as they focus on singular methods or actions that are not sufficient on their own according to the document's stipulations.",
    "latency_ms": 1963.45,
    "client": "AIA Health Insurance Pty Ltd",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_151",
    "question": "What is the definition of \"Latent Data\" according to the legal document?",
    "options": {
      "A": "Data stored in easily accessible formats for routine use",
      "B": "Data that is routinely shared between parties in discussions",
      "C": "Data stored on routine backup media, considered inaccessible without specialized tools",
      "D": "Data that can be retrieved by anyone using standard tools"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Data stored on routine backup media, considered inaccessible without specialized tools.\n\nReasoning:\n\nThe definition of \"Latent Data\" is consistently described across multiple sections of the provided context. Specifically, \"Latent Data\" refers to data stored by a party on routine backup media, including deleted files, non-logical data types, memory dumps, swap files, temporary files, printer spool files, and metadata. This data can customarily be retrieved only by computer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. This definition is explicitly stated in sections [1], [2], [3], [4], and [5] of the context. \n\nFor example, section [1] states: \"\u2018Latent Data\u2019 refers to data that is stored by a party on routine back-up media, including but not limited to deleted files and other non-logical data types, memory dumps, swap files, temporary files, printer spool files and metadata that can customarily be retrieved only by computer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques.\"\n\nTherefore, option C accurately captures the definition of \"Latent Data\" as described in the legal document.",
    "latency_ms": 2405.85,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_153",
    "question": "What is the definition of \"Latent Data\" according to the legal document?",
    "options": {
      "A": "Data that is readily accessible and can be easily retrieved without specialized tools.",
      "B": "Data stored on routine backup media that can only be retrieved by computer forensics experts.",
      "C": "Data that is publicly available and does not require permission to disclose.",
      "D": "Data that is intentionally hidden and cannot be retrieved by any means."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Data stored on routine backup media that can only be retrieved by computer forensics experts.\n\nReasoning:\n\nThe definition of \"Latent Data\" is consistently described across the provided context as data that is stored by a party on routine backup media, including deleted files and other non-logical data types, memory dumps, swap files, temporary files, printer spool files, and metadata. It is specifically noted that this data can customarily be retrieved only by computer forensics experts and is generally considered inaccessible without the use of specialized tools and techniques. This aligns with option B, which accurately captures the essence of the definition provided in the documents. \n\nThe other options do not fit the definition:\n- Option A is incorrect because the data is not readily accessible and requires specialized tools.\n- Option C is incorrect because the data is not publicly available and is considered Confidential Information.\n- Option D is incorrect because the data can be retrieved by computer forensics experts using specialized tools, so it is not entirely irretrievable.",
    "latency_ms": 2909.84,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_154",
    "question": "Under the agreement, what is one permitted use of Confidential Information?",
    "options": {
      "A": "To publicly disclose for marketing purposes",
      "B": "To perform services for authorized third parties under the Primary Agreement in accordance with applicable law",
      "C": "To share with competitors",
      "D": "To sell to third parties for profit"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: To perform services for authorized third parties under the Primary Agreement in accordance with applicable law.\n\nReasoning:\n\nThe documents consistently outline that Confidential Information can be used for purposes related to fulfilling obligations under the agreement. Specifically:\n\n1. Document [1] states that COMPANY Personnel may use Humana Confidential Information necessary to meet obligations under the Agreement, restricted by state rules, laws, and regulations.\n\n2. Document [3] mentions that each party shall use the other party\u2019s Confidential Information only for the Purpose set forth in the agreement or as otherwise permitted under the agreement.\n\n3. Document [4] specifies that Confidential Information is to be used only for the purposes of carrying out the agreement.\n\n4. Document [5] indicates that Confidential Information should be used for purposes related to the services and fulfilling obligations or exercising rights under the agreement.\n\nThese clauses collectively suggest that the permitted use of Confidential Information is to perform services as outlined in the agreement, which may involve authorized third parties, provided it complies with applicable laws. This aligns with option B, making it the correct choice. \n\nOptions A, C, and D are not supported by the documents, as they explicitly restrict public disclosure, sharing with competitors, and selling for profit without prior written consent or authorization.",
    "latency_ms": 2333.71,
    "client": "Blue Shield of California",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_155",
    "question": "What is the permitted use of Confidential Information according to the NDA?",
    "options": {
      "A": "For marketing purposes",
      "B": "To develop new products independently",
      "C": "For any business purpose",
      "D": "To evaluate a business relationship with the disclosing party"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: To evaluate a business relationship with the disclosing party.\n\nReasoning:\n\nThe context provided from the NDA documents outlines the definition and handling of \"Confidential Information.\" Specifically, the documents describe \"Confidential Information\" as information related to the business of the Disclosing Party, which is shared with the Nondisclosing Party for the purpose of evaluating a potential business relationship. This is evident from the language used in the documents, which frequently refers to the information being related to the \"Potential Transaction\" or the \"business of the Disclosing Party.\"\n\nThe documents do not mention using the Confidential Information for marketing purposes (A), developing new products independently (B), or for any business purpose (C). Instead, the focus is on maintaining confidentiality and using the information strictly for evaluating the business relationship, as indicated by the repeated emphasis on the context of a \"Potential Transaction\" and the need to preserve confidentiality.\n\nTherefore, the permitted use of Confidential Information according to the NDA is to evaluate a business relationship with the disclosing party, making option D the correct choice.",
    "latency_ms": 3007.88,
    "client": "Advise Insurance",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_156",
    "question": "What is the Vendor\u2019s recovery time objective (RTO) for software product authorization codes and Vendor\u2019s standard software technical support?",
    "options": {
      "A": "24 hours",
      "B": "48 hours",
      "C": "72 hours",
      "D": "12 hours"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: 24 hours.\n\nReasoning:\n\nThe Vendor's recovery time objective (RTO) for software product authorization codes and Vendor\u2019s standard software technical support is explicitly stated in document [2]. According to section 11.4 of the Lorica Health - Services Agreement, the RTO for these specific functions is \"24 hours for software product authorization codes and Vendor\u2019s standard software technical support.\" This provides clear guidance on the expected recovery time for these critical business functions in the event of a disaster.",
    "latency_ms": 1380.63,
    "client": "AIA Health Insurance Pty Ltd",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_157",
    "question": "What rights do individuals have concerning their protected health information under the BAA?",
    "options": {
      "A": "The right to obtain a copy of their information in an electronic format",
      "B": "The right to delete their information permanently",
      "C": "The right to financial compensation for their information",
      "D": "The right to prevent any disclosure of their information"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: The right to obtain a copy of their information in an electronic format.\n\nReasoning:\n\nThe documents explicitly state that under the BAA, individuals have the right to obtain a copy of their information in an electronic format. This is clearly mentioned in multiple sections across the provided context:\n\n- \"Individuals' rights to obtain a copy of the individual's information in an electronic format;\" (as seen in [1], [2], [3], [4], and [5]).\n\nThe other options (B, C, and D) are not supported by the text:\n\n- B: The right to delete their information permanently is not mentioned in the documents.\n- C: The right to financial compensation for their information is not mentioned; in fact, [1] states, \"The Receiving Party shall not be obligated to compensate the Disclosing Party for Confidential Information.\"\n- D: The right to prevent any disclosure of their information is not mentioned; instead, the documents focus on rights related to obtaining and transmitting information, auditing, monitoring, and reporting breaches.\n\nTherefore, option A is the only correct choice based on the explicit information provided in the documents.",
    "latency_ms": 1991.59,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_158",
    "question": "What should the Receiving Party do when required by law to disclose Confidential Information?",
    "options": {
      "A": "Ignore the subpoena or order and maintain confidentiality at all costs.",
      "B": "Disclose the information immediately without notifying the Disclosing Party.",
      "C": "Notify the Disclosing Party and seek protective orders or relief.",
      "D": "Disclose the information without seeking the highest level of confidentiality."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Notify the Disclosing Party and seek protective orders or relief.\n\nReasoning:\n\nThe documents consistently outline the procedure that the Receiving Party must follow when required by law to disclose Confidential Information. Specifically, the Receiving Party is obligated to:\n\n1. **Provide Written Notice**: The Receiving Party must first give written notice of the legal requirement to the Disclosing Party. This is explicitly stated in multiple documents, such as in [3], [4], and [5], where it mentions, \"The Receiving Party will first give written notice of such requirement to the Disclosing Party.\"\n\n2. **Permit Intervention**: The Receiving Party must allow the Disclosing Party to intervene in any relevant proceedings to protect its interests in the Confidential Information. This is mentioned in [3], [4], and [5], where it states, \"will permit the Disclosing Party to intervene in any relevant proceedings to protect its interests.\"\n\n3. **Cooperate and Assist**: The Receiving Party must provide full cooperation and assistance to the Disclosing Party in seeking to obtain protection for the Confidential Information. This is highlighted in [3], [4], and [5], where it says, \"provide full cooperation and assistance to the Disclosing Party in seeking to obtain such protection.\"\n\n4. **Seek Protective Orders or Remedies**: The Receiving Party should assist the Disclosing Party in seeking protective orders or other remedies to ensure the Confidential Information receives confidential treatment. This is detailed in [2], where it states, \"cooperate with the Disclosing Party to obtain such protective order or other remedy.\"\n\nThese steps are designed to ensure that the Confidential Information is disclosed only to the extent legally required and with the highest level of confidentiality possible. Therefore, option C is the correct choice as it aligns with the actionable guidance provided in the documents.",
    "latency_ms": 3879.86,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_159",
    "question": "Under the agreement between Blue Shield of California and the Consultant, what are permissible uses of Confidential Information?",
    "options": {
      "A": "Only for internal management purposes",
      "B": "For commercial purposes unrelated to the Primary Agreement",
      "C": "For de-identifying Personal Information in accordance with Business Associate Agreements",
      "D": "For disclosure to unauthorized third parties"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: For de-identifying Personal Information in accordance with Business Associate Agreements.\n\nReasoning:\n\nThe agreement between Blue Shield of California and the Consultant outlines specific permissible uses of Confidential Information, which includes Personal Information. According to the context provided:\n\n1. **Permitted Uses and Disclosures**: The Business Associate (Consultant) is allowed to use and disclose Personal and Health Information as necessary to perform its obligations under the Agreement, for its proper management and administration, or to carry out its legal responsibilities. This includes ensuring that any third party to whom the information is disclosed agrees to implement reasonable safeguards and maintain confidentiality (as per [5]).\n\n2. **Prohibition on Unauthorized Use or Disclosure**: The agreement explicitly prohibits unauthorized use or disclosure of Confidential Information ([5]).\n\n3. **Confidential Information Restrictions**: The agreement restricts the use of Confidential Information to the stated Purpose and prohibits its use for commercial purposes unrelated to the agreement, reverse engineering, or disclosure to unauthorized third parties ([4]).\n\n4. **De-identification**: While the context does not explicitly mention de-identification, the permissible uses and the requirement for reasonable safeguards imply that de-identifying Personal Information in accordance with Business Associate Agreements is a permissible use, as it aligns with maintaining confidentiality and legal compliance.\n\nTherefore, option C is the most appropriate choice, as it aligns with the permissible uses and the need to maintain confidentiality and legal compliance as outlined in the agreement.",
    "latency_ms": 3117.65,
    "client": "Blue Shield of California",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_160",
    "question": "What is the duration for which the rights and obligations that accrue prior to the termination of the NDA survive?",
    "options": {
      "A": "Indefinitely",
      "B": "5 years",
      "C": "1 year",
      "D": "2 years"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: 5 years.\n\nReasoning:\n\nThe documents provide explicit information regarding the duration for which the rights and obligations that accrue prior to the termination of the NDA survive. Specifically:\n\n1. Document [1] states: \"The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this Agreement for a period of five (5) years.\"\n\n2. Document [2] similarly states: \"The rights and obligations accruing prior to termination as set forth herein shall survive the termination of this Agreement for a period of five (5) years.\"\n\n3. Document [3] mentions: \"All obligations to protect the confidentiality of the Confidential Information shall survive for a period of five years from the date of disclosure of the Confidential Information.\"\n\nThese documents consistently indicate a survival period of five years for the rights and obligations related to confidentiality after the termination of the NDA. Therefore, the correct option is B: 5 years. \n\nDocuments [4] and [5] mention a survival period of three years for confidentiality obligations, but they do not specifically address the survival of rights and obligations accruing prior to termination, which is the focus of the question.",
    "latency_ms": 2368.03,
    "client": "ATRIO Health Plans",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_161",
    "question": "What is the data sharing requirement for Licensee under the Agreement?",
    "options": {
      "A": "Licensee is not required to provide any data.",
      "B": "Licensee must provide claims and enrollment data monthly.",
      "C": "Licensee must provide claims and enrollment data semi-annually.",
      "D": "Licensee must provide claims and enrollment data annually."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "C: Licensee must provide claims and enrollment data semi-annually.\n\nReasoning: The document explicitly states that the Licensee agrees to provide its claims and enrollment data to the Licensor on at least a semi-annual basis. This requirement is in accordance with HIPAA requirements, and the data must be provided in the format specified in Exhibit E. The document does not mention monthly or annual data provision, nor does it state that the Licensee is not required to provide any data. Therefore, the correct answer is C.",
    "latency_ms": 1635.61,
    "client": "Capital Health Plan, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_162",
    "question": "What must the Receiving Party do with Confidential Information upon termination of the NDA with AdvantMed?",
    "options": {
      "A": "Retain all copies of Confidential Information indefinitely.",
      "B": "Deliver all documents and materials to a third party for safekeeping.",
      "C": "Destroy or deliver all documents and materials, retaining a single archival copy for dispute resolution purposes.",
      "D": "Destroy all copies, including the archival copy."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Destroy or deliver all documents and materials, retaining a single archival copy for dispute resolution purposes.\n\nReasoning:\n\nThe document [2] explicitly states the actions required of the Receiving Party upon termination of the NDA with AdvantMed. It specifies that the Receiving Party must \"destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party.\" However, it allows for the retention of \"a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\" \n\nThis clause provides clear guidance that while all other copies must be destroyed or returned, one archival copy can be kept specifically for legal purposes related to dispute resolution. Therefore, option C is the correct answer, as it aligns with the specific requirements and permissions outlined in the document.",
    "latency_ms": 1854.16,
    "client": "AdvantMed",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_164",
    "question": "Under what circumstances does this NDA become inoperative regarding Confidential Information?",
    "options": {
      "A": "When the information is independently developed by personnel who have had access to the Disclosing Party\u2019s Confidential Information.",
      "B": "When the information becomes generally available to the public through no fault of the Nondisclosing Party.",
      "C": "When the information becomes available on a non-confidential basis from a source bound by a confidentiality agreement.",
      "D": "When the information is disclosed by the Nondisclosing Party to the public."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: When the information becomes generally available to the public through no fault of the Nondisclosing Party.\n\nReasoning:\n\nThe NDA documents consistently state that the agreement becomes inoperative regarding portions of the Confidential Information that are or become generally available to the public, other than as a result of a disclosure by the Nondisclosing Party or its Representatives. This is explicitly mentioned in the following documents:\n\n1. Document [1] states: \"This Agreement shall be inoperative as to such portions of the Confidential Information that: (i) are or become generally available to the public, other than as a result of a disclosure by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives.\"\n\n2. Document [2] similarly states: \"Notwithstanding the foregoing, information shall not be considered Confidential Information if (ii) the information is or comes to be generally available within the public domain other than as a result of a breach of this Agreement.\"\n\n3. Document [3] and [5] both state: \"The term 'Confidential Information' does not include information which (i) is or becomes generally available to the public other than as a result of disclosure by Recipient in breach of this Agreement.\"\n\nThese clauses clearly indicate that the NDA becomes inoperative when the information becomes publicly available through no fault of the Nondisclosing Party, aligning with option B. \n\nOption A is incorrect because the NDA becomes inoperative when information is independently developed by personnel who have not had access to the Disclosing Party\u2019s Confidential Information, not those who have had access.\n\nOption C is incorrect because the NDA remains operative if the information is received from a source bound by a confidentiality agreement.\n\nOption D is incorrect because the NDA does not become inoperative when the information is disclosed by the Nondisclosing Party to the public; rather, it remains operative and such disclosure would likely be a breach of the agreement.",
    "latency_ms": 3378.56,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_166",
    "question": "Which of the following is NOT considered an exception to the definition of \"Confidential Information\" under the agreement?",
    "options": {
      "A": "Information that becomes publicly known through no breach of the agreement.",
      "B": "Information already known by the Receiving Party at the time of disclosure.",
      "C": "Personal information of customers and employees.",
      "D": "Information independently developed by the Receiving Party without reference to Confidential Information."
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is C: Personal information of customers and employees.\n\nReasoning:\n\nThe documents provided outline several exceptions to the definition of \"Confidential Information\" across different agreements. These exceptions generally include:\n\nA: Information that becomes publicly known through no breach of the agreement. This is explicitly mentioned in multiple documents, such as [1], [2], [3], and [5], where information in the public domain through no fault of the Receiving Party is not considered confidential.\n\nB: Information already known by the Receiving Party at the time of disclosure. This is also a common exception found in documents [1], [2], [3], and [5], where information that was rightfully known to the Receiving Party at the time of disclosure is excluded from being confidential.\n\nD: Information independently developed by the Receiving Party without reference to Confidential Information. This is another standard exception mentioned in documents [1], [2], [3], and [5], where independently developed information is not considered confidential.\n\nC: Personal information of customers and employees is not mentioned as an exception in any of the provided documents. The documents focus on business-related information and do not specifically address personal information of customers and employees as an exception to confidentiality. Therefore, this option does not fit the pattern of exceptions outlined in the agreements. \n\nThus, C is the correct answer as it is not listed as an exception to the definition of \"Confidential Information\" in the agreements provided.",
    "latency_ms": 2794.0,
    "client": "Albertsons Companies, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_167",
    "question": "Under what circumstances can the Recipient disclose Confidential Information according to the document?",
    "options": {
      "A": "When the information becomes generally known by third parties.",
      "B": "If required by law, with prior notification to the Owner.",
      "C": "When the Recipient independently develops the information.",
      "D": "Upon termination of the agreement."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: If required by law, with prior notification to the Owner.\n\nReasoning:\n\nThe documents provide specific circumstances under which the Recipient can disclose Confidential Information. According to the context provided:\n\n1. **Legal Requirement**: The documents state that if the Recipient is \"requested or required by judicial and other regulatory or investigative orders to disclose any of Discloser\u2019s Confidential Information,\" the Recipient must, \"to the extent practicable give Discloser prompt written notice prior to such disclosure (unless such notice is prohibited by law)\" (Document [1]). This aligns with option B, which allows disclosure if required by law, with prior notification to the Owner.\n\n2. **Public Information**: While the documents mention that information can be disclosed if it becomes publicly available without the Recipient\u2019s breach (Document [1]), this is not the same as \"generally known by third parties\" as stated in option A. The document specifies that Personal Data cannot be deemed Public Information.\n\n3. **Independent Development**: The documents allow for the use of information if it is \"independently developed by Recipient without reference to Discloser Confidential Information\" (Document [1]), but this does not permit disclosure of the original Confidential Information, only the use of independently developed information. Thus, option C is not correct in the context of disclosing the original Confidential Information.\n\n4. **Termination of Agreement**: Upon termination, the documents require the return or destruction of Confidential Information, not its disclosure (Document [1]). Therefore, option D is not correct.\n\nTherefore, the correct answer is B, as it directly aligns with the conditions under which disclosure is permissible according to the documents.",
    "latency_ms": 3703.54,
    "client": "The Standard",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_169",
    "question": "What is the legal requirement for handling Evaluation Material after a written request by the Disclosing Party?",
    "options": {
      "A": "Retain all copies indefinitely for archival purposes",
      "B": "Destroy all copies except a single archival copy retained by the legal department for dispute resolution",
      "C": "Make copies available to third parties for analysis before destruction",
      "D": "Return all copies to the Disclosing Party without retaining any copies"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: Destroy all copies except a single archival copy retained by the legal department for dispute resolution.\n\nReasoning:\n\nThe documents provide clear guidance on the handling of Confidential Information after a written request by the Disclosing Party. Specifically, multiple documents outline the requirement to destroy or return all copies of Confidential Information, with the exception of retaining a single archival copy for dispute resolution purposes:\n\n1. Document [1] states: \"the Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\n2. Document [3] similarly states: \"the Receiving Party shall destroy or deliver to Disclosing Party all documents or other materials furnished by Disclosing Party to the Receiving Party constituting or containing Confidential Information, together with all copies thereof, including all electronic and digital copies in the possession of the Receiving Party except a single archival copy that may be retained by the Receiving Party's legal department for dispute resolution purposes only.\"\n\nThese clauses explicitly permit the retention of a single archival copy by the legal department for dispute resolution purposes, while requiring the destruction of all other copies. Therefore, option B is the correct choice based on the explicit requirements stated in the documents.",
    "latency_ms": 2449.69,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_170",
    "question": "What is required of each Party upon termination of the NDA regarding Confidential Information?",
    "options": {
      "A": "Retain all Confidential Information for future reference",
      "B": "Share Confidential Information with all Affiliates",
      "C": "Disclose Confidential Information to legal authorities",
      "D": "Return all Confidential Information to the Disclosing Party and destroy any materials containing it"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: Return all Confidential Information to the Disclosing Party and destroy any materials containing it.\n\nReasoning:\n\nThe context provided in document [5] explicitly states the requirement upon termination of the NDA regarding Confidential Information. It mentions: \"Upon termination of this Agreement or upon request, both parties shall promptly return all documents and other tangible materials representing Confidential Information.\" This indicates that the parties are required to return all Confidential Information to the Disclosing Party. Although the document does not explicitly mention the destruction of materials, the requirement to return all tangible materials implies that the parties should not retain any copies, which typically includes destruction of any remaining materials. Therefore, option D is the most appropriate choice based on the provided information.",
    "latency_ms": 1937.23,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_171",
    "question": "Under the agreement between the Parties, what type of information is excluded from disclosure?",
    "options": {
      "A": "All types of information are included",
      "B": "Trade secrets",
      "C": "Proprietary information",
      "D": "Protected Health Information (PHI)"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Protected Health Information (PHI)\n\nReasoning:\n\nThe agreements explicitly state that information disclosed and received in the course of discussions concerning a Potential Transaction shall not include information defined as Protected Health Information (PHI) under federal regulations at 45 C.F.R. \u00a7 160.103, except insofar as such PHI may have been de-identified within the meaning of regulations at 45 C.F.R. \u00a7 164.514. This is clearly outlined in the documents [1], [2], and [3]. Additionally, document [4] mentions that the parties do not contemplate the release or exchange of PHI as defined by HIPAA, and if PHI is released or exchanged, a business associate agreement in compliance with HIPAA must be entered into. Document [5] also states that when the exchange of PHI is reasonably anticipated, a business associate agreement will be the controlling document. Therefore, PHI is specifically excluded from disclosure unless de-identified or covered by a business associate agreement.",
    "latency_ms": 2338.76,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_173",
    "question": "What is the required action for a Business Associate if it receives a request from an Individual to access their PHI?",
    "options": {
      "A": "Restrict access to the PHI",
      "B": "Provide immediate access to the PHI",
      "C": "Deny the request and notify the Individual",
      "D": "Forward the request to BCBSNE within 5 business days"
    },
    "correct_answer": "D",
    "predicted_answer": "B",
    "is_correct": false,
    "response": "The correct answer is B: Provide immediate access to the PHI.\n\nReasoning:\n\nThe documents provide clear guidance on the actions required by the Business Associate when it receives a request from an Individual to access their PHI. Specifically, document [5] states:\n\n\"Business Associate agrees:   \na. to provide access, at the request of BCBSNE, and in the time and manner designated by BCBSNE, to the PHI in a Designated Record Set, to BCBSNE or, as directed by BCBSNE, to an Individual in order to meet the requirements under 45 CFR 164.524 and, where applicable, the HITECH Act.\"\n\nThis clause indicates that the Business Associate is required to provide access to the PHI in a Designated Record Set to the Individual, as directed by BCBSNE, in order to comply with the requirements of 45 CFR 164.524. The document does not specify any restrictions or conditions that would prevent immediate access, nor does it mention forwarding the request to BCBSNE within a specific timeframe or denying the request. Therefore, the Business Associate must provide access to the PHI as requested.",
    "latency_ms": 2909.48,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_174",
    "question": "What is the duration of the Survival Period for confidential information after the expiration or termination of the NDA?",
    "options": {
      "A": "5 years",
      "B": "3 years",
      "C": "1 year",
      "D": "2 years"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: 3 years\n\nThe documents consistently state that the Survival Period for confidential information after the expiration or termination of the NDA is three years. Specifically, document [1] mentions, \"each Party\u2019s rights and obligations under this Agreement shall survive the expiration or termination of this Agreement for a period of three years from the date of such expiration or termination (the 'Survival Period').\" Similarly, document [3] states, \"The requirement to treat all Confidential Health Information as Confidential Information hereunder shall survive the termination of this Agreement... but in no event less than a period of three (3) years from the date of the Services.\" Document [4] and [5] also confirm this duration, stating, \"The requirement to treat all Data as confidential information hereunder shall survive the termination of this Agreement for a period of three (3) years, or longer, if required by law.\" Therefore, the correct answer is B: 3 years.",
    "latency_ms": 1902.84,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_175",
    "question": "What is the requirement for destroying Confidential Information as per the NDA with ACT.md?",
    "options": {
      "A": "Destroy all Confidential Information within 5 business days upon request",
      "B": "Destroy all Confidential Information within 3 business days upon request",
      "C": "Retain all Confidential Information indefinitely",
      "D": "Destroy only if instructed in a subsequent written agreement"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Destroy all Confidential Information within 5 business days upon request\n\nReasoning:\n\nThe NDA with ACT.md explicitly states that \"At any time upon the request of the Disclosing Party, the Receiving Party shall promptly (and in no event later than five business days after such request) destroy or cause to be destroyed all Confidential Information in the possession or control of the Receiving Party or its Representatives.\" This requirement is clear and actionable, specifying a timeframe of five business days for the destruction of Confidential Information upon request by the Disclosing Party. The document also notes that automatically generated computer back-up or archival copies are exempt from this destruction requirement, provided they are not used further and are protected under the agreement.",
    "latency_ms": 1411.93,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_176",
    "question": "What remedies are available for a breach of the NDA according to the document?",
    "options": {
      "A": "Exclusive remedy of specific performance",
      "B": "No remedies available",
      "C": "Only money damages",
      "D": "Specific performance and/or injunctive relief"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "Answer: D: Specific performance and/or injunctive relief\n\nExplanation:\n\nThe documents consistently state that money damages may not be a sufficient remedy for any breach of the NDA. Instead, they provide that the Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. This remedy is not deemed to be exclusive but is in addition to all other remedies available at law or in equity, including money damages.\n\nFor example, document [1] states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\" Similarly, document [4] mentions: \"The non-breaching party will be entitled to seek specific performance and injunctive or other equitable relief as a remedy for any breach.\"\n\nTherefore, the correct answer is D, as the documents explicitly provide for specific performance and/or injunctive relief as remedies for a breach of the NDA.",
    "latency_ms": 1860.38,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_177",
    "question": "Under what circumstances can either party assign their rights and obligations under the Agreement without prior written consent from the other party?",
    "options": {
      "A": "When the assignment is part of a merger",
      "B": "When the assignment is for a temporary basis",
      "C": "When the assignment is to a successor in ownership of substantially all of the business assets",
      "D": "When the assignment is to a third-party vendor"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "The correct answer is **C: When the assignment is to a successor in ownership of substantially all of the business assets**.\n\nReasoning:\n\nThe documents provide specific clauses that allow assignment without prior written consent under certain conditions. Here are the relevant findings:\n\n1. Document [1] states: \"either party may assign its rights and obligations under the Agreement, in whole or in part, to a parent or Affiliate or in the event of a merger, sale of a business unit, or majority stock ownership.\" This indicates that assignment is permissible without consent in the context of a merger or sale of a business unit.\n\n2. Document [4] specifies: \"either Party, without the prior written approval of the other Party, may assign its rights and obligations hereunder to a successor in ownership of substantially all the assets of the business.\" This directly supports option C, as it allows assignment to a successor in ownership of substantially all business assets without needing prior consent.\n\n3. Document [5] also supports this by stating: \"either Party may assign this Agreement without the written consent of the other Party to a corporation or other business entity succeeding to all or substantially all the assets and business of the assigning Party by merger or purchase.\"\n\nThese clauses collectively confirm that assignment is permissible without prior written consent when it involves a successor in ownership of substantially all business assets, aligning with option C. Options A, B, and D are not supported by the explicit permissions outlined in the documents.",
    "latency_ms": 2580.93,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_178",
    "question": "What does the NDA between Abarca Health LLC and the other party specify regarding product development and marketing?",
    "options": {
      "A": "Each party is free to develop and market new or improved products unless otherwise agreed in writing.",
      "B": "Both parties must disclose all product details to each other.",
      "C": "Both parties are restricted from developing new products.",
      "D": "Neither party can develop or market products without mutual consent."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The context provided does not explicitly mention an NDA between Abarca Health LLC and another party, nor does it specify any terms related to product development and marketing. Therefore, it is not possible to directly answer the question based on the given information. However, I can analyze the provided documents for any relevant clauses or information that might indirectly relate to product development and marketing.\n\n1. **Confidential Information and Restrictions**: The documents primarily focus on the handling of confidential information, including restrictions on disclosure and use. For example, the Receiving Party is prohibited from tampering with, modifying, adapting, translating, reverse engineering, decompiling, disassembling, or creating derivative works based on the Confidential Information ([2]).\n\n2. **Mutual Non-Disclosure Agreement**: The Mutual Non-Disclosure Agreement ([5]) outlines the exchange of confidential information between Cotiviti, Inc. and Abacus Insights, Inc., but does not mention product development or marketing.\n\n3. **Confidentiality Exceptions**: The documents specify exceptions to what constitutes confidential information, such as information that is independently developed or publicly available ([4]).\n\nGiven the focus on confidentiality and the lack of explicit mention of product development or marketing, none of the options directly align with the information provided. However, if we were to infer based on typical NDA clauses, option A might be the most plausible, as NDAs generally do not restrict parties from developing or marketing new products unless specifically agreed upon. \n\nTherefore, the correct answer based on typical NDA practices and the absence of specific restrictions in the provided context would be:\n\n**A: Each party is free to develop and market new or improved products unless otherwise agreed in writing.**\n\nThis answer is inferred from the general nature of NDAs, which typically do not impose restrictions on product development unless explicitly stated.",
    "latency_ms": 3626.63,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_179",
    "question": "How is a notice considered to be received if sent by email according to the MSA with ACA Health Benefits Fund?",
    "options": {
      "A": "Only upon receiving a delivery confirmation",
      "B": "Immediately upon sending",
      "C": "Four hours after sending or upon receiving a delivery confirmation, whichever occurs first",
      "D": "At 9:00 am on the next Business Day if sent after 5:00 pm"
    },
    "correct_answer": "C",
    "predicted_answer": "A",
    "is_correct": false,
    "response": "The context provided does not explicitly mention an MSA with ACA Health Benefits Fund or specific terms related to email notice receipt for such an agreement. However, document [5] outlines how notice is considered received when sent by email. According to document [5], notice sent by email is deemed given only with \"non-automated confirmation of receipt and acknowledgment of e-mail message content by the receiving party.\" Therefore, the correct answer is:\n\nA: Only upon receiving a delivery confirmation\n\nThis is based on the requirement for non-automated confirmation of receipt and acknowledgment of the email message content by the receiving party, as specified in document [5].",
    "latency_ms": 1384.63,
    "client": "ACA Health Benefits Fund",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_180",
    "question": "Under what condition is information NOT considered Confidential Information according to the NDA with AdvantMed?",
    "options": {
      "A": "If it is publicly known due to a breach by the Receiving Party.",
      "B": "If it is known to the Receiving Party before receipt from the Disclosing Party.",
      "C": "If it is disclosed by the Disclosing Party with consent.",
      "D": "If it is independently developed by the Receiving Party."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: If it is known to the Receiving Party before receipt from the Disclosing Party.\n\nReasoning:\n\nThe context provided does not explicitly mention an NDA with AdvantMed, but it does include several clauses from different NDAs that outline conditions under which information is not considered Confidential Information. These clauses are consistent across the documents, and they specify that information is not deemed confidential if:\n\n- It is known to the Receiving Party prior to receipt from the Disclosing Party directly or indirectly from a source other than one having an obligation of confidentiality to the Disclosing Party. This is explicitly stated in document [2] and similarly in documents [3] and [4].\n\nTherefore, option B is correct because it aligns with the common clause found in the NDAs provided, which states that information known to the Receiving Party before receipt from the Disclosing Party is not considered Confidential Information.",
    "latency_ms": 2444.11,
    "client": "AdvantMed",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_181",
    "question": "What remedy may be sought if a party breaches the agreement according to the legal document text?",
    "options": {
      "A": "Money damages only",
      "B": "Mandatory arbitration",
      "C": "Specific performance and/or injunctive relief",
      "D": "Termination of the agreement"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: Specific performance and/or injunctive relief\n\nReasoning:\n\nThe legal document text explicitly states that money damages may not be a sufficient remedy for any breach of the agreement. Instead, the non-breaching party is entitled to seek specific performance and injunctive or other equitable relief as a remedy for any breach. This is clearly outlined in multiple sections of the provided context:\n\n1. In [1], it is stated: \"The parties understand and agree that money damages may not be a sufficient remedy for any breach of this Agreement and that the non-breaching party will be entitled to seek specific performance and injunctive or other equitable relief as a remedy for any breach.\"\n\n2. In [2], [4], and [5], similar language is used: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach.\"\n\nThese sections confirm that specific performance and injunctive relief are available remedies, and they are not deemed exclusive, meaning they are in addition to other remedies available at law or equity, including money damages. However, the emphasis is on specific performance and injunctive relief as primary remedies for breach. Therefore, option C is the correct answer.",
    "latency_ms": 2844.46,
    "client": "Wellth, Inc.",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_182",
    "question": "What does the agreement specify regarding the binding powers and obligations of the parties involved?",
    "options": {
      "A": "Neither party has the power to bind the other to actions or debts.",
      "B": "Each party can bind the other to contracts.",
      "C": "Both parties share profits and liabilities.",
      "D": "The agreement creates a joint venture or partnership."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Neither party has the power to bind the other to actions or debts.\n\nReasoning:\n\nThe agreement explicitly states in section 9, \"Relationship of the Parties,\" that \"Nothing in this Agreement shall be deemed to create, either express or implied, the power in either Party to bind the other.\" This clause clearly indicates that neither party has the authority to obligate the other party to any actions or debts. Furthermore, it specifies that \"Neither Party shall be bound by the actions of the other, shall be liable for the debts of the other, or shall have a right to share in the profits of the other.\" This reinforces the notion that the parties are independent and do not have binding powers over each other.\n\nAdditionally, the agreement clarifies that it is not intended to be a joint venture, partnership, or other formal business organization, and neither party is under any obligation to enter into further agreements with the other party. This further supports the conclusion that option A is correct, as the agreement does not create any binding powers or shared obligations between the parties.",
    "latency_ms": 2564.5,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_183",
    "question": "What is the protocol for handling Latent Data as described in the legal document?",
    "options": {
      "A": "Latent Data can be freely shared with third parties.",
      "B": "Latent Data remains Confidential Information until it is destroyed.",
      "C": "Latent Data must be immediately destroyed upon receipt.",
      "D": "Latent Data is exempt from confidentiality and can be retained indefinitely."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: Latent Data remains Confidential Information until it is destroyed.\n\nReasoning: The documents consistently define \"Latent Data\" as data that is stored on routine backup media and includes types of data such as deleted files, memory dumps, and metadata, which are generally considered inaccessible without specialized tools. The protocol for handling Latent Data, as described in the documents, is that it \"shall be subject to destruction in due course but shall remain Confidential Information of the Disclosing Party until it is destroyed.\" This indicates that Latent Data retains its status as Confidential Information until it is properly destroyed, and there is no mention of it being freely shareable or exempt from confidentiality.",
    "latency_ms": 1735.56,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_184",
    "question": "What does the agreement state about the ownership of Confidential Information?",
    "options": {
      "A": "Confidential Information remains the sole and exclusive property of the Disclosing Party.",
      "B": "Confidential Information is jointly owned by both parties.",
      "C": "Confidential Information is owned by the Receiving Party.",
      "D": "Ownership of Confidential Information is determined by a separate contract."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: Confidential Information remains the sole and exclusive property of the Disclosing Party.\n\nReasoning:\n\nThe agreements consistently state that Confidential Information remains the sole and exclusive property of the Disclosing Party. This is explicitly mentioned in multiple documents:\n\n1. In document [1], it states, \"Confidential Information shall remain the sole and exclusive property of the Disclosing Party.\"\n2. Document [2] similarly states, \"Confidential Information shall remain the sole and exclusive property of the Disclosing Party.\"\n3. Document [3] affirms, \"The Confidential Information is the sole property of the Disclosing Party.\"\n4. Document [5] also confirms, \"All Confidential Information of Disclosing Party will remain the sole and exclusive property of Disclosing Party.\"\n\nThese clauses clearly establish that the ownership of Confidential Information is retained by the Disclosing Party, and no rights, title, or interest are granted to the Receiving Party beyond the limited right to review the information in connection with the purpose of the agreement.",
    "latency_ms": 1997.52,
    "client": "Maryland Physicians Care (MPC)",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_185",
    "question": "What does the Agreement specify about the relationship between the two Parties?",
    "options": {
      "A": "The Agreement establishes a joint venture.",
      "B": "The Agreement explicitly states no formal business organization is created.",
      "C": "The Agreement implies a partnership between the Parties.",
      "D": "The Agreement requires the Parties to share profits."
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: The Agreement explicitly states no formal business organization is created.\n\nReasoning:\n\nThe documents consistently specify that the agreements do not create any formal business organization such as a joint venture, partnership, or agency relationship between the parties. \n\n- Document [1] states, \"Nothing in this Agreement shall be deemed to create, either express or implied, the power in either Party to bind the other... This Agreement is not intended to be a joint venture, partnership or other formal business organization.\"\n- Document [2] mentions, \"This Agreement (a) does not create any agency, partnership or joint venture.\"\n- Document [3] specifies, \"Nothing in this Agreement shall be construed to create (i) a partnership, joint venture or other joint business relationship between the Parties.\"\n- Document [4] states, \"The parties are independent contractors hereunder and nothing in this Agreement shall be construed to imply or create a franchise, joint venture, partnership or principal-agent relationship between the parties.\"\n\nThese clauses clearly indicate that the agreements do not establish any formal business organization, thus supporting option B.",
    "latency_ms": 1933.15,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_186",
    "question": "What is the Receiving Party permitted to do with the Disclosing Party\u2019s Confidential Information according to the NDA?",
    "options": {
      "A": "Use the information solely for exercising rights and performing obligations under the Agreement",
      "B": "Use the information for any business purpose",
      "C": "Share the information freely with unauthorized persons",
      "D": "Disclose the information to a Third Party without permission"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Use the information solely for exercising rights and performing obligations under the Agreement\n\nExplanation:\n\nThe documents consistently emphasize that the Receiving Party is permitted to use the Disclosing Party's Confidential Information solely for specific purposes related to the agreement, such as evaluating, considering, or performing a Potential Transaction. This is evident in several clauses:\n\n1. Document [2] states that Confidential Information \"shall not be used by the Receiving Party or its Representatives in any way other than in connection with a transaction or a Potential Transaction with the other Party\" and \"shall be used solely for the purpose of evaluating, considering, or performing a Potential Transaction.\"\n\n2. Document [5] reiterates that the Confidential Information \"shall not be used by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives, directly or indirectly, for any purpose other than evaluating the Potential Transaction.\"\n\nThese clauses clearly restrict the use of Confidential Information to activities directly related to the agreement, such as evaluating or performing a transaction, which aligns with option A. The other options (B, C, and D) are incorrect because they suggest broader or unauthorized uses that are explicitly prohibited by the NDA.",
    "latency_ms": 2457.29,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_187",
    "question": "Under what circumstances can the Receiving Party disclose the Disclosing Party\u2019s Confidential Information?",
    "options": {
      "A": "When the information is known to the Receiving Party from a source with an obligation of confidentiality",
      "B": "When the information is independently developed by the Receiving Party using the Confidential Information",
      "C": "When required by applicable law, with prior written notice to the Disclosing Party",
      "D": "When required by applicable law, without notifying the Disclosing Party"
    },
    "correct_answer": "C",
    "predicted_answer": "C",
    "is_correct": true,
    "response": "Answer: C: When required by applicable law, with prior written notice to the Disclosing Party\n\nExplanation:\n\nThe documents consistently outline that the Receiving Party may disclose the Disclosing Party\u2019s Confidential Information when required by applicable law, but they must provide prior written notice to the Disclosing Party. This is a common clause found in non-disclosure agreements to ensure that the Disclosing Party has the opportunity to protect its interests, such as by seeking a protective order or other legal remedy to limit the disclosure.\n\nFor instance, in document [1], it states, \"the Receiving Party will first give written notice of such requirement to the Disclosing Party, and will permit the Disclosing Party to intervene in any relevant proceedings to protect its interests in the Confidential Information.\" Similarly, document [3] specifies that \"the Receiving Party will immediately notify the Disclosing Party in writing of any such requirement (and in any event, prior to disclosure of Confidential Information).\"\n\nThese clauses emphasize the necessity of notifying the Disclosing Party before any compelled disclosure, thereby making option C the correct choice. Option D is incorrect because it suggests disclosure without notification, which contradicts the requirements stated in the documents. Options A and B are incorrect as they do not pertain to legal requirements for disclosure but rather to exceptions to what constitutes Confidential Information.",
    "latency_ms": 3249.41,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_188",
    "question": "Under what circumstances can Confidential Information be disclosed according to the agreement?",
    "options": {
      "A": "Under no circumstances",
      "B": "If required by any government authority, law, or to establish rights under the agreement",
      "C": "Only with the explicit consent of the client",
      "D": "Only when both parties agree in writing"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "The correct answer is B: If required by any government authority, law, or to establish rights under the agreement.\n\nReasoning:\n\nThe documents provide several circumstances under which Confidential Information can be disclosed:\n\n1. **Legal and Regulatory Requirements**: Multiple sections across the documents allow for the disclosure of Confidential Information if required by law, regulation, valid court order, or other binding requirements of a competent governmental authority. For instance, document [5] states, \"The Receiving Party may release Confidential Information as required to comply with applicable law, regulation, valid court order, or other binding requirement of a competent governmental authority.\"\n\n2. **Notification and Assistance**: When disclosure is required by law, the Receiving Party is generally required to notify the Disclosing Party, as seen in document [5]: \"where permitted by applicable law: (i) the Receiving Party will immediately notify the Disclosing Party in writing of any such requirement (and in any event, prior to disclosure of Confidential Information).\"\n\n3. **Efforts to Limit Disclosure**: The Receiving Party is also expected to assist the Disclosing Party in attempts to limit or prevent the disclosure, as mentioned in document [5]: \"the Receiving Party provides all reasonable assistance to the Disclosing Party in any attempt by the Disclosing Party to limit or prevent the disclosure of Confidential Information.\"\n\nThese provisions collectively indicate that disclosure is permissible under legal compulsion, aligning with option B. Other options do not fully capture the conditions outlined in the documents.",
    "latency_ms": 4054.61,
    "client": "Blue Cross and Blue Shield of Nebraska",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_189",
    "question": "What types of information are considered \"Confidential Information\" under the NDA with 7-Eleven?",
    "options": {
      "A": "All non-public, proprietary information, regardless of labeling",
      "B": "Only information labeled as confidential",
      "C": "Only product information and customer lists",
      "D": "Only financial and employee information"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: All non-public, proprietary information, regardless of labeling\n\nReasoning:\n\nThe NDA with 7-Eleven defines \"Confidential Information\" broadly to include all confidential, non-public, or proprietary information, whether or not such information is labeled or otherwise identified as confidential. This is explicitly stated in the document:\n\n- \"Confidential Information\" includes information obtained through various means such as documents (written or electronic), observations, inspection of facilities, or discussions with the Disclosing Party or its Representatives.\n- It encompasses analyses, compilations, data studies, or other documents prepared by the Nondisclosing Party or its Representatives containing or based upon any such furnished information.\n- The definition covers a wide range of information types, including but not limited to terms and pricing under agreements, business and marketing plans, financial information, employee and contractor records, business methods, product information, pricing, sales data, supplier and vendor lists, and information about franchisees or licensees.\n\nThe NDA does not restrict \"Confidential Information\" to only labeled information or specific categories like product information or financial data. Therefore, option A is the correct choice, as it captures the comprehensive nature of what is considered confidential under the agreement.",
    "latency_ms": 2127.45,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_190",
    "question": "What is included in the definition of \"Confidential Information\" under the NDA with 7-Eleven?",
    "options": {
      "A": "All information disclosed only after the Effective Date",
      "B": "Non-public business methods and operating procedures",
      "C": "Public information shared between parties",
      "D": "Only information labeled as confidential"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: Non-public business methods and operating procedures\n\nReasoning:\n\nThe definition of \"Confidential Information\" under the NDA with 7-Eleven is comprehensive and includes various types of non-public, proprietary information. According to the document [1], \"Confidential Information\" encompasses all confidential, non-public, or proprietary information, whether or not labeled as confidential. This includes information obtained through documents, observations, inspections, or discussions, and extends to analyses, compilations, data studies, or other documents prepared by the Nondisclosing Party or its Representatives.\n\nSpecifically, the definition includes \"business methods and operating and production procedures\" as part of the confidential information ([1], clause (v)). This confirms that non-public business methods and operating procedures are indeed included in the definition of \"Confidential Information.\"\n\nOption A is incorrect because the definition includes information disclosed before, on, or after the Effective Date. Option C is incorrect because public information is explicitly excluded from the definition of \"Confidential Information.\" Option D is incorrect because the information does not need to be labeled as confidential to be considered \"Confidential Information.\"",
    "latency_ms": 2172.04,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_191",
    "question": "What is the duration for which the obligations regarding the use, protection, disclosure, return, and destruction of Confidential Information survive after the Effective Date?",
    "options": {
      "A": "5 years",
      "B": "2 years",
      "C": "1 year",
      "D": "3 years"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: 3 years.\n\nReasoning:\n\n1. **Document [1]** states that the rights and obligations regarding Confidential Information survive the termination of the agreement, which automatically occurs three years from the Effective Date. This implies that the obligations related to Confidential Information continue for three years after the Effective Date.\n\n2. **Document [2]** explicitly mentions that the receiving Party and its Representatives shall continue to be bound by their obligations under the agreement for a period of three years from the effective date of the agreement, even after the return or destruction of the Confidential Information or any termination of the agreement.\n\n3. **Document [4]** also specifies that each Party\u2019s obligations with respect to each item of the other Party\u2019s Confidential Information will survive for a period of three years following the disclosure of the applicable Confidential Information.\n\nThese documents consistently indicate that the obligations related to Confidential Information survive for three years after the Effective Date, making option D the correct choice.",
    "latency_ms": 1877.99,
    "client": "Ochsner Health System",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_192",
    "question": "What legal obligations must the Business Associate comply with when handling PHI?",
    "options": {
      "A": "Only the HIPAA Security Rule",
      "B": "All applicable requirements of HIPAA Security Rule, HIPAA Privacy Rule, and HITECH Act",
      "C": "Only the HITECH Act",
      "D": "Both the HIPAA Security Rule and the HIPAA Privacy Rule"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: All applicable requirements of HIPAA Security Rule, HIPAA Privacy Rule, and HITECH Act\n\nReasoning:\n\nThe documents provide clear guidance that the Business Associate must comply with all applicable requirements of the HIPAA Security Rule, HIPAA Privacy Rule, and the HITECH Act. Here are the relevant points from the documents:\n\n1. **Compliance with Existing Law**: Document [1] states, \"Business Associate acknowledges and agrees that, as of the effective dates for such provisions, Business Associate shall comply with each provision of HIPAA, the HITECH Act, or other applicable law, that extends a HIPAA requirement to Business Associate.\" This indicates a broad compliance requirement with all applicable laws related to HIPAA and HITECH.\n\n2. **Security Rule Compliance**: Document [2] mentions, \"Business Associate shall comply with the Security Rule to the extent required by HITECH.\" This confirms the obligation to adhere to the Security Rule as part of the HITECH Act requirements.\n\n3. **Amendments and Compliance**: Document [5] discusses the need for amendments to ensure compliance with evolving laws, stating, \"The parties specifically agree to take such action as is necessary to implement the standards and requirements of HIPAA, the HITECH Act, the HIPAA regulations and other applicable laws relating to the security or privacy of PHI.\"\n\nThese points collectively affirm that the Business Associate must comply with all applicable requirements of the HIPAA Security Rule, HIPAA Privacy Rule, and HITECH Act, making option B the correct choice.",
    "latency_ms": 3247.81,
    "client": "Community First Health Plans",
    "document_type": "unknown",
    "method": "RAG"
  },
  {
    "id": "qa_193",
    "question": "What must AdvantMed ensure before requesting records containing sensitive information such as mental health or HIV test results?",
    "options": {
      "A": "Only a general authorization is required.",
      "B": "Authorization from the healthcare provider is sufficient.",
      "C": "No authorization is needed if the records are used for research purposes.",
      "D": "Specific patient consent and compliance with federal and state laws are required."
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "D: Specific patient consent and compliance with federal and state laws are required.\n\nReasoning:\n\nThe context provided does not explicitly mention AdvantMed or the specific requirements for requesting records containing sensitive information such as mental health or HIV test results. However, based on the general principles of handling sensitive health information, specific patient consent and compliance with federal and state laws are typically required. This is consistent with the confidentiality obligations and protections outlined in the documents, particularly those related to HIPAA regulations and the protection of Protected Health Information (PHI).\n\nFor example, the documents mention that \"Protected Health Information shall be protected in accordance with the HIPAA Business Associate Agreement\" and that confidentiality obligations are set forth in accordance with HIPAA regulations. This implies that any sensitive health information, including mental health or HIV test results, would require specific patient consent and adherence to applicable laws to ensure privacy and compliance.\n\nTherefore, option D is the most appropriate choice given the context and standard practices for handling sensitive health information.",
    "latency_ms": 1913.38,
    "client": "AdvantMed",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_194",
    "question": "Under the NDA agreement between Abarca Health LLC and the other party, how can a party legally assign the agreement?",
    "options": {
      "A": "By obtaining prior written consent from the other party.",
      "B": "By either party notifying the other through personal delivery or certified mail.",
      "C": "By either party assigning its rights and obligations without consent.",
      "D": "By mutual verbal agreement between the parties."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "A: By obtaining prior written consent from the other party.\n\nReasoning: The context provided in document [4] specifies that the assignment of rights and liabilities under the agreement requires prior written consent from the non-assigning party. It states, \"this Agreement may not be assigned in whole or in part without the prior written consent of the non-assigning party,\" except under certain conditions such as a merger or acquisition where the successor assumes the obligations. This aligns with option A, which requires obtaining prior written consent from the other party for a legal assignment of the agreement.",
    "latency_ms": 1546.05,
    "client": "Abarca Health LLC",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_195",
    "question": "According to the NDA, under what conditions can the Nondisclosing Party share the Confidential Information?",
    "options": {
      "A": "Only after the Potential Transaction is completed",
      "B": "With any Representative without restrictions",
      "C": "Freely with any third party",
      "D": "With prior written consent of the Disclosing Party"
    },
    "correct_answer": "D",
    "predicted_answer": "D",
    "is_correct": true,
    "response": "The correct answer is D: With prior written consent of the Disclosing Party.\n\nReasoning:\n\nAccording to the NDA, the Nondisclosing Party is restricted from sharing the Confidential Information without the prior written consent of the Disclosing Party. The document explicitly states in section [1] (a) that \"the Confidential Information shall be kept strictly confidential and shall not, without the prior written consent of the Disclosing Party, be disclosed by the Nondisclosing Party or the Nondisclosing Party\u2019s Representatives, in any manner whatsoever, in whole or in part.\" This clause clearly establishes that any disclosure of Confidential Information requires the Disclosing Party's prior written consent, making option D the correct choice.\n\nAdditionally, the NDA outlines that the Nondisclosing Party can only share the Confidential Information with its Representatives who need to know it for evaluating the Potential Transaction and who have agreed in writing to be bound by provisions no less restrictive than those contained in the Agreement. This further supports the requirement for controlled and consented sharing of information, reinforcing that option D is the correct answer.",
    "latency_ms": 2447.33,
    "client": "7-Eleven",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_196",
    "question": "What is the procedure for resolving disputes under the AdvantMed MSA?",
    "options": {
      "A": "Disputes are referred to the Chief Executive Officer of each party",
      "B": "Disputes are resolved by the court within 48 hours",
      "C": "Disputes are resolved by a third-party mediator",
      "D": "Disputes are resolved through arbitration within 15 days"
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The correct answer is A: Disputes are referred to the Chief Executive Officer of each party.\n\nReasoning:\n\nThe procedure for resolving disputes under the AdvantMed MSA is explicitly outlined in the document. According to the context provided, specifically from document [2], section 10.15(a), it states: \"Any dispute arising out of, or relating to this Agreement, not resolved between the parties within fifteen (15) days shall be resolved in accordance with the following procedures. The parties shall refer the dispute to the Chief Executive Officer of each party, who shall have authority to resolve the dispute between the parties.\"\n\nThis clause clearly indicates that the initial step in the dispute resolution process involves referring the matter to the Chief Executive Officers of each party, who are expected to use reasonable efforts to confer and attempt to resolve the dispute. There is no mention of court resolution within 48 hours, third-party mediation, or arbitration within 15 days, making options B, C, and D incorrect.",
    "latency_ms": 2520.21,
    "client": "AdvantMed",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_197",
    "question": "What remedies are available to the Disclosing Party in case of a breach of the NDA?",
    "options": {
      "A": "Specific performance and/or injunctive relief only",
      "B": "Specific performance, injunctive relief, and money damages",
      "C": "No remedies are available",
      "D": "Money damages only"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "Answer: B: Specific performance, injunctive relief, and money damages\n\nReasoning:\n\nThe documents consistently state that the Disclosing Party is entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy a breach of the NDA. This is explicitly mentioned in multiple sections across the documents:\n\n1. Document [1] states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity, including but not limited to money damages.\"\n\n2. Document [2] similarly states: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity, including but not limited to money damages.\"\n\n3. Document [3] reiterates: \"The Disclosing Party shall be entitled to specific performance and/or injunctive relief, either temporary or permanent, as appropriate, to remedy such breach. Such remedy shall not be deemed to be the exclusive remedy for any such breach of this Agreement but shall be in addition to all other remedies available at law or in equity, including but not limited to money damages.\"\n\n4. Document [4] mentions: \"The Receiving Party agrees that the Disclosing Party shall be entitled to temporary or permanent injunctive relief to prevent or discontinue such disclosures without the necessity of proving damages or posting bond.\"\n\n5. Document [5] states: \"Each receiving party agrees that the disclosing party shall be entitled to injunctive relief, specific performance or other equitable relief or any or all of the foregoing, for any breach or threatened breach of this Agreement without the necessity of proving actual damages and without waiving any other remedies otherwise available at law or in equity.\"\n\nThese clauses collectively indicate that the Disclosing Party has access to multiple remedies, including specific performance, injunctive relief, and money damages, making option B the correct answer.",
    "latency_ms": 4064.29,
    "client": "ACT.md",
    "document_type": "NDA",
    "method": "RAG"
  },
  {
    "id": "qa_198",
    "question": "Under the MSA with AdvantMed, what are the conditions under which Confidential Information can be disclosed to Optum Health - CDO?",
    "options": {
      "A": "Only periodic status reports, minimum volume commitment, and fees can be disclosed.",
      "B": "No Confidential Information can be disclosed to Optum Health - CDO.",
      "C": "All Confidential Information can be disclosed with prior written permission.",
      "D": "Only periodic status reports and employee details can be disclosed."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "Answer: A: Only periodic status reports, minimum volume commitment, and fees can be disclosed.\n\nReasoning: According to the MSA with AdvantMed, the Client is permitted to disclose specific types of Confidential Information to the Optum Health \u2013 CDO business segment. The document explicitly states that the Client may disclose \"only the following information: (i) periodic status reports for the services performed under SOW #1, strictly limited to the number of records retrieved by Cotiviti under SOW #1 at a given point in time; (ii) the minimum volume commitment under SOW #1; and (iii) fees set forth in SOW #1.\" This disclosure is contingent upon Optum Health - CDO agreeing to hold such pricing in strict confidence within the business segment and not further disclosing such pricing. Therefore, the correct option is A, as it accurately reflects the specific conditions under which Confidential Information can be disclosed to Optum Health - CDO.",
    "latency_ms": 2323.21,
    "client": "AdvantMed",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_199",
    "question": "Under the AdvantMed MSA, what is a condition for disclosing Confidential Information to third parties?",
    "options": {
      "A": "Disclosure is allowed with the Disclosing Party\u2019s prior written permission.",
      "B": "Disclosure is allowed to anyone as long as it is for the purpose for which it was disclosed.",
      "C": "No conditions apply, free disclosure is allowed.",
      "D": "Disclosure is only allowed to Optum Health-CDO business segment without restrictions."
    },
    "correct_answer": "A",
    "predicted_answer": "A",
    "is_correct": true,
    "response": "The context provided does not explicitly mention an \"AdvantMed MSA\" or any specific conditions related to disclosing Confidential Information under such an agreement. However, based on the general principles outlined in the documents provided, the correct answer would likely be:\n\nA: Disclosure is allowed with the Disclosing Party\u2019s prior written permission.\n\nReasoning:\n\n1. **General Confidentiality Obligations**: Across the documents, there is a consistent requirement that Confidential Information must be kept confidential and not disclosed without prior written consent from the Disclosing Party. For example, document [3] states, \"shall not, without the prior written consent of Disclosing Party, disclose such information to any person for any reason at any time.\"\n\n2. **Restrictions on Disclosure**: Document [1] specifies that disclosure is restricted unless required by law or mutually agreed upon in writing by the parties. Document [5] also emphasizes that Confidential Information should be used exclusively for the Purpose and not disclosed in contravention of the agreement.\n\n3. **Conditions for Disclosure**: The documents generally require that any disclosure to third parties must be under confidentiality agreements that are no less stringent than those in the original agreement, as seen in document [3].\n\nGiven these consistent themes across the documents, option A aligns with the typical conditions for disclosing Confidential Information in such agreements. Options B, C, and D do not reflect the standard practices outlined in the provided context.",
    "latency_ms": 2399.45,
    "client": "AdvantMed",
    "document_type": "MSA",
    "method": "RAG"
  },
  {
    "id": "qa_200",
    "question": "What is the duration for which obligations related to trade secrets survive after the termination of the Agreement?",
    "options": {
      "A": "2 years",
      "B": "For as long as the information qualifies as a trade secret",
      "C": "5 years",
      "D": "1 year"
    },
    "correct_answer": "B",
    "predicted_answer": "B",
    "is_correct": true,
    "response": "B: For as long as the information qualifies as a trade secret\n\nReasoning:\n\nThe documents consistently state that the obligations related to trade secrets will continue for as long as the information qualifies as a trade secret. This is explicitly mentioned in multiple sections across the provided context. For instance, in [1], it states, \"Receiving Party\u2019s obligations respecting Disclosing Party\u2019s 'trade secrets' (as such term is defined in 18 U.S.C. 1839) shall continue for so long as such information qualifies as a trade secret.\" Similar language is found in [2], [3], [4], and [5], reinforcing that the duration is not fixed to a specific number of years but rather depends on the status of the information as a trade secret. Therefore, the correct answer is B.",
    "latency_ms": 1846.62,
    "client": "Crumdale Partners - Better Benefits",
    "document_type": "unknown",
    "method": "RAG"
  }
]